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Abstract 
Bacteria belonging to the genus Aeromonas are ubiquitous water-borne organisms 
that are also present in many foods. Some strains are human gastrointestinal pathogens. 
However, the disease-causing mechanisms of these bacteria are not well understood. 
This is particularly true for intestinal colonisation, which is a critical step in the disease 
process. When this thesis commenced, there was evidence that filamentous surface 
structures (type IV pili) purified from diarrhoea-associated species had an important role 
in colonisation. These pili were designated "bundle-forming pili" (Bfp) because of their 
tendency to form bundles linking bacteria. 
The initial aim of this thesis was to clone the genes encoding Bfp pili from a 
diarrhoeal isolate of Aeromonas veronii biovar sobria (strain BC88). Although 
traditional approaches (transposon mutagenesis, screening of libraries with degenerate 
oligonucleotide probes, DNA probes, and a Bfp antiserum) were unsuccessful at 
achieving this, a small region of a gene encoding the Bfp pilin protein was ultimately 
cloned using a degenerate PCR approach. Moreover, a second type IV pilus gene cluster 
was also cloned from this strain. Characterisation of this newly discovered pilus family 
(designated Tap, for "type IV Aeromonas pilus") was then undertaken. 
The tap gene cluster from A. veronii biovar sobria BC88 was shown to comprise 
four genes that were all transcribed in the same direction. These genes exhibited high 
sequence homology to genes encoded by similar gene clusters, identified by other 
investigators, from strains of A. hydrophila, Vibrio cholerae and V. vulnificus. 
To assess the significance of Tap pili for Aeromonas virulence, the distribution of 
the tap genes was determined in Aeromonas reference strains (including both 
pathogenic and non-pathogenic species), and in a range of clinical and environmental 
isolates of those species most commonly associated with human gastrointestinal disease. 
The tap cluster was present in all Aeromonas strains tested. A defined mutation in tapA 
from A. veronii biovar sobria BC88 was then constructed. Inactivation of this gene did 
not alter the ability of this strain to adhere to epithelial or intestinal cells in vitro, or to 
colonise the intestinal tract of infant mice (colonisation and competition experiments). 
Furthermore, the tapA mutant strain was not attenuated in its ability to cause disease in 
rabbits (removable intestinal tie adult rabbit diarrhoeal model; performed by Dr. M. J. 
Albert, International Center for Diarrheal Disease Research, Dhaka, Bangladesh). 
To investigate the expression and assembly of Tap pili, an antiserum was 
constructed against a recombinant protein produced by overexpression of tapA in 
Escherichia coli. Western blot analysis showed that TapA was expressed. However, Tap 
pili on the cell surface were not seen by immune electron microscopy. (Previous studies 
in our laboratory have demonstrated that Bfp pill are the predominant structures 
expressed on the surface of Aeromonas bacteria during growth in vitro.) 
Hence, this thesis identified a second family of type IV pili in Aeromonas species. 
The function and expression results obtained to date suggest that Tap pili are not as 
significant as Bfp pili for colonisation of the intestinal tract. However, the widespread 
distribution of the tap genes in Aeromonas species, as well as in other bacterial 
pathogens, suggests that they are important for some aspect of the biology of these 
organisms. 
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1.1. Introduction 
Aeromonas bacteria are a major component of the aerobic bacterial population 
in surface water supplies worldwide. It is widely recognised that some species 
(psychrophilic and mesophilic) are major pathogens for salmonid fish. In addition, 
some mesophilic species appear to be able to cause disease in humans. Such diseases 
include severe extraintestinal infections, primarily affecting immuno-compromised 
individuals, in addition to gastrointestinal illnesses, which primarily affect children 
less than 5 years of age, the elderly and the immuno-compromised. There also 
appears to be a species-associated disease spectrum (Table 1.1). Of the 17 species 
currently recognised, only eight are associated with human disease. 
Over recent years, there have been major advances in the understanding of the 
taxonomy and disease mechanisms of this genus, although to date, there is no way to 
recognise definitively whether a particular isolate is pathogenic. Identification to 
species level is probably not sufficient, since it is likely that only a subset of strains 
within a disease-associated species are pathogenic. Therefore, current approaches to 
solve this problem rely on identifying particular bacterial components involved in the 
disease process. To date, numerous toxins and colonisation factors have been 
identified, but none of these are possessed more frequently by strains of clinical 
origin than by strains of environmental origin. Hence, they have not proven very 
useful as markers of pathogenic strains. 
Colonisation of the intestine by diarrhoeal pathogens is an essential part of the 
disease process and is usually mediated, at least in part, by filamentous structures 
termed "pili'. Type IV pili are essential colonisation factors for many bacterial 
pathogens, whether they infect intestinal or extra-intestinal sites. At the 
commencement of this thesis, type IV pili had been purified from several strains of 
Aeromonas species (Hokama et al., 1990; Hokama and Iwanaga, 1992; Iwanaga and 
Hokama, 1992; Kirov and Sanderson, 4996; Nakasone et al., 1996). Although there 
was substantial indirect evidence that type IV pili are major colonisation factors for 
Aeromonas, the genes encoding them had not been cloned and mutation analysis of 
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Table 1.1. Association of Aeromonas species with human disease a 
Species b 	 Disease 
Common clinical association' 
A. hydrophila HG1 
A. caviae HG4 
A. veronii biovar sovria HG8/10 
gastroenteritis 
haemolytic uraemic syndrome d 
septicaemia 
meningitis 
peritonitis 
wound infections 
pneumonia 
gastroenteritis 
septicaemia 
wound infections 
gastroenteritis 
septicaemia 
wound infections 
meningitis 
Less frequent clinical association b 
A. hydrophila HG3 	 gastroenteritis 
septicaemia 
wound infections 
A. veronii biovar veronii HG8/10 	gastroenteritis 
septicaemia 
A. jandaei HG9 	 septicaemia 
cellulitis 
A. schubertii HG12 	 septicaemia 
cellulitis 
A. trota HG14 	 gastroenteritis 
a  Modified from Janda and Abbott (1998). 
HG, hybridisation group (see section 1.2.2). 	• 
Based on frequency of isolation from clinical materials. 
A. hydrophila has been documented as a rare cause of haemolytic uraemic syndrome (see section 
1.4.6). 
function had not been performed. Furthermore, morphological studies indicated that 
there were several different types of pili on Aeromonas species. 
Therefore, the aims of this thesis were to characterise the type IV pili produced 
by Aeromonas bacteria at both the molecular and functional level. The literature 
review to follow will provide essential background information on the taxonomy and 
virulence determinants of Aeromonas species, with particular emphasis on how 
molecular studies are contributing to knowledge that will help identify pathogenic 
strains. The review is divided into three major sections, which discuss the taxonomy, 
toxins and adhesins possessed by members of this genus. 
1.1.1. Background 
Aeromonas bacteria are Gram-negative organisms that are ubiquitous in the 
aquatic environment and, as such, are a common contaminant of foods and water 
supplies. Members of this genus have been shown to cause a variety of diseases 
acquired by ingestion of contaminated food or water, or by infection following some 
form of physical trauma (Table 1.1). There is also a substantial body of evidence 
suggesting that at least some strains are significant enteropathogens. However, the 
association of Aeromonas species with gastrointestinal disease is somewhat more 
controversial since Koch's postulates have not been fulfilled, and the supporting 
evidence is primarily epidemiological. 
Part of this controversy also lies in the fact that no outbreaks caused by a single 
strain of Aeromonas have been documented. Although several smaller food-, and 
water-borne outbreaks have been reported, these have often failed to perform 
essential epidemiological investigations, such as the identification of identical strains 
from the source of infection and from the individual patients stools (Krovacek et al., 
1995). In studies where this type of analysis has been performed, the strains isolated 
from the proposed source of infection and the patient specimens are often different 
(de la Morena et al., 1993; Davin-Regli et al., 1998; Talon etal., 1998). 
Despite such controversies, there is still significant epidemiological data 
implicating some species of Aeromonas as diarrhoeal pathogens. Over the years there 
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have been several large-scale case-control studies on the isolation of Aeromonas 
strains from diarrhoeal and non-diarrhoeal stools. These studies have either 
supported or contradicted the idea that Aeromonas bacteria are enteropathogens. A 
majority of the large scale investigations conducted have shown a statistically higher 
isolation rate of Aeromonas bacteria from diarrhoeal stools when compared to 
asymptomatic stools (Gracey et al., 1982a; Burke et al., 1983; Agger, 1986). 
However, other studies have not found this trend (Figura et al., 1986; Kuijper et al., 
1987; Geiss et al., 1988). 
More intensive epidemiological investigations of Aeromonas bacteria in 
gastrointestinal disease have also been performed. These studies have involved the 
isolation of Aeromonas in pure culture as the sole potential pathogen from infected 
stools, 0-antigen or cytotoxin reactivity in patient acute and convalescent sera, and 
the observation that resolution of disease is accompanied by a disappearance of 
Aeromonas from stool specimens (recently reviewed in Janda and Abbott, 1998). 
Taken together, these observations support the idea that some strains of Aeromonas 
bacteria are enteropathogenic. Of the 17 species currently recognised, only three 
predominate in clinical specimens (Table 1.1). 
The clinical presentation of Aeromonas gastrointestinal disease is diverse. This 
observation probably reflects the immune status of the host as well as the different 
pathogenic mechanisms of the organism involved. Most cases present as a mild, self-
limiting, watery diarrhoea resembling disease caused by enterotoxigenic Escherichia 
coli. Less frequently, they are associated with chronic dysentery and severe invasive 
colitis (Gracey et al., 1982a; Gracey et al., 1982b). In rare instances, diseases 
resembling cholera (Champsaur et al., 1982), and haemolytic uraemic syndrome are 
seen (Bogdanovic etal., 1991; Robson et al., 1992). These rarer diseases may reflect 
the production of a cholera toxin-like enterotoxin (see section 3.1.5.) and possibly 
Shiga-like toxins (see section 3.1.6.), respectively, by the infecting strain. 
Current laboratory-based methods used to identify pathogenic bacteria from 
clinical and environmental sources involve taxonomic classification (usually 
biochemical), which may be followed by the identification of a specific virulence- 
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associated property, such as serotyping 0 antigens, or detection of specific toxins. As 
described above, identification of Aeromonas isolates to species level is not 
sufficient, and since the virulence mechanisms of these bacteria remain undefined, 
further investigation of pathogenic strains is not possible. Therefore, current research 
is focusing on the search for particular combinations of virulence-associated 
properties unique to pathogenic strains. 
Despite limitations, taxonomic identification will still form an essential part of 
the identification of pathogenic Aeromonas bacteria in the clinical laboratory, and in 
laboratory-based investigations into Aeromonas virulence factors. In the following 
section, the taxonomy of the Aeromonas genus will be discussed. 
1.2. Taxonomy 
The taxonomy of the genus Aeromonas is complex, although there have been 
significant advances over recent years, particularly in identification schemes for 
clinical strains. New, simplified biotyping schemes are being developed in an attempt 
to simplify classification of an isolate to a particular species. Currently, the only way 
to assign an isolate definitively is through complex molecular procedures. 
Consequently, a major problem with much research into this genus over the last 15 
years has been the over-simplification of taxonomy and the use of outdated 
classifications in published works. Given that there appears to be a species-associated 
disease spectrum for Aeromonas species (Table 1.1), and that many species have 
unique antibiotic resistance patterns, it is vital to speciate isolates correctly. This is 
particularly true for studies of pathogenesis since it may be that different species 
possess different mechanisms of disease production. 
The last edition of Bergey's Manual of Systematic Bacteriology (published in 
1984) classified the genus Aeromonas within the family Vibrionaceae (Popoff, 
1984). However, in the newest version of this manual, the genus Aeromonas has been 
assigned to a new family (the Aeromonadaceae), based on 16S and 5S rRNA 
sequence analysis as described by Colwell and co-workers (Colwell et al., 1986; 
Amy Carnahan, personal communication). Bergey's manual describes members of 
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this genus as Gram-negative, rod-shaped to coccoid cells. They are facultative 
anaerobes that are both oxidase- and catalase-positive, and able to reduce nitrate to 
nitrite. The mesophilic species are motile by means of a polar flagellum whereas the 
single psychrophilic species (A. salmonicida) is non-motile under standard in vitro 
culture conditions (Popoff, 1984). Some strains also produce peritrichous (lateral) 
flagella as described in section 1.10.1. 
The first major study into the taxonomy of Aeromonas was in 1976, when 
Popoff and Veron applied numerical taxonomy to classify 68 mesophilic strains on 
the basis of 50 variable biochemical, physical and metabolic characters (Popoff and 
Veron, 1976). This study divided these strains into two groups, which the authors 
proposed as two separate species, A. hydrophila (with biovars X1 and X2) and A. 
sobria (biovar Y). 
1.2.2. Molecular studies 
Popoff and colleagues followed up their initial study using DNA:DNA 
hybridisation (Popoff et al., 1981). They then designated three species; A. hydrophila 
(biovar X1 from the numerical taxonomy study), A. caviae (biovar X2) and A. sobria 
(biovar Y). These authors also noted, however, that each of these species could be 
divided into two or three distinct DNA hybridisation groups (HGs; termed 
genospecies, or genomospecies), which could not at that time be separated 
phenotypically (such phenotypic groups are termed phenospecies). Therefore, the A. 
hydrophila phenospecies contained HGs 1 to 3, phenospecies A. caviae contained 
HGs 4 to 6, and phenospecies A. sobria contained HGs 7 and 8. 
Expanding phenotypic typing since this time has led to the naming of the 
majority of these HGs (Allen et al., 1983; Popoff, 1984; Fanning et al., 1985; 
Hickman-Brenner et al., 1987; Hickman-Brenner et al., 1988; Schubert and Hegazi, 
1988; Carnahan et al., 1991a; Carnahan et al., 1991c; Carnahan and Joseph, 1991; 
Martinez-Murcia et al., 1992; Esteve et al., 1995; Huys et al., 1997). Currently there 
are 17 recognised genospecies as indicated in Table 1.2 (A. Carnahan, personal 
communication). 
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Table 1.2. Currently recognised Aeromonas genospecies a 
HG Genospecies Phenospecies Reference 
1 A. hydrophila A. hydrophila Popoff, 1984 
2 A. bestiarum A. hydrophila-like Popoff, 1984 
3 A. salmon icida A. salmonicida 
subspecies salmonicida 
masoucida 
achromogenes 
Popoff, 1984 
3 A. salmonicida A. smithia 
3 Unnamed A. hydrophila 
4 A. caviae A. caviae Popoff, 1984 
5A A. media A. caviae-like 
5B A. media A. media Allen et al., 1983 
6 A. eucrenophila A. eucrenophila Schubert & Hegazi, 1988 
7 A. sobria A. sobria Popoff, 1984 
8 A. veronii A. veronii biovar sobria Hickman-Brenner et al., 
1987 
9 A. jandaei A. jandaei Carnahan & Joseph, 1991; 
Carnahan et al., 1991a 
10 A. veronii A. veronii biovar veronii Fanning et al., 1985 
11 Unnamed Aeromonas spp. Fanning et al., 1985 
(ornithine positive) 
12 A. schubertii A. schubertii Hickman-Brenner et al., 
1988 
13 Aeromonas Group 501 A. schubertii-like Hickman-Brenner et al., 
1988 
14 A. trota A. trota Carnahan et al., 1991b 
15 A. allosaccharophila A. allosaccharophila Martinez-Murcia et al., 1992 
16 A. encheleia A. encheleia Esteve et al., 1995 
17 A. popoffii A. popoffii Huys et al., 1997 
a Taken from A. Carnahan (personal communication). 
1.2.3. Taxonomy of strains associated with gastrointestinal disease 
Genetic studies conducted on large numbers of faecal isolates have shown that 
A. hydrophila HG1, A. caviae HG4 and A. veronii biovar sobria HG8 predominate in 
Aeromonas-associated gastrointestinal disease (Kuijper et al., 1989; Altwegg et al., 
1990; Janda, 1991; Janda and Koldca, 1991). Other species which have been 
associated with human gastroenteritis are A. hydrophila HG3, A. jandaei HG9, A. 
veronii biovar veronii HG10, and A. trota HG14 (Kirov, 1997). 
All Aeromonas strains used in this thesis have been biotyped using the schemes 
of Kirov et al. (1986), based on a small biochemical screen described by Popoff and 
Veron (1976), or the Aerokey II dichotomous key described by Carnahan et al. 
(1991b). Some strains used have also been characterised genetically to genospecies 
level. All strains used in this thesis, their source, and their method of taxonomic 
classification are listed in Appendix 1. 
1.3. Overview of the pathogenic mechanisms of Aeromonas species 
Based upon studies conducted to date, the pathogenesis of gastrointestinal 
disease caused by Aeromonas bacteria appears to be multifactorial, involving a 
variety of adhesive and toxic mechanisms which may, and probably do, vary between 
the different species and individual strains. Potential virulence factors identified to 
date suggest that the majority of pathogenic strains (particularly A. hydrophila and A. 
veronii biovar sobria) cause disease by an adhesive-toxic mechanism resembling the 
pathogenesis of enterotoxigenic Escherichia coli and Vibrio cholerae. However, 
there are likely to be differences in the mechanisms used by these two species as they 
appear to possess different adhesive mechanisms and, indeed, colonise different sites 
of the intestine as determined in a mouse model of colonisation (Sanderson et al., 
1996). A. veronii biovar sobria is more commonly associated with dysenteric illness 
and, therefore, may also be invasive, although there have been very few studies 
investigating Aeromonas invasion. A. caviae strains may act by an alternative 
mechanism resembling enteropathogenic or enteroinvasive E. coli, since the majority 
10 
of strains either do not produce exotoxins under the same conditions as A. veronii 
biovar sobria and A. hydrophila, or they are unable to produce them (Singh and 
Sanyal, 1992b; Wang et al., 1996; Heuzenroeder etal., 1999) A. caviae strains have 
been shown to adhere to, and invade HEp-2 cells (Shaw et al., 1997). 
The underlying problem with the investigation of Aeromonas virulence factors 
involved in the production of gastrointestinal disease is the lack of a suitable animal 
model that reliably reproduces diarrhoeal symptoms. Throughout the remaining 
review several different models of virulence factor characterisation will be described. 
They include models of the fish disease furunculosis, LD 50 assays, and models 
measuring specific virulence mechanisms such as haemolysis of erythrocytes and 
adhesion to cell lines. However, it should be noted that while these methods may be 
suitable for defining putative functions, their relevance to human disease is more 
difficult to establish. Therefore, some care should be taken when interpreting the 
results from many of these studies with respect to the pathogenesis of gastrointestinal 
disease. 
The next section will review Aeromonas virulence determinants studied to date 
with a particular emphasis on how their molecular analysis has contributed to current 
insights in their association with disease. 
1.4. Toxins 
The ability of pathogenic bacteria to exert effects characteristic of their 
particular disease relies on the interplay of one or more virulence factors that damage 
host tissue via a toxic, invasive, or enteropathogenic mechanism. Although 
Aeromonas species have been reported to be invasive, no particular invasin 
molecules have been described which promote this process. Similarly, no cell-contact 
dependent enteropathogenic mechanism has been reported. For this reason, toxic 
mechanisms are the major focus of this review. 
1.4.1. Historical aspects 
Toxins are by far the most widely studied virulence factors of Aeromonas 
species. Many terms have been used to describe these toxins based on their 
functional activity (e.g. cytotoxic, cytotonic, enterotoxic and haemolytic activities), 
and properties (e.g. heat-labile or heat-stable). The early studies on Aeromonas toxins 
were performed with cell-free culture supernatants containing "soups" of exported 
proteins, which were subsequently characterised by their activity on a variety of cell 
lines and in several animal models (Thelestam and Ljungh, 1981; Stelma et al., 1988; 
Singh and Sanyal, 1992a). However, these approaches had major pitfalls regarding 
the interpretation of results. For example, the presence of relatively strong toxins 
would mask the presence of other toxins with more subtle effects. Likewise, many 
strains are known to produce a variety of extracellular proteases, which have been 
shown to be involved in the activation of some toxins. Consequently, the so-called 
heat-lability of a particular toxin may simply be a reflection of the stability of the 
protease required for activation. 
The use of molecular techniques have helped to resolve much of the confusion 
surrounding Aeromonas toxins, so much so that aerolysin, the major haemolytic 
toxin secreted by Aeromonas species, is one of the best characterised bacterial 
haemolytic toxins. 
1.4.2. Aerolysin 
Table 1.3 summarises toxic proteins that have been identified to be secreted by 
Aeromonas bacteria. The genetic determinant encoding a haemolytic toxin from 
Aeromonas was first cloned from an isolate of A. hydrophila by Howard and 
colleagues (Howard and Buckley, 1986; Howard et al., 1987). Genes encoding 
similar toxins have since been cloned from numerous other strains, each of which has 
been designated one of several different names (e.g. aerolysin, cytolysin, Asaotoxin, 
p-haemolysin, cytolytic- and cytotoxic enterotoxin). By comparing the primary 
amino acid sequences and molecular weights of these toxins, they can broadly be 
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Table 1.3. Toxins and proteases identified in Aeromonas species 
Toxin MW Gene Homologues 
(kD a) cloned 
Haemolytic toxins 
Aerolysin 53.8-54.7 Yes P. aeruginosa haemolysin 
S. aureus a-toxin 
C. perfringens 6-toxin 
C. petfringens perfringolysin 0 
Haemolysin —64 Yes V. cholerae HlyA 
GCAT 37.4 Yes V. cholerae lecithinase 
V. parahaemolyticus lecithinase 
V. mimicus lecithinase 
Enterotoxins 
Cholera toxin-like No V. cholerae cholera toxin 
enterotoxin 
Alt 44 Yes A. hydrophila phospholipase Al 
Cytotonic enterotoxin 70 No A. hydrophila lipase 
Other toxins 
Shiga-like toxin 1 unknown No Enterohaemorrhagic E. colt Stx1 
Proteases 
Zinc protease 19 No P. aeruginosa LasA 
Metalloprotease 37-38 Yes A. otyzae neutral protease 
P. atrinum penicillolysin 
Metalloprotease 34 No V. cholerae haemagglutinin / 
protease 
Serine protease 64-68 Yes H. vulgaris protease 
A. aegypti protease 
Serine protease 22 No unknown 
divided into two types, those homologous to the original toxin cloned by Howard and 
colleagues (1987) and those homologous to haemolysin (HlyA) from Vibrio cholerae 
(Table 1.3.). Wong et al. (1998) have proposed that the terms aerolysin (AerA) and 
haemolysin (HlyA) be used to describe these proteins, respectively. This 
nomenclature will be used throughout this thesis. 
1.4.2.1. Sequence analysis 
• Alignment of the predicted amino acid sequences of the aerolysin gene 
products suggests that there are at least two different variants of this toxin. The 
toxins designated AHH3 and AHH5 (Hirono et al., 1992), and Act (Chopra et al., 
1993) exhibit a high degree of identity with the aerolysin cloned by Howard and 
colleagues (1987). In contrast, those designated ASA1 (Hirono et al., 1992), AerA 
(Husslein et al., 1988), and ASH3 (Hirono and Aoki, 1993) exhibit considerable 
sequence divergence from the family of toxins described above in their N- and C-
terminal regions, but show a high degree of identity with each other. All of the 
aerolysin-like gene products described to date, however, appear to have a molecular 
weight ranging from 53.8 to 54.7 lcDa. Preproaerolysin is encoded by aerA, which is 
clustered with two other genes, aerB and aerC (Chalcraborty et al., 1986). These 
genes are involved in the modulation of aerolysin activity and in the expression of 
aerA, respectively. 
Chopra et al. (1993) cloned a cytotoxic enterotoxin gene from a diarrhoeal 
isolate of A. hydrophila, which they designated "Act" to differentiate it from 
aerolysin. The reason for this differentiation was the fact that substitution of two 
amino acid residues shown to be crucial for the haemolytic activity of aerolysin did 
not affect the biological activity of Act. Although still the subject of some debate 
(Buckley and Howard, 1999), Act is probably analogous with aerolysin since both 
toxins have high sequence homology (93% identity), and similar molecular weights, 
pore sizes, and mechanisms of action and activation. 
Although the primary amino acid sequence of aerolysin appears to be fairly 
unique, a short (31 amino acid) region does exhibit homology with Pseudomonas 
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aeruginosa haemolysin, Staphylococcus aureus a-toxin, and Clostridium perfringens 
E-toxin and perfringolysin 0 (Parker et al., 1996). 
1.4.2.2. Mechanism of action 
Preproaerolysin is secreted from the cell, and is activated to form aerolysin 
following the removal of a small C-terminal peptide (— 40 amino acids), by one of a 
number of proteases (e.g. trypsin, chymotrypsin, and metalloproteases), which may 
be either bacterial or host in origin (Abrami et al., 1998a; van der Goot et al., 1992). 
Binding of the aerolysin dimer to the host receptor increases its local concentration 
and initiates a process referred to as oligomerisation (Parker et al., 1996). This 
process involves the dissociation of the soluble toxin into monomers and the 
formation of an extremely stable heptamer. Subsequently, the hydrophobic region 
near the C-terminus is thought to promote insertion into the target cell membrane 
(Parker et al., 1996). 
Recently, it has been suggested that aerolysin does not cause cell death simply 
by allowing the leakage of intracellular components. Abrami et al. (1998b), have 
proposed a more elaborate mechanism involving selective permeabilisation of the 
target cell to small ions, such as potassium, which causes depolarisation of the 
plasma membrane. This, in turn, results in dramatic vacuolation of the endoplasmic 
reticulum, and selective alteration of the early biosynthetic membrane pathway by 
inhibiting transport of newly synthesised membrane proteins to the plasma 
membrane. 
1.4.2.3. Virulence studies 
Early experiments with purified aerolysin and culture filtrates from 13- 
haemolytic A. hydrophila isolates provided the first evidence that aerolysin exhibited 
haemolytic, cytotoxic and enterotoxic activities, and that it may be an important 
virulence determinant for Aeromonas species. Asao et al. (1984) purified a 
haemolytic protein with a molecular weight (MW) of approximately 50 kDa, 
consistent with the MW of aerolysin. This haemolysin lysed rabbit erythrocytes, 
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elicited cytotoxic activity to Vero cells, and caused fluid accumulation in infant 
mouse intestines and in ligated rabbit ileal loops. A subsequent study demonstrated 
that culture filtrates from 19 of 21 (90%)13-haemolytic isolates of A. hydrophila were 
enterotoxic in rabbit ileal loops, whereas those from non-haemolytic strains did not 
cause fluid accumulation (Stelma et al., 1986). Moreover, antiserum raised against 
the toxin purified by Asao et al. (1984), abolished this activity from four isolates. 
Taken together, these studies provided the initial indirect evidence that aerolysin 
played an important role in Aeromonas pathogenesis. However, proof was still 
lacking that aerolysin is important, or indeed whether it was produced, during the 
infection process. 
Such proof was provided when isogenic mutants in the aerolysin genes were 
constructed and analysed in animal systems. Chakraborty et al. (1987), constructed a 
deletion-insertion mutation in the aerA and aerB genes from a strain of A. 
hydrophila. In a mouse toxicity model (intraperitoneal injection), this mutant had a 
LD50 >8 x 108 compared with LD 50 values of approximately 7 x 10 7 and 5 x 10 7 for 
the wild type and genetically reconstituted strains, respectively. Furthermore, the 
wild type strain was recovered from the blood, liver and spleen of infected animals 
whereas the mutant was never recovered from these sites. In addition, specific 
neutralising antibodies against aerolysin were detected in mice surviving this 
intraperitoneal challenge, demonstrating that aerolysin was produced during systemic 
infection with A. hydrophila. 
A more recent study by Wong et al. (1998), investigated the role of aerolysin 
and haemolysin (see section 1.4.3) in an infant mouse assay. Inactivation of aerA 
caused a nine-fold, although not statistically significant, increase in LD 50 following 
oral challenge. A statistically significant 20-fold increase in LD 50 was observed only 
when both aerA and hlyA were inactivated. It was only in the double mutant that 
haemolytic and cytotoxic activities were abolished, demonstrating that, at least in this 
strain of A. hydrophila, more than one haemolytic protein may be involved in 
virulence. 
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1.4.3. Haemolysin 
Genes encoding 13-haemolytic toxins distinct from aerolysin have been cloned 
from several strains of Aeromonas. These toxins, termed haemolysin (HlyA), are 
larger (— 64 kDa) than aerolysin (— 54 lcDa) and have only 17.8 to 19.6% amino acid 
sequence identity with the aerolysin cloned by Howard et al. (1987). They do, 
however, exhibit homology (41% identity and 54% similarity for AHH1; Hirono and 
Aoki, 1991) with HlyA from Vibrio cholerae El Tor (Alm etal., 1988). 
To date, there has been limited work aimed at elucidating the expression, 
mechanism of action, or role in virulence of HlyA from Aeromonas (HlyA'). 
However, a hydrophobic N-terminal region has been proposed as a signal sequence, 
and HlyAA' could be activated by trypsinisation (Hirono and Aoki, 1991). These 
observations are consistent with the mechanisms known for the secretion and 
activation of both HlyA from Vibrio cholerae (HlyAvc) and aerolysin (Alm et al., 
1988; van der Goot et al., 1992). HlyAve has been shown to form pores in lipid 
bilayers with a pore size of — 0.7 nm (Menzl et al., 1996). Therefore, given the 
sequence similarity between HlyA Aem and HlyAvc, it is not unreasonable to assume 
that the former is also a pore-forming toxin (Wong etal., 1998). 
The only report to date investigating the role of HlyAA' in Aeromonas 
virulence was the study by Wong et al. (1998) described above (section 1.4.2.3). 
Wong et al. (1998) did not observe a decrease in haemolytic or cytotoxic activity of a 
hlyA mutant compared to a wild type strain. Moreover, following oral challenge of 
infant mice, no increase in LD,„ was observed for a hlyA mutant. This lack of 
attenuation could be explained by the fact that the strain examined possessed a 
functional aerA gene. The results of Wong and colleagues (section 1.4.2) indicated 
that while aerolysin is the predominant toxin responsible for haemolytic activity in 
Aeromonas, haemolysin may also be an important virulence determinant for some 
strains, or that the presence of both haemolytic toxins is a requirement for virulent 
strains of A. hydrophila (Wong et al., 1998). 
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1.4.4. Glycerophospholipid:cholesterol acyltransferase (GCAT) 
Both Aeromonas and Vibrio species produce a novel lipase that has the unusual 
ability to produce cholesterol esters. This 37.4 kDa enzyme was named 
glycerophospholipid:cholesterol acyltransferase (GCAT) based on the first reaction it 
was shown to catalyse (Buckley, 1982). GCAT is capable of catalysing the 
hydrolysis of a number of lipids, and destroys host cells by digesting their cell 
membranes. For this reason, GCAT is also a haemolytic toxin. The structural gene 
encoding GCAT has been cloned and sequenced from two strains of A. hydrophila 
and one strain of A. salmonicida (Thornton et al., 1988). 
GCAT is believed to be a critical virulence determinant in the pathogenesis of 
the fish disease, furunculosis, caused by strains of the psychrophilic, non-human 
pathogen A. salmonicida. However, a role for GCAT in mammalian disease is much 
less likely, as GCAT is significantly less efficient at lysing mammalian cells. This 
probably reflects higher amounts of sphingomyelin in the latter, which is not a 
substrate for GCAT (Buckley, 1982). 
In summary, three different haemolytic toxins from Aeromonas species have 
been genetically characterised. Although all are capable of causing cell lysis, only 
aerolysin and haemolysin are likely to play roles in human disease. In addition, there 
are probably other toxins that remain to be characterised, such as the toxins with a-
haemolytic activities described by Ljungh et al. (1981), Rodriguez et al. (1992), and 
Thelestam and Ljungh (1981). 
1.4.5. Cytotonic enterotoxins 
Cytotonic enterotoxins differ from the toxins described above in that they 
cause intestinal fluid accumulation without cell lysis. The principal mechanism by 
which cytotonic enterotoxins act is by increasing intracellular cyclic AMP (cAMP), 
cyclic GMP (cGMP) and/or prostaglandin E2 (PGE2) levels. Cytotonic enterotoxins 
have been identified in many strains of Aeromonas by their ability to cause intestinal 
fluid accumulation in one of several animal models, or by their ability to elongate 
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Chinese hamster ovary (CHO) cells. Cytotonic enterotoxins from several strains have 
been shown to cross-react immunologically with cholera toxin (CT), and these CT-
cross reactive toxins were all heat stable (56°C, 20 min) and able to elevate cAMP up 
to a level —20% that produced by CT (Schultz and McCardell, 1988). Furthermore, 
Schultz and McCardell (1988) identified CT homologous DNA sequences in several 
A. hydrophila strains with DNA probes directed against the genes encoding the A2 
and B subunits of CT. However, despite the fact that all of these studies were 
performed more than 10 years ago, no CT homologues have been cloned or purified 
from Aeromonas species. 
To date, the genes encoding three cytotonic enterotoxins have been cloned 
from Aeromonas species (Chalcraborty et al., 1984; Chopra et al., 1994), although 
published DNA sequences exist for only one of these. Chopra et al. (1994) cloned 
two cytotonic enterotoxin genes from A. hydrophila. One gene encoded a heat-stable 
toxin (56°C, 20 min) while the other encoded a heat-labile toxin. The gene encoding 
the heat labile toxin (alt) was subsequently sequenced and its product (Alt) 
biologically characterised. Alt exhibited significant homology at the amino acid level 
with phospholipase Al (Plal; 96% identity, 97% similarity) from Aeromonas 
hydrophila (Merino et al., 1999), although Alt did not exhibit phospholipase activity. 
Sequence alignment with Alt demonstrates that the majority of the Alt protein 
(amino acids 2 to 327, of 368) aligns with an internal region (amino acids 334 to 669, 
of 805) of Plal, suggesting that Alt is possibly an N- and C-terminal truncated 
variant of Plal . 
The enterotoxic activity of Alt resulted from its ability to increase intracellular 
cAMP and PGE2 to levels approximately half of those obtained with CT, although 
Alt did not exhibit immunological cross-reactivity or sequence similarity with 
cholera toxin. The alt gene product had a predicted molecular weight of 38 lcDa, 
slightly less than Alt purified from A. hydrophila (44 IcDa), suggesting that it may be 
post-translationally modified. This was supported by the fact that native Alt from A. 
hydrophila had higher activity than recombinant Alt. A possible role for Alt during 
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infection was demonstrated in a mouse ligated ileal loop assay. Mice immunised with 
Alt exhibited a 39% decrease in fluid accumulation when compared with non-
immunised animals (Chopra et al., 1994). However, a definitive role for Alt in 
Aeromonas virulence awaits the testing of isogenic mutants defective in Alt 
production. 
A 70 kDa cytotonic enterotoxin was purified from a strain of A. hydrophila by 
McCardell et al. (1995). This heat stable toxin caused elongation of CHO cells, 
which did not occur as a result of increased cAMP, cGMP or PGE 2 levels. Although 
no homologous proteins were identified in the Genbank or SwissProt databases, the 
N-terminal sequence does exhibit 61% identity and 77% similarity with amino acids 
17 to 36 of an extracellular lipase (Lip) from A. hydrophila (Chuang et al., 1997), 
characterised after the study of McCardell et al. (1995). Unprocessed Lip had a MW 
(79.9 kDa) similar to the purified cytotonic enterotoxin (70 IcDa). Therefore, it is 
possible that this enterotoxin is a variant of a lipase, which would explain why it 
failed to elevate cAMP, cGMP or PGE2 levels as part of its cytotonic activity. 
In summary, Aeromonas species have the ability to produce several types of 
cytotonic enterotoxin. All Aeromonas cytotonic enterotoxins, which have been 
characterised at the molecular level, appear to have been derived from lipases. These 
toxins presumably act by insertion into, and disruption of, the cell membrane. 
However, other enterotoxins remain to be characterised genetically, and at least one 
of these may be analogous to the major enterotoxin produced by pathogenic strains 
of V. cholerae. 
1.4.6. Shiga-like toxins 
There are several reports implicating strains of Aeromonas as a causative agent 
of haemolytic uraemic syndrome (HUS) (Bogdanovic et al., 1991; Robson et al., 
1992). This disease is traditionally caused by strains of enterohaemorrhagic 
Escherichia coll. HUS occurs as a result of the production of one or more toxins of 
the Shiga-like toxin (Stx) family, and attaching and effacing lesions similar to those 
produced by enteropathogenic E. coli. The Stx family from enterohaemorrhagic E. 
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co/i consists of two major, immunologically non-cross-reactive groups termed Stx 1 
and Stx2. These toxins consist of an enzymatically active 32 lcDa A subunit linked to 
five identical 7.7 kDa B subunits that are responsible for binding to target cell 
membranes. The toxicity of the A subunit results from its ability to remove a single 
adenine residue from 28S rRNA, thereby inhibiting protein synthesis (Nataro and 
Kaper, 1998). Epidemiological studies have indicated that Stx 1 is more important 
than Stx2 in the development of HUS (Nataro and Kaper, 1998). 
A recent study has demonstrated the presence of Stxl in a limited number of 
Aeromonas species (Hague et al., 1996). Culture filtrates of 4 of 39 isolates (3 
clinical A. hydrophila and 1 environmental A. caviae) produced cytopathic effects on 
Vero cells that could be neutralised by E. coli 0157:H7 Stx 1 antiserum. Furthermore, 
DNA from these strains could be amplified with Stx 1 specific primers, and the genes 
encoding Stx 1 in Aeromonas were localised to a 2.14 kb plasmid. Brown et al. 
(1997) demonstrated that plasmid DNA is uncommon in Aeromonas species. 
Therefore, the significance of Stx 1 in Aeromonas pathogenesis remains to be 
answered, and the presence of stx genes in Aeromonas strains associated with HUS 
will need to be confirmed. The possibility that plasmid or phage DNA, containing stx 
genes, is integrated into the Aeromonas genome has not been explored. 
1.4.7. Proteases 
Several proteases have been identified from strains of Aeromonas species 
following protein purification or gene cloning experiments (Table 1.3). Although for 
most of these there is little or no evidence of direct involvement in pathogenicity, 
they do induce tissue damage and cause cell death. However, this is probably not 
their primary purpose, as microbial proteases have been shown to have several other 
roles (Howard et al., 1996). Many bacterial toxins, such as Shiga-like toxins, cholera 
toxin, and at least three toxins produced by Aeromonas (aerolysin, haemolysin and 
GCAT) are activated by proteolytic cleavage (Hilton et al., 1990; Hirono and Aoki, 
1991; van der Goot et al., 1992; Gordon and Leppla, 1994). Furthermore, proteases 
are able to degrade immunoglobulins and components of the complement system, 
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which would facilitate the initial propagation of a pathogen, and proteases may also 
supply amino acids during infection (Gordon and Leppla, 1994). Therefore, while not 
directly responsible for disease production, proteases are involved in enhancing the 
pathogenesis of many diseases. Proteases identified to date fall into two broad 
classes, metalloproteases (inhibited by ethylenediaminetetraacetic acid; EDTA) and 
serine proteases (inhibited by phenylmethylsulphonyl fluoride; PMSF). 
Representatives of each of these groups have been identified in Aeromonas species. 
Of the proteases identified to date, only two serine proteases have been shown 
to have any role in pathogenesis, and both are involved in the infection of salmonid 
fish. Both A. hydrophila and A. salmonicida have been shown to produce an 
unusually high molecular weight, 64 to 68 lcDa serine protease, which is thought to 
be an important virulence determinant, along with GCAT, in the pathogenesis of 
furunculosis by A. salmon icida. Purified serine protease administered 
intramuscularly along with GCAT, results in the production of classic furuncles in 
salmonid fish (Ellis, 1991). 
A second serine protease (22 lcDa) has also been identified by protein 
purification from a single strain of A. hydrophila (Rodriguez et al., 1992). Although 
no DNA or protein sequences have been obtained for this protein, it has been shown 
to be toxic in rainbow trout (LD 50 of 150 ng/g). 
1.4.8. Distribution of toxin genes 
Despite all of the studies described in section. 1.4.1 to 1.4.7, there are still very 
few advances in our ability to identify pathogenic strains. The simplest approach to 
accomplish this is to examine the distribution of putative virulence factors in 
pathogenic and non-pathogenic isolates. Here, again, problems arise because of the 
difficulties in determining whether a given Aeromonas isolate is capable of causing 
disease in simple animal models. For this reason, these studies have often relied on 
the use of isolates of clinical and environmental origin. 
There have been few studies examining the distribution of toxin genes in 
Aeromonas species. Husslein et al. (1991; 1992) examined 257 strains from clinical 
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and environmental sources with gene probes comprising the aerolysin gene (aerA), 
and the aerA promoter region. This study detected aerA in virtually all A. veronii 
biovar sobria and A. hydrophila isolates and in about half of all A. caviae strains, 
regardless of whether these strains were isolated from clinical or environmental 
sources. A particularly interesting finding of this study was that the aerA promoter 
probe hybridised with only a small, biochemically-clustered group of atypical A. 
veronii biovar sobria strains. These strains have since been designated as a new 
species, A. trota. 
Recently, a study by Heuzenroeder et al. (1999), surveyed the presence of hlyA 
and aerA genes in clinical and environmental isolates of Aeromonas. The hlyA gene 
was detected in 96% of A. hydrophila, 12% A. veronii biovar sobria and 35% A. 
caviae, while 78% of A. hydrophila, 97% A. veronii biovar sobria, and 41% of A. 
caviae isolates tested possessed aerA. These observations supported previous studies 
investigating the distribution of aerA (Hirono et al., 1992) and hlyA (Hirono and 
Aoki, 1991), in that both genes were present in the majority of strains tested, and that 
this distribution did not correlate with the source of isolation. All "pathogenic" 
isolates of A. hydrophila, as determined by LD 50 values for infant mice, possessed 
both hlyA and aerA. This observation supported previous experiments conducted by 
these authors, investigating the virulence of aerA and hlyA mutants of A. hydrophila 
in an infant mouse model (Wong et al., 1998). Interestingly, hlyA was rarely detected 
in A. veronii biovar sobria isolates, despite this species being haemolytic. In contrast, 
hlyA was detected in 41.1% of A. caviae isolates, an organism rarely reported as 
being haemolytic. Heuzenroeder et al. (1999) proposed that both aerA and hlyA are 
required for full virulence of A. hydrophila. However, hlyA is less likely to be 
important for A. veronii biovar sobria due to its sporadic distribution in this species. 
This observation supports the idea mentioned earlier that the mechanisms of disease 
production by A. hydrophila and A. veronii biovar sobria are likely to differ. 
There are at least two further studies that have investigated the distribution of 
the aerolysin gene in Aeromonas species, although very few strains were tested in 
each study (Lior and Johnson, 1991; Pollard et al., 1990). Both studies involved the 
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use of PCR to detect aerA using primers designed from the sequence published by 
Howard et al. (1987). Using this procedure, aerA was detected for all haemolytic A. 
hydrophila strains, but not from haemolytic strains of any other Aeromonas species, 
suggesting that the primers were specific only for aerA from A. hydrophila. 
Hence, while a large number of toxin genes have been identified and cloned, 
very little is known about the distribution of each of these throughout the genus 
Aeromonas. Of the small number of studies of this type that have been published, it 
appears that for most of these toxins, only a subset of strains possess the genes 
encoding them. Further work investigating the distribution of each toxin in clinical 
and environmental isolates is necessary to determine whether any of these genes have 
potential for use as a marker of pathogenic strains. 
In summary, despite all of the studies described above in section 1.4, it appears 
that simply investigating the ability to produce toxins is insufficient to identify 
pathogenic Aeromonas strains. Therefore, effort has shifted to investigate the 
mechanisms of colonisation possessed by these bacteria, as adhesion to host cell 
surfaces is a necessary first step in the pathogenesis of most bacterial pathogens. 
1.5. Colonisation factors 
The investigation of adhesive mechanisms is more complex than the 
investigation of toxins. Pathogenic bacteria often possess multiple distinct 
colonisation factors, which may be expressed at different times during the infectious 
process, or by different strains of the same species. Moreover, the different 
colonisation factors may fulfil redundant roles, and the effect of mutating one factor 
may be masked by the presence of another. 
For Aeromonas species, the colonisation process is also likely to involve 
multiple colonisation factors. For example, experiments where filamentous surface 
structures have been removed by mechanical shearing, or enzymatic treatment, have 
dramatically reduced adhesion levels (-80%), but not abolished it. There are also 
likely to be species-associated differences, since cell line and animal colonisation 
experiments have indicated that different species colonise different cell surfaces 
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(Kirov et al., 1995a; Sanderson et al., 1996). This is also true for other pathogens, 
such as the different E. coli pathotypes. Throughout the remainder of this review, 
many terms will be used to describe these colonisation factors. "Adhesins" are 
proteins that mediate adhesion to host cells. Similarly, "colonisation factors" mediate 
colonisation of host tissues. However, colonisation factors are not necessarily 
adhesins and vice-versa. For example, the toxin co-regulated pilus (TCP) is the major 
colonisation factor for V. cholerae although, to date, this structure has not been 
shown to mediate adhesion to intestinal tissue. Instead, TCP appears to mediate 
bacterium-bacterium interactions that facilitate microcolony formation (Attridge et 
al., 1996; Tamamoto et al., 1998; Fullner and Mekalanos, 1999). 
The next sections will discuss the outer membrane-associated adhesins 
identified in Aeromonas species, followed by a detailed discussion of the filamentous 
surface structures that have formed the basis for the studies described in this thesis. 
1.6. Outer membrane-associated adhesins 
1.6.1. Lipopolysaccharides 
Lipopolysaccharides (LPS) are amphipathic molecules consisting of three 
subunits; lipid A, core oligosaccharide and the 0-antigen side chain. Lipid A is 
responsible for the toxicity of bacterial endotoxin, and consists of a hydrophobic 
region of six fatty acid side chains that anchor the LPS molecule into the outer 
membrane. The core oligosaccharide consists of 10 to 15 sugar units that anchor the 
0-antigen side chain to lipid A. The 0-antigen side chain, also known as the somatic 
antigen, consists of many repeating oligosaccharide units. The somatic antigen is 
responsible for the unique 0 serotype used to classify many bacterial species. For 
some pathogens, this classification is useful for identifying pathogenic strains (e.g. V. 
cholerae 01 and E. coli 0157). Strains expressing somatic antigen are often referred 
to as "smooth" strains due to their colony morphology. Likewise, strains not 
expressing somatic antigen are often referred to as "rough" strains. 
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Although a serotyping scheme has been developed for use with Aeromonas 
species (Sakazaki and Shimada, 1984; Cheasty et al., 1988; Thomas et al., 1990), it 
is not in widespread use, and is used much less than the schemes currently used for 
the identification of pathogenic E. coli and V. cholerae strains. Despite these 
limitations, however, there have been a few studies investigating the prevalence of 
particular serotypes in clinical specimens and the role of LPS in virulence. For 
Aeromonas, serogroup 0:34 appears to be the most common serogroup associated 
with disease, and one study has found that it accounts for 26.4% of all Aeromonas 
infections (Merino et al., 1997a). Serogroup 0:11 is also commonly associated with 
human disease, accounting for 10-30% of infections (Koldca et al., 1991). Despite the 
fact that the chromosomal locus encoding LPS biosynthesis has not been cloned or 
sequenced, there are several reports documenting a possible role for LPS in 
Aeromonas pathogenesis. 
Several studies have suggested that strains expressing somatic antigen (smooth 
LPS strains) are more virulent than rough LPS strains. For example, smooth LPS 
strains belonging to serotype 0:34 exhibit higher adhesion to cell lines and intestinal 
tissue, and have lower LD 50 values than rough strains (Francki and Chang, 1994; 
Aguilar et al., 1997; Merino et al., 1998). Likewise, A. hydrophila serogroup 0:34 
strains grown at 20°C (expressing smooth LPS) were shown to be more than twice as 
adhesive to HEp-2 cells than strains grown at 37°C (rough LPS). When Tn5 mutants 
were isolated with defects in the rfb gene, which is responsible for 0 antigen 
biosynthesis, adhesion of the resulting rough LPS strains was low, regardless of 
growth conditions (Merino et al., 1996a). Similar results were also obtained in a 
germ-free chicken gut colonisation model (Merino et al., 1996b). However, some 
caution must be observed when analysing defects in LPS biogenesis genes as defects 
in protein export can also occur. For example, rfb mutants of V. cholerae are 
defective in the translocation of toxin co-regulated pilus subunit proteins across the 
outer membrane (Iredell and Manning, 1997a; Iredell and Manning, 1997b; Iredell et 
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al., 1998). Therefore, these defects in adhesion may be due, at least in part, to 
pleiotrophic defects in the secretion of outer membrane proteins. 
Of particular interest, recent investigations by Aguilar et al. (1997) and Merino 
et al. (1998) have demonstrated that the defect in 0 antigen biosynthesis observed 
when strains were grown at 37°C could be reversed when strains were grown under 
high osmolarity conditions (Luria broth + 300 inM NaC1). This switch from rough to 
smooth LPS production occurred concurrently with increased haemolytic and 
cytotoxic activities, increased adhesion to HEp-2 cells, and lowered LD 50 values for 
rainbow trout and mice following intraperitoneal injection. These results indicate not 
only that LPS might be an important adhesin for serogroups 0:13, 0:33, 0:34, and 
0:44, but that the environmental conditions required for smooth LPS biosynthesis 
may be responsible for the global regulation of many Aeromonas virulence factors. 
1.6.2. Outer membrane proteins 
The protein component of the Gram-negative outer membrane is responsible 
for numerous functions, including the transport of nutrients and by-products of 
metabolism in and out of the cell in addition to the adherence of bacterial cells to 
host receptors. Jeanteur et al. (1992) purified and determined the N-terminal amino 
acid sequences of six outer membrane proteins (OMPs) from a strain of A. 
hydrophila, and these were found to be homologous to OMPs from several other 
Gram-negative bacteria, some of which have roles in virulence (Table 1.4.). 
Subsequent studies by Quinn et al. (1993; 1994) identified three carbohydrate-
reactive OMPs that may be involved in the association of Aeromonas bacteria to host 
tissues. Two of these proteins were shown to be homologous with proteins I and II 
from the study of Jeanteur et al. (1992) 
Protein I, a 47 IcDa protein homologous with LamB from E. coli, also appears 
to be the same as the 43 IcDa protein identified from A. veronii biovar sobria by 
Nandapalan and Chang (Nandapalan and Chang, 1989). Monoclonal antibodies 
raised against this protein inhibited mannose-sensitive haemagglutination and 
adhesion of A. veronii biovar sobria to HEp-2 cells. 
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Table 1.4. Outer membrane proteins identified in Aeromonas species 
Outer membrane MW Homologue Function 
protein' (kD a) 
Protein I 47 E. colt LamB Uptake of maltose 
A. hydrophila adhesion 
Protein II 39 E. colt OmpF / Osmoregulation 
OmpC S. flexneri invasion 
A. hydrophila adhesion 
Protein III 36 E. colt PhoE Polyanion porin 
Protein IV 24 V. cholerae OmpK Unknown 
Protein V 30 E. colt OmpA E. colt serum resistance 
Protein VI 25 V. cholerae OmpW ? Adhesion 
FkpA 28.7 S. typhimurium Invasion 
FkpA 
IlpA 22.4 E. colt SlyD Unknown 
a 	Proteins Ito VI designated according to Jeanteur et al. (1992). 
Protein V from the study of Jeanteur et al. (1992) was a 30 kDa protein 
homologous with OmpA from members of Enterobacteriaceae. This protein has been 
shown to contribute to serum resistance and pathogenicity of E. coli K1 (Weiser and 
Gotschlich, 1991). A protein homologous with protein V has been purified from A. 
salmonicida, and this protein elicited protective immunity in rainbow trout following 
intraperitoneal immunisation (Lutwyche et al., 1995). Two, tandemly located, genes 
encoding OmpA have since been cloned from A. salmon icida, and these were shown 
to be widespread among Aeromonas species by PCR analysis (Costello et al., 1996). 
Another two outer membrane proteins from Aeromonas species, which have 
been genetically characterised, are the immunophilin-like proteins, IlpA and FkpA, 
cloned from A. hydrophila A6 (Wong et al., 1997). These genes were cloned using a 
polyclonal rabbit antiserum that protected against oral infection of infant mice by this 
strain. FkpA was homologous to FkpA from Salmonella typhimurium, and a 
mutation in fkpA from this species resulted in a decreased ability to invade 
macrophages (Home et al., 1997). A mutation constructed in the Aeromonas fkpA 
gene, however, resulted in no loss in virulence. However, a role for this protein 
during systemic infection was not investigated, nor was a mutation in ilpA (Wong et 
al., 1997). 
In summary, both the LPS and OMPs may play significant roles in the 
adhesion to, and colonisation of, host tissues by Aeromonas species, and yet these 
roles remain to be elucidated. The initial contact between a bacterial pathogen and 
the host cell surface, however, is almost always mediated by filamentous surface 
structures, which are the major focus of this thesis. Therefore, the following sections 
will present a detailed review of these structures as they contribute to the 
pathogenicity of bacteria in general, with particular focus on enteropathogenic 
bacteria, followed by a review on what was known about Aeromonas filamentous 
surface structures. 
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1.7. Filamentous surface structures 
Bacteria are known to produce numerous different types of filamentous 
structures on their surface, and these can broadly be divided into flagella, pili, and 
filamentous bacteriophages. 
Flagella are long, thick bacterial organelles, which have either a polar or 
peritrichous location on the cell surface. Flagella are the primary structures 
responsible for chemotaxis and motility. Each flagellum is driven by a membrane-
located motor that rotates as a consequence of proton or sodium flux. Coupled to the 
motor is a protein hook structure connected to the long, flagellin polymer. These 
structures are often composed of multiple flagellin subunits, which are sometimes 
responsible for adhesion to host receptors. 
Pili (synonymous with "fimbriae"), are thinner (< 10 nm) than flagella 	20 
nm), and almost always have a peritrichous location on the cell surface. Pili are 
currently classified into several morphological and genetic types, of which types I 
and IV are the most widely distributed amongst pathogenic bacteria. These pili types 
will be discussed in more detail in the following sections. Pili are known to mediate 
the initial binding of almost all Gram-negative bacterial pathogens to host cell 
surfaces, and are also involved in inter-bacterial interactions and microcolony 
formation. Throughout this thesis the term "pili" will be used in preference to 
"fimbriae', being the most commonly used term to describe these structures in the 
Aeromonas literature. 
Filamentous bacteriophages are virus particles shed as long filaments from the 
cell surface. For this reason they are often indistinguishable, morphologically, from 
pili and are often mistaken for these structures. Bacteriophages often form an 
important part of the biology of their host, as they may encode genes, such as toxins 
and colonisation factors, beneficial for the host bacterium. 
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1.8. Flagella 
In addition to their role as motility organelles, flagella have been implicated as 
important virulence factors for several bacterial pathogens in their ability to mediate 
adhesion to, and invasion of, epithelial and intestinal cell surfaces. For example, the 
polar flagellum is essential for full invasive ability of Campylobacter jejuni (Grant et 
al., 1993), and for full adhesion of Vibrio cholerae to intestinal tissue (Attridge and 
Rowley, 1983; Benitez et al., 1997). 
As mentioned above, the flagellin polymer often consists of several distinct 
flagellin subunits that have varying roles in adhesion. The diarrhoeal pathogen 
Campylobacter jejuni, for example, possesses two flagellin genes flaA and flaB, and 
mutation of flaA, but not flaB, reduced the ability of this organism to invade INT407 
intestinal cells (Grant et al., 1993). 
Recently, five flagellin genes have been found to be possessed by the human 
pathogen Vibrio cholerae (Klose and Mekalanos, 1998). While isogenic mutations in 
each of these genes have not been investigated in animal models of experimental 
cholera, Attridge and Rowley (1983) have suggested a role for the V. cholerae 
flagellum in adherence. These authors demonstrated that spontaneous non-motile 
(non-flagellated) strains, and motile strains sheared of filamentous surface structures 
(non-flagellated) adhered at much lower levels 1 to 5%) to mouse intestinal tissue 
than a wild-type motile (flagellated) strain. 
Flagella also appear to be involved in intestinal colonisation by Salmonella 
typhimurium, although non-flagellated mutants were not attenuated in a murine 
model of typhoid fever (Lockman and Curtiss, 1990). In this same model, however, 
fim flu double mutants, which lack both type I pili and flagella, respectively, were 
significantly attenuated, while single fim or flu mutations alone did not affect 
virulence (Lockman and Curtiss, 1992). These results suggest that the fimbriae and 
flagellum have redundant roles during the process of intestinal colonisation by S. 
typhimurium. 
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Several bacteria, such as V. parahaemolyticus, possess lateral flagella in 
addition to the polar flagellum. For this organism, the polar system is used for 
swimming in liquid environments and the lateral system is used for swarming 
motility over surfaces (Sar et al., 1990). The latter is believed to allow growth on 
surfaces and in biofilms. Both polar and lateral systems are driven by reversible 
motors embedded in the cytoplasmic membrane. However, the polar flagellum is 
driven by a sodium-motive force, whereas the lateral flagellum is driven by a proton-
motive source (Atsumi et al., 1992). Expression of lateral flagella is initiated, along 
with a concurrent elimination of polar flagellum expression, following sensing of a 
high viscosity environment. This differential expression is controlled by sensing a 
decrease in torque of the polar flagellum (Kawagishi et al., 1996). 
In summary, it can be seen that flagella are not only important virulence factors 
for diarrhoeal pathogens in their role as motility organelles, but also in their ability to 
mediate adhesion to the intestinal mucosa. Several bacterial pathogens possess two 
distinct flagellar systems, which have been called the "polar" and "lateral" flagellar 
systems. Aeromonas species also appear to possess both of these systems, and these 
will be discussed in more detail in section 1.10.1. 
1.9. Phi 
1.9.1. Type ! pili 
Type I pili were originally described in Salmonella species and were defined as 
bacterial surface filaments that caused mannose-sensitive agglutination of guinea pig 
erythrocytes. Since that time they have been described on numerous Gram-negative 
bacteria, and are often referred to as "common pili". These structures have been 
found to mediate adhesion to a variety of different cell types such as erythrocytes, 
leukocytes, enterocytes, respiratory epithelial cells, protozoa, yeasts, fungal hyphae 
and plant root hairs (Duguid and Old, 1994). Although the term "type I pilus" refers 
to the common pili produced by E. coli and Salmonella species, the pili produced by 
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several other bacterial species exhibit significant homology to the type I pili and will 
also be discussed in this section. 
Pili structurally and genetically homologous to the common type I pili 
described above are known colonisation factors for many pathogenic bacteria, 
including uropathogenic and enterotoxigenic E. coli (ETEC), Haemophilus 
influenzae and Bordetella pertussis. To date, numerous pili of this type have been 
identified in E. colt, with at least 14 currently known to be produced by various 
strains of ETEC alone (Nataro and Kaper, 1998). In this organism, the production of 
a specific pilus type confers the species specificity of the pathogen. For example, 
K88 pili mediate binding to pigs, K99 pili are specific for calves and lambs in 
addition to pigs, while CFA/I, CFA/II, CFA/III and CFA/IV pili are all specific for 
human intestinal tissues. Similarly, the H. influenzae pilus confers specificity to 
buccal and bronchial epithelial cells (Gilsdorf et al., 1997). 
Type I pili are composed of a major repeating subunit as well as minor 
components responsible for their adhesive nature. The E. coli P pilus, which 
mediates binding of uropathogenic E. coli to the urogenital tract epithelium, is 
composed of a major repeating subunit protein, PapA, anchored into the outer 
membrane via PapH. PapA is guided to the cell surface by a conserved chaperone 
molecule (PapD) and an outer membrane usher (PapC). At the distal end of the pilus 
is the tip fibrillin, which is composed of PapE, and the tip adhesin, PapG. 
Morphologically this structure appears as a rigid rod with a short, thin fibrillin at the 
tip (Finlay and Falkow, 1997). Type I and H. influenzae pili are assembled via a 
similar pathway, and are similar to P pili, except that they are flexible structures. 
In summary, pili homologous to the E. coli type I pili are important 
colonisation factors for many diarrhoeal and extraintestinal pathogens. Similar 
structures have been identified on strains of Aeromonas species, and although they 
have not been characterised in great detail, they do appear to exhibit structural and 
sequence homology to the E. coli type I pilus, and will be discussed further in section 
1.10.2.2. 
31 
1.9.2. Type IV pili 
Type IV pili are assembled by a different pathway than type I pili, which 
involves components of the main terminal branch of the general secretion pathway 
(type II secretion pathway). These pili have been found in many diverse Gram-
negative bacterial species, including Pseudomonas aeruginosa, Neisseria species, 
Moraxella species, E. coli and V. cholerae. The experiments described in this thesis 
are concerned with the investigation of the type IV pili produced by Aeromonas 
bacteria. Therefore, the structure, genetics, and function of these structures will now 
be reviewed in detail. 
1.9.2.1. Structure of type IV pili 
Broadly, type IV pili are divided into two classes (Strom and Lory, 1993). 
"Classical" type IV pili (type IVA pili) have a short N-terminal leader sequence 
usually composed of 6 amino acids preceding a conserved phenylalanine residue. 
Type IVB pili are bundle-forming pili, which have been found in V. cholerae (toxin 
co-regulated pilus; TCP), enteropathogenic E. coli (bundle-forming pilus; BFP) and 
enterotoxigenic E. coli (longus pilus). These structures have a longer leader sequence 
of 13 to 25 amino acids and the N-terminal amino acids of the mature pilins are 
either a methionine or a leucine. However, recent evidence obtained for V. cholerae 
has demonstrated that TCP is a filamentous bacteriophage assembled via the type IV 
pilus biogenesis pathway. Although, to date, this has only been shown for the TCP 
pilus, it is possible that the other type IVB pili may also be filamentous 
bacteriophages. Indeed, all of the genes required for assembly of the 
enteropathogenic E. colt (EPEC) BFP are clustered in a similar fashion to the tcp 
gene cluster (Donnenberg et al., 1997), whereas the genes involved in assembly of 
the type IVA pili, at least for P. aeruginosa, are dispersed throughout the 
chromosome (Alm and Mattick, 1997). 
As described above, type IV prepilin proteins possess a short, positively 
charged leader sequence that is generally 6-7 amino acids in "classical" type IV pili 
and 13-25 amino acids long in type IVB pili. This leader sequence has been shown to 
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be a substrate for an enzyme termed a "prepilin peptidase" in P. aeruginosa (Pill); 
Nunn and Lory, 1991), N. gonorrhoeae (PilD; Dupuy and Pugsley, 1994),V. cholerae 
(TcpJ; Kaufman et al., 1991) and A. hydrophila (TapD; Pepe et al., 1996). These 
enzymes also process prepilin-like proteins ("pseudopilins"), which comprise 
components of the type II secretion pathway (e.g. XcpTUVW from P. aeruginosa; 
Nunn and Lory, 1993). 
Type IV pilin proteins can be divided into two structural regions, a conserved 
domain and a variable domain, based on amino acid sequence similarity. The 
conserved domain spans approximately 40 amino acids and consists of the leader 
sequence, a domain highly conserved among all type IV pili, and a slightly less well 
conserved domain which is generally conserved only within a particular species 
(Strom and Lory, 1993; Tennent and Mattick, 1994). Critical amino acid residues 
include a glycine at -1, which is required for cleavage, and a glutamate at +5, which 
is essential for assembly and efficient methylation of the mature protein (Strom and 
Lory, 1991). Towards the C-terminus there is another region of homology containing 
two cysteine residues (12 to 28 amino acids apart) which are involved in the 
formation of a disulphide loop within the subunits of N. gonorrhoeae MS 11 and P. 
aeruginosa PAK and PAO. D. nodosus contain an additional two cysteine residues 
which form another disulphide loop near the end of the conserved amino terminus 
(Mattick et al., 1991; Tennent and Mattick, 1994). 
Type IV pili are approximately 6 nm in diameter and can be several pm in 
length (Tennent and Mattick, 1994). Most type IV pili are composed of a single 
repeating subunit ranging in size from 145 to 160 amino acids (15-18 kDa) which 
show a high degree of N-terminal amino acid sequence similarity among different 
species (Strom and Lory, 1993). The exceptions are the type IV pili produced by 
Neisseria species, which appear to possess a tip-located adhesin (Pi1C; Rudel et al., 
1995). 
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1.9.2.2. Functions of type IV pili 
Type IV pili are involved in the colonisation of mucosal surfaces by diverse 
bacterial species. In addition, these structures have also been demonstrated to have 
other roles, such as twitching motility and their ability to act as receptors for 
bacteriophages (Tennent and Mattick, 1994). 
1.9.2.2.1. Adhesion 
A number of studies have shown that type IV pill mediate binding to epithelial 
cells. Type IV pili from P. aeruginosa (Woods et al., 1980; Doig et al., 1988), N. 
gonorrhoeae (Pearce and Buchanan, 1978), N meningitidis (Virji et al., 1993); V. 
cholerae (Attridge et al., 1996; Taylor et al., 1987) and enteropathogenic E. coli 
(Giron et al., 1991) have all been shown to mediate adhesion to epithelial cells 
and/or colonisation of host mucosal surfaces. Although the target ligand is not known 
for most type IV pili, it has been shown that the P. aeruginosa type IV pilus binds to 
specific glycoproteins from buccal epithelial cells (Doig et al., 1990; Schweizer et 
al., 1998). The binding of type IV pili to host receptors has been shown to be host 
and pilus specific, at least for the M bovis type IV pilus, since expression of M bovis 
pili by P. aeruginosa allows this strain to adhere to cultured bovine lens epithelial 
cells (Ruehl et al., 1993). Monoclonal antibody studies on the P. aeruginosa type IV 
pilus indicated that the adhesin moiety lies near the C-terminal disulphide loop (Doig 
et al., 1990). In contrast, similar studies on the N gonorrhoeae type IV pilus 
indicated that the adhesin lies towards the C-terminus of the N-terminal conserved 
region (Rothbard et al., 1985). 
1.9.2.2.2. Twitching Motility 
Twitching motility is a flagellar-independent motility manifested as a jerky 
motion of the bacterial cell when viewed in suspension, and as rapidly spreading 
colonies on agar surfaces incubated under humid conditions. Such motility appears to 
be important for full virulence of P. aeruginosa, as non-twitching, hyperpiliated 
mutants are non-infectious (Hazlett et al., 1991). Electron microscopic studies of 
twitching motility mutants, and the pattern of bacteriophage binding, led to the 
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suggestion that twitching motility is a process mediated by pilus extension and 
retraction, presumably operating via a pilin subunit assembly-disassembly cycle 
(Bradley, 1980). It has been suggested that twitching motility, protein secretion and 
DNA uptake all occur via rotation of a basal complex which spans the inner and 
outer membranes. This complex would consist of several proteins with type IV 
leader sequences, and would be driven by energy provided by nucleotide binding 
proteins, such as XcpR or ComG-1 in P. aeruginosa (Mattick and Alm, 1995). 
1.9.2.2.3. Other functions of type IV pili 
Several other functions have also been attributed to type IV pili, including their 
role as bacteriophage receptors and in mediating competence for DNA uptake. These 
roles may enhance pathogenicity by indirect mechanisms, such as by the acquisition 
of new virulence determinants. In one case, this has indeed been shown to be the 
case. Production of the toxin-co-regulated pilus (TCP) by strains of V. cholerae is a 
prerequisite for this bacterium to cause cholera. TCP has been shown not only to be 
the major virulence determinant required for colonisation of the intestinal tract 
(Attridge et al., 1996; Taylor et al., 1987), but it also acts as a receptor for a 
filamentous bacteriophage that encodes cholera toxin, the major toxin responsible for 
the production of cholera dysentery (Waldor and Mekalanos, 1996). As described 
earlier, it has recently been demonstrated that TCP itself is a bacteriophage (Karaolis 
et al., 1999). Therefore, in order to become fully pathogenic, certain strains of V. 
cholerae must first have become infected with the TCP phage, and the subsequent 
expression of this pilus (phage) enables the bacterium to colonise the host intestine 
and to become toxigenic (Karaolis et al., 1998). 
In summary, type IV pili have been described on a wide variety of Gram-
negative bacterial pathogens. These structures are characterised by a number of 
conserved molecular features, particularly by their N-terminal amino acid sequences. 
Although the role of type IV pili in pathogenesis is poorly understood for many 
species, these structures are known to perform several functions, including adhesion 
to host cell surfaces and twitching motility. Type IV pili have been identified on 
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several strains of Aeromonas species, and what was known regarding these structures 
at the commencement of this thesis will be discussed in detail in section 1.10.2.2. 
1.10. Aeromonas filamentous surface structures 
1.10.1. Aeromonas flagella 
With regard to diarrhoeal disease, very little is known regarding the role of the 
Aeromonas polar or lateral flagellum systems. It has been demonstrated that the 
possession of polar flagella is essential for the ability of A. hydrophila 0:34 strains to 
adhere to, and invade fish cell lines (Merino et al., 1997b). Two tandemly located 
flagellin genes, flaA and flaB, have been cloned from a strain of A. salmonicida 
(Umelo and Trust, 1997), but the adhesive and invasive ability of isogenic mutant 
strains has not been examined. Although A. salmon icida is generally considered to be 
non-motile, due to the lack of a polar flagellum, growth at 30 to 37°C has been 
shown to induce a motile phenotype due to the production of these structures 
(McIntosh and Austin, 1991). 
The presence of peritrichous, or lateral, flagella has also been noted in 
Aeromonas species (Shimada et al., 1985; Thornley et al., 1997). The lateral flagellin 
has been purified, and the N-terminal amino acid sequence of this protein exhibited 
significant homology with the lateral flagellin of Vibrio parahaemolyticus (Thornley 
et al., 1997). Two genes (lafAl and lafA2) have been cloned that encode the lateral 
flagellin proteins, as well as a gene (lafB) predicted to encode a flagellar hook 
protein (J. G. Shaw, personal communication). To date, the genes encoding lateral 
flagella have only been found in — 35 to 50% of strains tested. The role(s) of these 
structures in colonisation of the gastrointestinal tract are currently under 
investigation in our laboratory, and in the laboratories of other investigators. 
1.10.2. Aeromonas pili 
The majority of work investigating Aeromonas pili has involved protein 
purification and morphological studies. At the commencement of this thesis, there 
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was only one study published investigating an Aeromonas pilus at the genetic level 
(Ho et al., 1992). The remainder of this review is divided into two major sections 
discussing these morphological and protein purification studies. 
1.10.2.1. Morphological studies 
Studies of the filamentous structures produced by Aeromonas species using 
electron microscopic techniques have painted a complex picture of these appendages. 
Numerous different morphological types have been observed and these vary with the 
species, source and growth conditions of a particular isolate. 
Broadly, Aeromonas pili described in the literature have been divided into two 
different morphological types, the "short-rigid" (SIR) and the "long-flexible/wavy" 
(L/W) pili. However, this nomenclature is somewhat over-simplified, since within 
each morphological group, a variety of pilus types have been observed. L/W pili of 
varied widths (4-10 nm), may occur singly or in bundles (Carrello et al., 1989; Ho et 
al., 1990; Kirov et al., 1995b; Kirov et al., 1998). SIR pili (7-10 nm in width) have 
also been observed, as have filamentous networks and aggregates that do not clearly 
emanate from any one point on the bacterium (Kirov et al., 1995b). The latter are 
morphologically similar to E. coli curli (Olsen et al., 1989), and the V. cholerae Type 
B fimbriae identified in the study by Hall et al. (1988). 
The filamentous structures described in the study by Kirov et al. (1995b) were 
increased in number when bacteria were grown at low temperatures (. 20°C) in 
liquid medium, and this observation correlated with increased cell-line adhesion 
levels for strains grown under such conditions. Similarly, strains sheared of their 
surface structures exhibited decreased adhesion to cell lines. The long-flexible and 
short-rigid pili have been characterised further by protein purification studies. 
1.10.2.2. Protein purification studies 
1.10.2.2.1. Short-rigid (SIR) pili 
Short-rigid pili have been purified from three strains of A. hydrophila (Sato et 
al., 1989; Ho et al., 1990; Honma and Nakasone, 1990). The 17 IcDa subunit protein 
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exhibited high N-terminal amino acid sequence homology with the type I pilin 
proteins from Serratia marcescens, Haemophilus influenzae, and the P pilus of 
uropathogenic E. coli (Ho et al., 1990). However, in contrast with the latter, the 
Aeromonas pili did not haemagglutinate human or guinea pig erythrocytes (Ho et al. 
1990). Furthermore, these pili did not bind to intestinal cells (Sato et al., 1989; 
Honma and Nakasone, 1990). Therefore, the role, if any, of these pili in intestinal 
colonisation remains unknown. However, short-rigid pili are involved in 
autoaggregation of bacteria and, as such, may assist in microcolony formation 
(Honma and Nakasone, 1990). 
1.10.2.2.2. "Mini pilin" 
The long-flexible pilus characterised by Ho et al. (1990) was an entirely novel, 
flexible "pilus" identified on a strain of A. hydrophila. This pilus was composed of a 
unique 46 amino acid hydrophobic polypeptide repeating subunit, and had an N-
terminal sequence that exhibited no homology with any other known pilus proteins. 
This pilus was maximally expressed under defined environmental conditions (growth 
at 22°C vs 37°C, iron limiting conditions, and liquid medium) and haemagglutinated 
erythrocytes in a fiicose, mannose and galactose resistant manner. The gene encoding 
mini pilin (fxp) was subsequently cloned and localised to a 7.6 kb plasmid (Ho et al., 
1992). However, sequences homologous with fxp were not identified by Southern 
hybridisation in any of 66 other Aeromonas strains analysed in this study. The 
authors proposed that fxp encoded a unique structure, possibly widely distributed in 
nature, that was carried on a genetic element rapidly lost from most strains during in 
vitro cultivation (Ho et al., 1992). This suggestion was supported by the study of 
Brown et al. (1997), who demonstrated that plasmid DNA is uncommon in 
Aeromonas species. 
An alternative possibility for the true identity of "mini pilin" was revealed in 
1996 following the discovery of a filamentous bacteriophage (CD4). This phage 
encodes the cholera, Ace and Zot toxins possessed by epidemic and pandemic strains 
of V. cholerae (Waldor and Mekalanos, 1996). The major repeating subunit of CTX•1) 
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(Cep) was similar to "mini pilin" (Fxp) with respect to size (50 and 47 amino acids, 
respectively), hydrophobicity, and amino acid sequence homology (27.5% identity, 
64% similarity). Moreover, the replicative form of CTX(I) DNA was 7 kb, 
comparable to the size of the "mini pilin" plasmid (7.6 kb). Therefore, it seems likely 
that the flexible pilus characterised by Ho et al. (1990; 1992) is actually a 
filamentous phage particle. This fact may also give some clues as to the promiscuous 
nature of fxp. In V. cholerae, CTX4) uses the toxin co-regulated pilus (TCP) as a 
receptor, and uptake of the phage particle not only relies on the recipient strain 
possessing TCP genes, but also that they are expressed. In Aeromonas, the receptor 
for Fxp, like TCP, may only be expressed by a limited subset of strains, for example, 
those belonging to a specific species and serogroup, during growth in defined 
environmental conditions. Hence, the distribution of strains possessing fxp would, at 
most, be limited to these strains. 
1.10.2.2.3. Long-flexible pili 
The "mini-pilin" described above has often been confused with other L/W pili 
produced by Aeromonas species. Clearly, this structure is different from other pilus 
structures purified from the surface of several strains of Aeromonas bacteria, and 
these pili have been studied in more detail at the protein level than the structures 
described above. L/W pili are the predominant type produced by Aeromonas strains 
(particularly A. veronii biovar sobria) recovered from diarrhoeal stools (Carrello et 
al., 1988; Kirov et al., 1995b). Examination of these strains by electron microscopy 
revealed L/W pili existing as isolated structures and as rope-like bundles (Kirov et 
al., 1995b). However, subsequent immunogold labelling of surface pili on a strain of 
A. veronii biovar sobria, with an antiserum raised against the purified subunit protein, 
revealed that both isolated and bundles of pili were composed of the same subunit 
protein (Kirov and Sanderson, 1996). Due to their tendency to form bundles, these 
pili have been referred to as bundle-forming pili (Bfp). It should be noted, however, 
that these structures belong to the type IVA class of pili, and are different to the type 
IVB bundle forming pili of enteropathogenic E. coli. The observed difference in pilus 
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morphologies composed of the same subunit protein is reminiscent of the type IV pili 
produced by Neisseria men ingitidis. For this species, similar morphological changes 
in surface pili have been shown to occur as a consequence of primary amino acid 
sequence changes producing alternate glycosylation sites (Virji et al., 1993). 
L/VV pili have been purified from the surface of several Aeromonas isolates, 
and N-terminal amino acid sequencing has revealed that they all belong to the type 
IV class of pili (Hokama et al., 1990; Hokama and Iwanaga, 1992; Iwanaga and 
Hokama, 1992; Kirov and Sanderson, 1996; Nakasone et al., 1996; Kirov et al., 
1998). These pili were all 19 to 23 kDa in size and approximately 7 nm in diameter. 
The N-terminal sequences of the Aeromonas pili were most similar to the mannose-
sensitive haemagglutinin (MSHA) pilus of Vibrio cholerae (Fig. 1.1.). 
Although the N-terminal sequences of these pili are highly homologous, there 
does appear to be significant antigenic diversity between the pili of different strains. 
Large-scale antigenic screening of several culture collections have identified few 
cross-reactive isolates (Hokama et al., 1990; Hokama and Iwanaga, 1992; Iwanaga 
and Hokama, 1992; Kirov and Sanderson, 1996). This observation presumably 
reflects significant sequence divergence in the primary amino acid sequence of the C-
terminal regions of the pilin proteins. Antigenic variation may also be aided by 
alternate glycosylation states as described above (Virji et al., 1993). 
1.10.2.2.4. Role as colonisation factors 
The Aeromonas L/W pili appear to mediate adhesion to intestinal tissue. All 
purified pili examined to date have been shown to adhere to either formalin-fixed 
rabbit intestinal tissue (Hokama and Iwanaga, 1992; Iwanaga and Hokama, 1992; 
Nakasone et al., 1996; Kirov et al., 1999), or to human intestinal tissue obtained as 
surgical specimens (Hokama et al., 1990; Kirov et al., 1999). Furthermore, pre-
treatment of the intestinal tissue with purified pili, or pre-treatment of the bacteria 
with the Fab fraction of immune antisera, dramatically reduced adhesion levels. 
Levels of reduction of 50% (pili pre-treatment) and 80% (antisera pre-treatment) 
have been reported (Nakasone et al., 1996; Kirov et al., 1999). These pili either 
failed to haemagglutinate human erythrocytes (Iwanaga and Hokama, 1992; Kirov 
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Fig. 1.1. Amino acid sequence alignment of type IV pilin proteins purified 
from Aeromonas species. 
Conserved residues are shaded black. Species abbreviations and the pilin subunit 
designations are as follows: Bfp pili; Avbs BC88, A. veronii biovar sobria BC88, Sfp 
(Kirov and Sanderson, 1996); Ac CA195, A. caviae CA195, Cfp (Kirov et al., 1998); As 
Ae24, 'A. sobria' Ae24 (Hokama and Iwanaga, 1992); As TAP13, 'A. sobria' TAP13 
(Iwanaga and Hokama, 1992); As Ael, 'A. sobria' Ael (Hokama and Iwanaga, 1991); Ah 
Ae6, A. hydrophila Ae6 (Hokama et al., 1990); At 1220, A. trota 1220 (Nakasone et al., 
1996); Vc MshA, Vibrio cholerae 01 El Tor Phil 6973, MshA (Jonson et al., 1994); Ah 
Ah65. 
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Avbs BC88 : TLIELVIVIIILGILAVTAAPKFLN : 26 
Ac CA195 : M TLIELVIVIIILGILAVTAAPKFLNLQDD : 30 
At 1220 : Y TLIELVIVIIILGILAVTAAPKFL  : 25 
As Ae24 : Y TLIELVIVIIILGILADDA  : 20 
As TAP13 : Y TLIELVIVIIILGILA  : 17 
As Ael : M TLIELVIVI  : 10 
Ah Ae6 : M TLIELVIVI  : 10 
Vc MshA : TLIELVTVI ILGILAVTAAPP.  FLNLQ : 30 
and Sanderson, 1996; Nakasone et al., 1996), or did exhibit haemagglutination in a 
galactose- and mannose-sensitive, fucose-resistant manner (Hokama et al., 1990; 
Hokama and Iwanaga, 1992). The latter is identical to the sugar sensitivity exhibited 
by the MSHA pilus of V. cholerae (Jonson et al., 1991). 
The adhesive ability of the purified pili supports results obtained in several 
more indirect studies. Maximal adhesion to cell lines has been shown to occur when 
strains are grown under conditions that promote the expression of flexible pili. 
Furthermore, removal of the structures by mechanical or enzymatic methods has 
been shown to decrease adhesion levels by 60 to 80% (Carrello et al., 1988; Kirov et 
al., 1995a). 
1.11. Overall summary 
In summary, although still the subject of some controversy, it is widely 
believed that some strains of Aeromonas bacteria are significant enteropathogens. 
The use of molecular biology techniques has dramatically increased the knowledge 
of the taxonomy and virulence mechanisms of Aeromonas species. Three species of 
Aeromonas are commonly associated with human gastroenteritis, and the 
pathogenesis of diarrhoeal disease caused by each of these is likely to involve 
different virulence mechanisms. However, there are still many unresolved questions 
regarding Aeromonas pathogenesis and it is not possible to identify pathogenic 
strains definitively. It is likely that such strains possess a combination of virulence 
factors that allow the production of diarrhoeal disease symptoms. Adhesion and 
colonisation of the gastrointestinal tract is an important initial step in this process and 
filamentous surface structures are likely be involved in this initial binding. Type IV 
pili have been purified from several strains of Aeromonas and work to date suggests 
that these structures are important colonisation factors for all three species commonly 
associated with gastrointestinal disease. However, the role of these structures has not 
been established definitively. The genetic analysis and role of these structures in 
Aeromonas gastrointestinal infection will be investigated in this thesis. 
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1.12. Aims of this thesis 
The initial aim of this thesis was to clone the genes encoding the type IV pili 
expressed by a strain of A. veronii biovar sobria (Bfp). In the course of this 
investigation, the genes encoding a second family of type IV pili (Tap) were cloned, 
demonstrating that Aeromonas species encode two families of type IV pili (Ch 3). 
The genes encoding Tap pili were found to be widely conserved in the genus 
Aeromonas (Ch 4). The expression of the encoded Tap pili, and an analysis of the 
ability of wild type and mutant strains to adhere to cell lines, and to colonise and 
produce diarrhoeal symptoms in animal models was investigated to determine the 
significance of Tap pili as colonisation factors (Ch 5). 
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2.1. Bacterial strains and plasmids 
Aeromonas isolates used in this thesis were obtained from the culture 
collection stored at the Discipline of Pathology, University of Tasmania, or were 
gifts from other laboratories. A detailed list of all A. veronii biovar sobria, A. 
hydrophila and A. caviae strains is given in Appendices la, lb and lc, respectively. 
Aeromonas type strains, and any strains not belonging to the above species are listed 
in Appendix id. E. coli laboratory strains are listed in Appendix le. A list of 
plasmids used in this thesis is given in Appendix 2. 
2.2. Bacterial maintenance and growth conditions 
All bacterial strains were stored in glycerol storage medium (Appendix 3.1.2) 
at -80°C and as stabs in minimal maintenance medium (MMM, Appendix 3.1.1). 
All bacterial strains, except for E. coli laboratory strains, were routinely 
cultured in tryptone soya broth containing 0.6% yeast extract (TSBY, Appendix 
3.1.3) or on tryptone soya agar containing 0.6% yeast extract (TSAY, Appendix 
3.1.4). 
E. coli strains were routinely cultured in Luria-Bertani (LB) broth (Appendix 
3.1.5) or on LB agar (Appendix 3.1.6). 
Antibiotics and other additives were added to growth media, when required, at 
the concentrations listed in Appendix 4. 
2.3. Animals 
Animals used in this thesis were housed in appropriate cages, either within the 
Discipline of Pathology Animal holding facility (mice) or at the Central Animal 
House, University of Tasmania (rabbits). Rabbits used for the removable intestinal 
tie adult rabbit diarrhoea! (R1TARD) model were held at the Centre for Diarrhoea! 
Disease Research, Dhaka, Bangladesh. All animals were obtained and used with 
permission of the University of Tasmania Ethics Committee (Animal 
Experimentation). 
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Mice used in this thesis were BALB/c inbred mice. Rabbits used for antiserum 
production were New Zealand white rabbits. 
2.4. Enzymes and immunoconjugates 
Enzymes and immunoconjugates used in this thesis are listed in Appendix 5. 
2.5. DNA extraction procedures 
2.5.1. Preparation of genomic DNA 
Genomic DNA was prepared from Aeromonas strains using a modification of 
the procedure described by Ausubel et al. (1994). In brief, overnight cultures (10 ml) 
were pelleted by centrifugation (3000 x g, 15 min) and resuspended in 5.7 ml TE 
buffer. Sodium dodecyl sulphate (SDS) and proteinase K were added to final 
concentrations of 0.5% w/v and 100 pg/ml, respectively. Following incubation at 
37°C for 1 h, NaCl was added to a final concentration of 0.8 M, followed by 0.8 ml 
CTAB solution (Appendix 6.1.2.), and the mixture was mixed gently by inversion 
and incubated at 65°C for 10 min. CTAB, exogenous polysaccharides and proteins 
were removed by one to three extractions with chloroform. DNA was recovered 
following the addition of 0.7 volumes of isopropanol and centrifugation (3000 x g, 
30 min) at 4°C and resuspended in sterile milliQ water. 
2.5.2. Preparation of plasmid DNA 
2.5.2.1. Boiling miniprep method 
Small scale preparations of small (< 10 kb), high copy number plasmids were 
prepared using the protocol of Liu and Misra (1995). Briefly, 200 [IL overnight 
cultures in Terrific broth (Appendix 3.1.7) were grown in 1.5 ml Eppendorf tubes 
with vigorous shaking. Cells were pelleted by brief centrifugation (15000 x g, 2 min) 
and resuspended in 40 IA STT buffer (Appendix 6.1.3) containing 1 mg/ml 
lysozyme. The resulting cell suspensions were lysed by placing in a boiling water 
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bath for 1 min, and cell debris was removed by centrifugation (15000 x g, 10 min). 
The remaining supernatant was used directly for restriction enzyme digestion and 
agarose gel electrophoresis. 
2.5.2.2. Alkaline lysis 
Small and large scale preparations of plasmid DNA were prepared according to 
the protocol of Birnboim and Doly (1979). Briefly, overnight cultures were prepared 
in 50 ml LB or Terrific broth. Cells were recovered by centrifugation (3000 x g, 15 
min), and were resuspended in 4 ml of Solution I (Appendix 6.1.4.). Solution II (8 
nil; Appendix 6.1.5) was added and the mixture was mixed gently by inversion and 
incubated at room temperature for 5 min. SDS and the majority of chromosomal 
DNA was precipitated following the addition of 6 ml ice-cold solution III (Appendix 
6.1.6), and the resulting mixture was again mixed by inversion. Following incubation 
on ice for at least 10 min, the flocculent white precipitate was removed by 
centrifugation (3000 x g, 15 min) at 4°C, and RNA was removed by digestion with 
RNase A at a final concentration of 5 p,g/m1 for 10 min. Plasmid DNA was recovered 
by centrifugation (3000 x g, 30 min) at 4°C, following the addition of 0.7 volumes of 
isopropanol, and resuspended in sterile milliQ water. 
The above procedure was scaled appropriately for larger and smaller culture 
volumes. 
2.5.2.3. Small scale minipreps for sequencing 
Small scale plasmid preparations for DNA sequencing were prepared using 
Qiaprep spin kits (Qiagen, Hilden, Germany), according to the manufacturer's 
directions. 
2.5.2.4. Large scale plasmid preparations 
Large scale plasmid preparations were prepared using Qiagen midiprep 
columns (Qiagen, Hilden, Germany), according to the manufacturers directions. 
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2.6. Analysis and manipulation of DNA 
2.6.1. DNA quantitation, digestion, and electrophoresis 
DNA was quantified by measuring absorbance at 260 and 280 nm, digested 
with restriction enzymes, and separated by agarose gel electrophoresis using TAE 
buffer (Appendix 6.2.1), as described by Sambrook etal. (1989). 
2.6.2. Isolation of DNA fragments by agarose gel electrophoresis 
DNA fragments separated by agarose gel electrophoresis were purified using 
an agarose gel DNA extraction kit (Boehringer Mannheim, Castle Hill, Australia). 
For size-fractionation of chromosomal DNA digests, agarose gel slices were frozen 
at —80°C, and the DNA was recovered by spinning through a cone of Whatman 3M 
filter paper placed in a 1.5 ml Eppendorf tube. The DNA was then ethanol 
precipitated and resuspended in sterile milliQ water. 
2.6.3. End-filling with Klenow fragment 
DNA polymerase I large (Klenow) fragment was used to end-fill 5' DNA 
overhangs to allow blunt-end cloning experiments, according to the manufacturers 
instructions. Briefly, the desired DNA fragment was purified as described in section 
2.7.2, precipitated with 0.1 volumes of 3 M sodium acetate and 2.5 volumes of ice-
cold 95% ethanol, and resuspended in 9 11,1_, of sterile water. The DNA solution was 
transferred to a 37°C waterbath and 1 pi,L of Klenow mix (Appendix 6.3.1) was 
added. Following incubation (37°C for 3 min), 1 [IL dNTP mix (Appendix 6.3.2) was 
added and the mixture was allowed to incubate for a further 5 min at 37°C. The 
Klenow fragment was inactivated by incubation at 65°C for 10 min, and the resulting 
mixture used directly for ligation reactions. 
2.6.4. In vitro cloning 
DNA fragments were ligated into plasmid vectors using T4 DNA ligase 
according to standard methods (Sambrook et al., 1989). The ligation reaction was 
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allowed to incubate (1 to 4 h) before being transformed into competent E. coli cells 
(see section 2.8.1). 
2.6.5. Dye-terminator sequencing 
DNA sequencing was performed by the dye-terminator method (Perkin Elmer, 
Norwalk, U.S.A.) using double-stranded plasmids as template DNA. M13 forward 
and reverse oligonucleotides (Appendix 7) were used as primers. Cycle sequencing 
was performed on a PTC100 thermal cycler (MJ Research, Boston, U.S.A.) and 
analysed on a ABI prism 377 DNA sequencer (Perkin Elmer, Norwalk, U.S.A.) at the 
Molecular Biology Facility, School of Biomolecular and Biomedical Science, 
Griffith University, Nathan, Queensland, Australia. The nucleotide sequence of both 
strands was determined for all inserts. DNA sequences were assembled using 
Sequence Navigator computer software (Perkin Elmer, Norwalk, U.S.A.). Searches 
for homologous database sequences were performed using BLAST (Basic Local 
Alignment Search Tool, National Center for Biotechnology Information; (Altschul et 
al., 1990; Gish and States, 1993; Altschul et al., 1997). 
2.7. Bacterial transformation and conjugation 
2.7.1. Bacterial transformation 
To prepare competent E. coli, an overnight culture of the appropriate E. coli 
strain was inoculated into 200 ml LB broth and grown to mid-log phase (0D 650 = 0.6) 
at 37°C. This culture was cooled briefly (5 min) on ice and cells were pelleted by 
centrifugation (5000 x g, 15 min, 4°C). The cell pellet was resuspended in 100 ml 
solution a (Appendix 6.4.1), and the cells were again recovered by centrifugation. 
The cell pellet was then resuspended in 10 ml solution 13 (Appendix 6.4.2), and 
incubated on ice for approximately 2 h. Aliquots (500 IA) of this cell suspension 
were snap-frozen in liquid nitrogen, and stored at —80°C. 
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For transformation, 100 pl competent cells were added to the plasmid solution 
(-10 111) to be transformed and incubated on ice for 10 min. The cells were heat 
shocked in a 37°C waterbath for 3 min, and returned to ice for a further 15 min. SOC 
medium (400 pi; Appendix 3.1.9) was added to each tube, and the cells were 
incubated at 37°C with shaking (200 rpm) to allow expression of the antibiotic 
resistance marker. Individual transformants were selected by plating aliquots of each 
transformation mixture onto LB agar containing the appropriate selective antibiotics. 
IPTG (1 mM) was added for selection of clones in pZEr0-2.1, while IPTG and 50 
ps/m1X-gal were added for the selection of clones by blue/white screening. 
2.7.2. Bacterial conjugation 
Mobilisable plasmids were transferred to recipient cells following conjugal 
mating on solid media. This system utilised the RP4 mobilisation system present 
within E. coli 517 -1Apir. Cultures (500 IlL) of log phase donor (E. coli S17-1Apir 
containing the appropriate donor plasmid) and recipient cells were mixed and the 
bacteria recovered by centrifugation. The bacterial pellet was gently resuspended 
(100 1AL LB broth), pipetted onto the surface of a LB agar plate, and incubated at 
37°C. Following incubation, the conjugation mix was harvested into 5 ml LB broth, 
and serial dilutions were plated onto LB agar plates containing the appropriate 
selective and counter-selective antibiotics. 
2.8. Preparation of cosmid DNA libraries 
A cosmid library of A. veronii biovar sobria BC88 DNA was constructed in the 
cosmid vector pTB023 (see section 3.3.1.1). DNA from strain BC88 (250 rig) was 
digested in a reaction volume of 300 tiL. Following the addition of 15 U Sau3A I, the 
reaction mix was briefly mixed and incubated at 37°C. Aliquots (50 IlL) were taken 
after 0, 15, 30, 60, 90 and 120 s, and the enzyme was heat-inactivated by incubating 
at 80°C for 15 min. Digestion was monitored by agarose gel electrophoresis, and 
fractions that resulted in — 40 kb fragments were ligated into pTB023. The latter was 
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prepared by digesting pTB023 with BamH I, after which the enzyme was inactivated 
by incubation at 80°C for 15 min. Approximately 101.ig of the BC88 DNA fragments 
were mixed with 1 !As of the vector and ligated overnight at room temperature. 
The ligation mixture was packaged directly into bacteriophage k using 
Packagene extract (Promega, Madison, U.S.A.). Following incubation at room 
temperature for 2 h, 400 III, phage buffer (Appendix 6.5.1) was added, and the 
mixture was used to transduce 2 ml E. coli S17-12pir by incubation at 37°C for 30 
mm. Transductants were selected on LB agar containing 25 [ig/m1 chloramphenicol. 
E. coli S17-1Apir used for phage infection was prepared as follows. Following 
overnight growth at 37°C in LB broth supplemented with 0.2% maltose, a log-phase 
culture was prepared by adding 1 ml of the overnight culture to 20 ml LB broth 
supplemented with 0.2% maltose and 2 mM Mg504 , followed by incubation at 37°C 
for 2 h with shaking. Bacteria in the resulting culture were pelleted and resuspended 
in 2 ml LB supplemented with maltose and MgSO 4, as described above. 
Individual cosmid clones were screened for full-sized inserts by replica plating 
on LB agar containing 12.5 Ag/m1 tetracycline. As DNA fragments were cloned into 
the BamH I site, situated within the coding region of the tetracycline resistance gene 
of pTB023, only Tet s clones would contain full-length insert DNA. 
2.9. Polymerase chain reaction 
2.9.1. Synthesis of oligonucleotides 
All oligonucleotides used in this thesis were synthesised commercially, and are 
listed in Appendix 7. The annealing temperature used for each PCR primer is also 
listed. 
2.9.2. Polymerase chain reaction (PCR) 
Each PCR mixture (50 [tL) consisted of 5 1.11, 10 x PCR buffer (Appendix 
6.6.1), 0.2 mM each of dGTP, dATP, dCTP and dTTP, 2.5 U HotStarTaq DNA 
49 
polymerase, 250 ng of each primer; and 1 — 5 !IL of template DNA. An initial 
denaturation step (96°C for 10 min), was followed by 30 - 40 cycles of denaturation, 
annealing and extension on a PTC100 thermal cycler with a hot bonnet (MJ 
Research, Boston, USA). 
For labelling of DNA probes used in Southern hybridisation experiments, 0.18 
mM dTTP and 0.02 mM digoxigenin-11-dUTP (Boehringer Mannheim, Castle Hill, 
Australia) were added to each reaction tube. 
2.10. DNA hybridisation 
2.10.1. Southern hybridisation 
DNA samples were digested with restriction enzymes and fragments were 
separated by agarose gel electrophoresis as described in section 2.7.1. The DNA was 
then depurinated in 0.25 M HC1 for 15 mm, denatured in 0.5 M NaOH, 1.5 M NaCl 
for 15 mm, and transferred overnight to a nylon membrane (Micron Separations Inc., 
Westborough, USA), using 0.5 M NaOH, 1.5 M NaC1 as described by Sambrook et 
al. (1989). Following transfer, membranes were washed in 2 x SSC for 10 mm, and 
baked at 120°C for 20 min. Membranes were prehybridised for 1 h in hybridisation 
solution (Appendix 6.7.2, 6.7.3), at 42°C. For high stringency hybridisation, 40% v/v 
deionised formamide was included in the hybridisation solution. Hybridisation was 
performed at 42°C overnight in 40 ml hybridisation solution containing the 
appropriate labelled DNA (25 ng/ml), or oligonucleotide (10 pmol/ml) probe. 
Subsequently, membranes were washed twice in 2 x SSC, 0.1% SDS at room 
temperature and twice in 0.5 x SSC, 0.1% SDS at 50°C (low stringency), or 65°C 
(high stringency). 
Hybridisation with digoxigenin (DIG)-labelled probes was detected using the 
DIG luminescent detection kit (Boehringer Mannheim, Castle Hill, Australia) as 
follows. Membranes were washed briefly in wash buffer (Appendix 6.7.5) and 
protein binding sites were blocked by incubating in buffer 2 (Appendix 6.7.6) for 30 
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min at room temperature. The membranes were incubated in a 1:5000 dilution of 
sheep-anti-DIG-alkaline phosphatase conjugate (in buffer 2) for 1 h, and washed 
twice in wash buffer for 15 min. Membranes were then equilibrated in buffer 3 
(Appendix 6.7.7) for 5 min, and incubated with 1 m1/100 cm' CSPD solution (1:100 
dilution in buffer 3) for 15 min. Membranes were then sealed in plastic bags, 
incubated at 37°C for 30 min, and exposed to Cronex orthoTG X-ray film (Sterling 
Diagnostic Imaging, Newark, U.S.A.). Exposed films were detected using an 
automatic processor (Kodak, Rochester, U.S.A.), located in the Department of 
Radiology, Royal Hobart Hospital. 
2.10.2. DNA colony blot 
For colony blotting experiments, individual bacterial cultures (5 ml) were 
pipetted onto the surface of nylon membranes and lysed by incubation in lysis buffer 
(Appendix 6.7.8) for 15 min. Following lysis, the membranes were neutralised by 
incubating in neutralisation buffer (Appendix 6.7.9) for 5 min and in 2 x SSC for 15 
min. Membranes were baked (120°C, 30 min) and washed in 3 x SSC, 0.1% SDS for 
3 h. The membranes were then subjected to hybridisation with DIG-labelled probes 
as described in section 2.12.1. 
2.11. Blotting and immunological detection of proteins 
2.11.1. Colony blotting 
Individual bacterial cultures were either pipetted directly onto the surface of 
nitrocellulose membranes (broth cultures), or were applied by colony lift procedures 
(agar cultures), according to standard methods (Sambrook et al., 1989). The bacterial 
cells were lysed by placing the membrane onto a piece of filter paper soaked with 0.5 
M HC1 for 5 min. The membranes were then neutralised by washing in 0.05 M Tris-
HC1, pH 7.4 for 5 min. Immune detection was performed as described in section 
2.13.4. 
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2.11.2. SDS-PAGE 
Protein samples for electrophoresis were prepared by dilution into 1 x 
Lugtenberg's buffer (Appendix 6.8.1) followed by incubation in a boiling water bath 
for 5 min. 
Proteins were separated by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) by a modification of the protocol of Laemmli (1970), 
using the Mini-Protean II Dual Slab Cell system (Bio-Rad, Hercules, U.S.A.). 
Samples were subjected to electrophoresis in a polyacrylamide gel (Appendix 6.8) in 
1 x SDS-PAGE running buffer (Appendix 6.8.6). Proteins were visualised by 
staining in Coomassie blue (Appendix 6.8.7) for 1 h, washed in destain solution 
(Appendix 6.8.8) until the appropriate coloration was obtained, and rinsed twice (10 
min) in milliQ water. Destained gels were preserved by soaking in gel drying 
solution (Appendix 6.8.9) and pressing between two sheets of cellophane. 
2.11.3. Western transfer 
Proteins were transferred from polyacrylamide gels to nitrocellulose 
membranes following the protocol of Towbin et al. (1992), using a Mini Trans-Blot 
system (Bio-Rad, Hercules, U.S.A.). Electrophoretic transfer was conducted in 
transfer buffer (Appendix 6.9.1) at 30 V, overnight at 4°C. 
2.11.4. Immunological detection 
Protein binding sites were blocked by incubating the nitrocellulose membranes 
in blocking solution (Appendix 6.9.4) on an orbital shaker for 30 min. Membranes 
were then incubated in primary antibody solution (primary antibody diluted into 
blocking solution) for 2 to 24 h. Unbound primary antibody was removed by 
washing membranes three times in TTBS (Appendix 6.9.3) and once in TBS 
(Appendix 6.9.2). Membranes were then incubated in secondary antibody solution 
(secondary antibody solution diluted into blocking solution). Unbound secondary 
antibody was removed by washing membranes three times in TTBS and twice in 
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TBS. Immunodetected proteins were then visualised by incubating membranes in 
colour development solution (Appendix 6.9.5) until the appropriate level of staining 
was visible. Membranes were then washed extensively in milliQ water, dried, and 
sealed in plastic bags. 
2.12. Preparation of TapA antiserum 
A polyclonal rabbit antiserum raised against TapA from A. hydrophila Ah65 
was obtained from Dr. M. S. Strom, Northwest Fisheries Science Center, Seattle, 
U.S.A. An antiserum against TapA from A. veronii biovar sobria BC88 was prepared 
by the procedure described below. 
2.12.1. Induction of T7 expression cultures 
Expression of recombinant proteins from pET15b was accomplished following 
induction of the XDE3 lysogen (encoding T7 RNA polymerase) present in E. coli 
BL21(DE3) by a modification of the protocol described by the pET system manual 
(Novagen, Madison, U.S.A.). E. coli BL21(DE3) harbouring the appropriate plasmid 
was grown to mid-log phase (0D600=0.6) in LB broth containing 100 pig/m1 
carbenicillin, and the XDE3 lysogen was induced by the addition of 1 mM IPTG. 
Approximately 30 min after induction, rifampicin (200 1.1g/m1) was added to inhibit 
the activity of the host RNA polymerase. The induced culture was allow to incubate 
for a further 4.5 h at 37°C, with shaking (60 rpm). 
2.12.2. Inclusion body isolation 
Soluble and insoluble fractions of induced E. coli BL21(DE3) cultures were 
isolated according to the method of Reischl (1998). The induced cells from a 2 1 
culture were collected by centrifugation (5000 x g, 5 min) and resuspended in 200 ml 
sonication buffer (Appendix 6.10.1). Lysozyme and PMSF were added to final 
concentrations of 25 [Ig/m1 and 0.25 mM, respectively, and the cell suspension was 
sonicated 10 times on ice (30 s burst at full power, 30 s cooling). The insoluble 
material (crude inclusion bodies) was recovered by centrifugation (4000 x g, 20 min) 
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and the supernatant (soluble fraction) was retained for analysis. The insoluble 
material was washed by resuspending in 100 ml sonication buffer and centrifuging as 
above. 
2.12.3. Semi-purification of recombinant TapA 
Semi-purification of recombinant TapA (r-TapA) was accomplished by a 
modification of the protocol described by Reischl (1998). The insoluble material 
obtained in section 2.13.2, above, was resuspended in suspension buffer (Appendix 
6.10.2) containing 4 M urea, and vortexed vigorously for 5 min. The insoluble 
fraction was recovered by centrifugation (4000 x g, 10 min) and the supernatant 
saved for analysis. This procedure was repeated four times with suspension buffer 
containing 6 M urea. The final pellet was dissolved in 5 ml 1 x Lugtenberg's buffer. 
2.12.4. Production of antisera 
Polyclonal antibodies were generated against the r-TapA protein in New 
Zealand white rabbits. The r-TapA protein was isolated by SDS-PAGE. The gel slice 
containing the appropriate protein band was homogenised in 2 ml PBS by passing 
three times through a 18 gauge needle and three times through a 22 gauge needle. 
The resulting homogenate (— 100 ps r-TapA) was emulsified in 1 ml complete 
Freund's adjuvant and administered subcutaneously at multiple sites to each of three 
rabbits. The rabbits were boosted at days 21, 35, and 49 with —100 !As r-TapA 
emulsified in incomplete Freund's adjuvant. Blood (— 5 ml) was collected from the 
rabbits at days 28, 42, and 56, and assessed for antibody production. A final bleed of 
approximately 20 ml was taken at day 63. 
Sera were prepared as follows. Blood samples were allowed to clot, and placed 
at 4°C for 4 h to allow clot retraction. Clots were then removed carefully using a 
sterile pasteur pipette, and remaining cells were removed by centrifugation (3000 x 
g, 15 min, 4°C). Complement was inactivated by incubating the sera at 56°C for 15 
min. 
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2.12.5. Absorption of antisera 
Polyclonal antisera were absorbed against whole bacterial cells, bacterial cell 
lysates immobilised on nitrocellulose membranes, or against an acetone powder of 
the appropriate bacterial strain. 
For whole cell absorptions, a 1 ml culture of the appropriate bacterial strain 
was pelleted by centrifugation (15000 x g, 1 min) and resuspended in 1 ml of the 
unabsorbed antiserum containing 0.01% w/v NaN 3 . The mixture was incubated 4 to 
16 h at 4°C, and the bacterial cells were removed by centrifugation (15 000 x g, 2 
min). This procedure was repeated as needed. After the final absorption, the 
antiserum was sterilised by passing through a 0.2 [tm filter (Gelman Sciences, Ann 
Arbor, U.S.A.). 
For absorptions against whole cell lysates, lysates of the appropriate bacterial 
strain were immobilised on nitrocellulose membranes by western transfer as 
described in Section 2.13.3. The antiserum to be absorbed was diluted 1 in 5 in 
blocking solution (Appendix 6.9.4) and incubated with the nitrocellulose membrane 
sealed in plastic bags overnight, with shaking, at 4°C. This procedure was repeated 
as required, and the antiserum was sterilised by passing through a 0.2 i_tm filter 
(Gelman Sciences, Ann Arbor, U.S.A.). 
For absorption against an acetone powder, an acetone powder of the 
appropriate bacterial strain was prepared as follows. Cells from an overnight culture 
were pelleted by centrifugation (5000 x g, 10 min) and resuspended in 6 ml of 0.85% 
saline. Following incubation on ice for 5 min, 24 ml ice cold acetone was added, and 
the solution was mixed by vortexing. Insoluble material was pelleted by 
centrifugation (10000 x g, 10 min, 4°C), and resuspended in 10 ml ice cold acetone 
by vortexing. After incubation on ice for 10 min, the insoluble material was again 
recovered by centrifugation, transferred to Whatman 3M filter paper, and allowed to 
dry overnight. The pellet was then transferred to an air-tight container and ground 
into a fine powder using the blunt end of a sterile glass pasteur pipette. The resulting 
powder was subsequently used for absorptions by adding to antiserum samples to a 
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final concentration equivalent to 1% w/v. The mixture was incubated overnight at 
4°C with shaking, and the powder was removed by centrifugation (15000 x g, 5 
min). This procedure was repeated as needed, and the antiserum was sterilised as 
described above. 
2.13. Transmission electron microscopy 
Electron microscopic examinations were performed using a Philips 410 
transmission electron microscope housed in the Discipline of Pathology, University 
of Tasmania. 
2.13.1. Negative staining of bacteria 
A drop (60 111) of bacterial broth culture (or a quarter of a loop of agar culture 
suspended in 500 ml PBS) was placed onto clean dental wax, and a formvar-coated 
200 mesh nickel grid was floated on the bacterial suspension for 3 min. The grid was 
then washed by dipping 5 times into a drop of distilled water, excess fluid was 
removed by touching a small piece of filter paper to the side of the grid. The grid was 
floated on a 60 11,1 drop of uranyl acetate (Appendix 6.11.3) for 30 s, washed 
extensively with distilled water and allowed to dry on a piece of filter paper. 
2.13.2. Immune electron microscopy 
For immunogold electron microscopic examination, bacteria on formvar coated 
grids were prepared as described above, washed briefly in a drop of TTB buffer 
(Appendix 6.11.2) and floated on a drop of 5% bovine serum albumin in TTB for 15 
min to block protein binding sites. The grids were then washed three times in TTB 
and reacted on a drop of the TapA antiserum (1:10, 1:100 and 1:1000 dilution in 
TTB) for 60 min, which had been absorbed against an acetone powder of A. veronii 
biovar sobria BC88tapA::S2 as described in section 2.12.5. Grids were then washed 
as before and exposed to goat anti-rabbit IgG conjugated with 10 nm gold particles 
(BioCell, Cardiff, U.K.) diluted 1:50 in TTB for 60 min. The grids were then washed 
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and negatively stained, as described above. A 1:100 dilution of BI p antiserum served 
as a positive control for all immunogold electron microscopy experiments. 
2.14. Characterisation of Aeromonas veronii biovar sobria 
BC88tapA::f2 
2.14.1. Crude toxin preparation 
Crude toxin preparations consisted of cell-free culture supematants prepared 
from each test strain. In brief, following incubation in 5 ml TSBY (37°C, 200 rpm, 
20 h) cells were removed by centrifugation (3000 x g, 30 min) and the supernatant 
was sterilised by passing through a 0.2 mm filter (Gelman Sciences, Ann Arbor, 
U.S.A.). 
2.14.2. Haemolysin production 
Rabbit erythrocytes were prepared from New Zealand white rabbits by 
collecting approximately 2 ml blood into 10 ml Alsever's solution (Appendix 6.12.1) 
and the cells were recovered by centrifugation (600 x g, 10 min). The cells were then 
resuspended in PBS (Appendix 6.13.1), centrifuged as above, and the PBS and buffy 
coat were removed with a sterile pasteur pipette. This procedure was repeated until 
the PBS supernatant remained clear, and a 1% suspension of cells was prepared by 
adding 100 !al erythrocytes to 10 ml PBS. 
For the assay, 10011.1 PBS was added to all wells of a 96-well microtitre tray (U 
bottom wells; Nalgene, Rochester, U.S.A.), except those in column 2 and rows A (to 
which 100 111 distilled water was added for a positive control) and B (to which 100 
ml TSBY was added for a negative control). Each crude toxin preparation was added, 
in duplicate, to wells in column 2 except rows A and B. Doubling dilutions of each 
toxin were prepared from rows 2 to 12 by placing 100 p.1 of toxin into the following 
well containing PBS. The final 100 p.1 from row 12 was discarded. 100 p.1 of the 
erythrocyte suspension prepared above was then added to each well and the tray was 
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incubated at 37°C for 1 h followed by incubation at 4°C for 1 h. After this incubation 
the tray was centrifuged (600 x g, 10 min, 4°C). The haemolysin titre for each 
sample recorded as the highest dilution in which 50% haemolysis was observed. A. 
veronii biovar sobria CA110 (titre > 2048) and A. caviae CA 195 (titre = 0) were 
included as controls. 
2.14.3. Cytotoxin production 
A 96-well cell culture plate was seeded with Vero cells as described in section 
2.16.1, and incubated (37°C, 5% CO 2) until a confluent monolayer was produced. 
Serial 2-fold dilutions of each toxin to be assayed were then applied to each well, as 
described for the haemolysin assay (Section 2.16.2), except that MEM + 5% FCS 
was used in place of PBS. The plate was incubated for 40 min (37°C, 5% CO 2) after 
which the medium in each well was replaced with fresh medium. The cytotoxin titre 
was recorded as the highest dilution in which 75% of cells were dead or rounded. 
2.14.4. Enterotoxin production 
Enterotoxin production was measured by intestinal fluid accumulation in 2- to 
4-day-old suckling mice (Burke et al., 1981). Pontamine sky blue (0.05% w/v) was 
added to each crude toxin preparation to be assayed in order to aid visualisation 
during administration into the stomach. Each toxin (100 ill) was injected directly into 
the stomach of suckling mice via a 29 gauge needle. Mice were incubated in a moist 
37°C environment for 2 h after which they were placed on pre-weighed squares of 
aluminium foil and killed by cervical dislocation. Each mouse was then dissected and 
the intestines removed. Enterotoxin activity was recorded as a ratio of intestinal 
weight to the remaining body weight (IW:RBW). A ratio 0.075 was recorded as 
positive. 
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2.15. Cell culture 
2.15.1. Maintenance of cell lines 
Two cell lines, HEp-2 human laryngeal carcinoma cells (ATCC CCL23) and 
Henle 407 intestinal cells (ATCC CCL16) were used. All cell lines were cultured in 
Eagle's minimal essential medium (MEM; Appendix 3.2.1.) containing 5-10% foetal 
calf serum (FCS) and incubated at 37°C in a 5% CO 2 atmosphere incubator (Heraeus, 
Plainfield, U.S.A.). 
Cell lines to be subcultured were examined with an inverted phase contrast 
microscope to verify confluence and integrity of the monolayer. The old culture 
medium was removed and the monolayer was washed with 10 ml PBS, after which 1 
ml trypsin solution (Appendix 6.13.2.) was added. Following incubation (1 to 2 min), 
the cells were dislodged, and 10 ml MEM + 10% FCS was added. The cells were 
subsequently washed by centrifugation (600 x g, 5 min) and resuspended in 1 ml 
fresh MEM + 10% FCS. Approximately 0.3 ml of this cell suspension was then 
added to 10 ml MEM + 10% FCS in a T-25 tissue culture flask (Sarstedt, Leicester, 
U.K.) and incubated at 37°C in a 5% CO 2 atmosphere. 
2.15.2. Freezing and thawing of cell lines 
Cells to be frozen were washed, trypsinised and pelleted, as described above, 
and resuspended in 1 ml MEM containing 10% FCS and 20% v/v 
dimethylsulphoxide in 2 ml cryogenic vials (Nalgene, Rochester, U.S.A.). The vials 
were gradually frozen to —80°C using a Cryo-freezing container (Nalgene, Rochester, 
U.S.A.) and stored under liquid nitrogen. 
For recovery, vials of frozen cells were rapidly thawed in a 37°C water bath, 
and the cell suspension was diluted with an equal volume of MEM + 10% FCS 
added dropwise over 5 min, followed by a 15 mm incubation at room temperature. 
An equal volume of MEM + 10% FCS was again added dropwise over 5 min, and 
the cell suspension was allowed to stand for a further 15 min. The cells were washed 
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three times by centrifugation (200 x g, 5 min) and resuspension in 10 ml MEM + 
10% FCS. They were finally resuspended in 10 ml growth medium and incubated at 
37°C in a 5% CO2 atmosphere. 
2.15.3. Bacterial adhesion to cell lines 
Adhesion to cell lines was assessed by bright field microscopy, as described by 
Carrello etal. (1988). Briefly, 1 ml aliquots (1 x 10') of each strain in MEM + FCS 
were inoculated onto semi-confluent cell line cultures grown on glass coverslips. 
Following incubation (37°C, 5% CO2) for 60 min, non-adherent bacteria were 
removed by washing four times with 2 ml PBS. Cell monolayers were fixed with 1 
ml 3:1 methanol:acetic acid for 5 min, and stained with May-Grunwald and Geimsa 
stains (BDH, Poole, UK) and mounted for microscopy. A minimum of three 
coverslips were assayed for each strain in each experiment. 
2.15.4. Bacterial adhesion to intestinal tissue 
Bacterial adhesion to intestinal tissue was assessed as follows. Briefly, 5 x 10 6 
cfu of each strain to be tested diluted into 1 ml MEM + 10% FCS was inoculated 
onto intestinal tissue in 24-well tissue culture plates. Following incubation (37°C, 
5% CO2, 1 h), intestinal specimens were washed with PBS, fixed in formalin, 
embedded in paraffin and sectioned. Sections (10 lim) on glass slides were 
deparaffinised, hydrated and stained with haematoxylin - eosin for light microscopy. 
2.16. In vivo animal experiments 
2.16.1. Infant mouse colonisation and competition experiments 
BALB/c infant mice were inoculated orally with test bacteria according to the 
protocol of Attridge et al. (1993). Log phase cultures of each strain to be tested were 
diluted to obtain a culture containing — 2 x 10 8 cfu/ml. Blue food colouring (5 il1/m1) 
was added to facilitate monitoring of the inoculation procedure. The number of 
bacteria administered was determined retrospectively by plate counts. Three- to 5- 
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day-old infant mice were removed from their mothers 4 h prior to infection. They 
were inoculated by intragastric lavage with 50 [1.1 of bacterial suspension (— 1 x 10 7 
cfu per mouse) and held at 25°C for 24 h, after which time they were sacrificed and 
their intestines removed. The intestines were homogenised in 5 ml PBS and 
individual bacteria were quantitated by plate counts of serial dilutions of each 
homogenate on TSAY plates. 
For competition assays, log-phase cultures of wild-type and mutant strains 
were diluted to — 2 x 10 cfu/ml and a suspension containing equal volumes of each 
strain was prepared. Each mouse was administered 50 p,1 (— 5 x 10 5 of each test 
strain) of this suspension by intragastric lavage as described above. The precise input 
ratio was determined retrospectively by plating serial dilutions of the suspension on 
TSAY (total bacteria) and TSAY containing 50 mg/ml spectinomycin (mutant 
bacteria). Mice were sacrificed after 24 h, and their intestines were removed and 
homogenised in PBS. Individual bacteria were quantitated on selective media, as 
described above. The colonisation index was calculated as the ratio of wild-type to 
mutant colonies following 24 h incubation. 
2.16.2. Removable intestinal tie adult rabbit diarrhoeal (RITARD) 
model 
The RITARD model was performed by Dr. M. J. Albert at the International 
Center for Diarrhoeal Disease Research, Dhaka, Bangladesh. In brief, Aeromonas 
strains were tested in New Zealand white rabbits (1.25 to 1.65 kg, 7 to 9 weeks old, 3 
to 4 weeks post weaning) according to the protocol of Pazzaglia et al. (1990). Each 
strain was tested in nine rabbits, while five rabbits received E. coli EC101 as a 
negative control. Each rabbit was administered with 1 x 10 10 cfu in 10 ml BHIB, 
injected into the jejunum close to the ligament of Treitz. Animals were monitored for 
seven days for diarrhoeal symptoms and faecal shedding of bacteria. They were 
sacrificed 8 d post challenge. 
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3.2. Cloning of part of a type IV pilus gene cluster from Aeromonas veronii biovar 
sobria BC88 
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3.2.1.1. Degenerate oligonucleotide probe based on the Bfp N-terminal amino 
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3.3.2. Cloning of the 5' end of the bfp subunit gene by PCR 
3.4. Discussion 
3.1. Introduction 
As outlined in section 1.10.2.2, the type IV pili purified from diarrhoeal 
Aeromonas strains comprise a related family of structures, which have been termed 
Bfp pili. The initial aim of the experiments described in this chapter was to clone the 
gene(s) encoding the Bfp pilus expressed by A. veronii biovar sobria BC88. This 
would allow construction of an isogenic mutant strain, lacking this pilus, which 
could be used to establish definitively that this structure plays an important role in 
enterocyte adhesion and in vivo colonisation. Secondly, the availability of the cloned 
gene(s) would allow their distribution in Aeromonas species to be determined, and 
establish whether this pilus might be useful as a marker for virulent strains. 
3.2. Cloning of part of a type IV pilus gene cluster from Aeromonas 
veronii biovar sobria BC88 
Several different approaches were employed to clone genes encoding type IV 
pili from A. veronii biovar sobria BC88. These approaches included traditional 
methods such as transposon mutagenesis, the use of oligonucleotide and DNA 
probes, and library construction followed by screening with a Bfp-specific antiserum. 
However, these methods were not successful at cloning the genes encoding the Bfp 
pilus. Therefore, I will provide a brief overview of these experiments below. The 5' 
end of a gene encoding the Bfp pilin was ultimately cloned by PCR using degenerate 
primers based on the N-terminal amino acid sequence of this protein. 
Initial attempts to identify the bfp gene(s) utilised the transposon TnphoA, 
which specifically enriches for mutations in genes encoding exported proteins. This 
approach was unsuccessful due to something intrinsically incompatible between the 
transposon system chosen and Aeromonas species. Following mating of five separate 
phoA strains of A. veronii biovar sobria BC88 with E. coli SM101pir (pRT733), 
kanamycin resistant transconjugants were obtained at a frequency of approximately 1 
x 10 following five hours mating. However, transconjugants expressing active phoA 
fusions were obtained at a frequency less than 1 x 10' per kanamycin-resistant 
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transconjugant. These observations are consistant with pRT733 being efficiently 
mobilised into the recipient Aeromonas strains, but being stably maintained in these 
strains. Alternatively, the phoA strains may have been pleiotrophic protein export 
mutants rather than being mutated specifically in the phoA gene. To answer this latter 
possibility, each of the phoA mutants were examined by transmission electron 
microscopy for the ability to produce surface pili. All strains were found to express 
pili on their surface, indicating that they retained the ability to secrete extracellular 
proteins. Therefore, it appeared that the suicide vector used to deliver this transposon 
was at least partially stable in the Aeromonas recipient strains. Furthermore, 
subsequent experiments indicated that Aeromonas species may encode multiple 
copies of the bfp subunit gene (Section 3.2.2, below), which would make transposon 
mutagenesis unsuitable for preparing a Bfp mutant. Consequently, attempts were 
made to clone and mutate the bfp gene(s) directly. 
Four DNA probes were then used in an attempt to identify bfp gene(s) 
encoding type IV pili by Southern hybridisation. This approach led to the cloning of 
a type IV prepilin gene, although, as described below, this gene did not encode the 
Bfp pilin protein, but led to the demonstration that Aeromonas species possess genes 
encoding a second family of type IV pili. 
3.2.1. Design and construction of probes 
Four DNA probes were initially used in an attempt to identify the gene 
encoding the Bfp pilin by Southern hybridisation. These probes are illustrated in Fig. 
3.1. 
3.2.1.1. Degenerate oligonucleotide probe based on the Bfp N-terminal amino 
acid sequence (P001) 
The availability of the N-terminal amino acid sequence of Bt p from BC88 
(Kirov and Sanderson, 1996) provided the opportunity to construct a degenerate 
probe, which could be used to identify DNA sequences corresponding to the Bfp 
sequence. This probe was constructed based on amino acids 19 to 25 of the N- 
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Fig. 3.1. DNA probes used in this study. 
a. Degenerate oligonucleotide probe P001 based on the N-terminal amino acid sequence 
of the Bfp pilin protein. 
b. 111 bp probe to the N-terminal 37 amino acids of Vibrio cholerae MshA. Below is a 
sequence alignment of the N-terminal amino acid sequence of MshA (Jonson et al., 
1994) and Bfp (Kirov and Sanderson, 1996). 
C. 1.2 kb Hind III fragment containing Pseudomonas aeruginosa PA01 pilA. 
d. 1.0 kb BamH I fragment containing Aeromonas hydrophila Ah65 tapA. 
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terminal amino acid sequence to avoid possible cross-reaction with proteins that 
possess type IV pilin-like N-terminal amino acid sequences, and was designed with 
reference to Aeromonas codon usage data (Codon Usage Database, DNA Information 
and Stock Center, National Institute of Agrobiological Resources, Tsulcuba, Japan; 
http://www.dna.affrc.go.jp/—nakamura). The construction of this probe (P001) is 
depicted in Fig. 3.1a. 
3.2.1.2. Vibrio cholerae mshA N-terminal probe 
As described in section 1.10.2.2, the N-terminal amino acid sequence of the 
Bfp pilin proteins exhibit high homology with the Vibrio cholerae mannose-sensitive 
haemagglutinin pilus subunit, MshA. The gene encoding this protein from V. 
cholerae 01 El Tor (strain Phil 6973) has been cloned and sequenced by Jonson et 
al. (1994). Therefore a probe based on the region of the mshA encoding the first 37 
amino acids of MshA was constructed. In this region, there are only 5 amino acid 
residue mismatches between the Bfp subunit protein and MshA (see Fig. 3.1b). This 
probe was constructed by subcloning a 111 bp EcoR VlBstU I fragment from 
pGJX111 (Jonson et al., 1994) into the EcoR V site of plasmid pZEr0-2.1, 
generating pTB024. The insert of pTB024 was labelled with digoxigenin by PCR 
using M13 forward and reverse primers. 
3.2.1.3. Pseudomonas aeruginosa pilA probe 
A probe consisting of the entire gene encoding the Pseudomonas aeruginosa 
prepilin, pilA and the N-terminal region of pilB (Fig. 3.1c), was constructed by 
labelling the 1.2 kb Hind III fragment contained in plasmid pAW102 with 
digoxigenin, as described in section 3.2.1.2. 
3.2.1.4. Aeromonas hydrophila Ah65 tapA probe 
During the course of these studies, the sequence of a type IV pilus biogenesis 
gene cluster (tapABCD) from A. hydrophila Ah65 was deposited into the Genbank 
database (accession number U20255), and later published (Pepe et al., 1996). The 
predicted amino acid sequence of the cloned pilin gene (tapA) differed slightly from 
the N-terminal sequences of the Bfp pili purified from diarrhoea! isolates. However, 
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these authors suggested that the discrepancies may reflect difficulties in obtaining 
reliable N-terminal sequences, particularly for the modified (N-methylated) N-
terminal amino acid residues characteristic of mature type IV pilin proteins (Pepe et 
al., 1996). The tapA prepilin gene (contained in plasmid pCP1065; Fig. 3.1d) was 
labelled with digoxigenin as described in section 3.2.1.2. 
3.2.2. Degenerate oligonucleotide probe (P001) 
The degenerate oligonucleotide probe P001 was used to probe BamH I digests 
of DNA from BC88, and other Aeromonas strains from which Bfp-homologous 
proteins had been purified. The results are shown in Fig. 3.2. 
P001 hybridised with multiple bands from BC88, A. hydrophila Ae6, A. veronii 
biovar sobria Ae24 and A. caviae CA195, but did not hybridise with DNA from A. 
veronii biovar sobria strains Ael and Tap13 under high stringency conditions (65°C, 
0.5 x SSC). P001 hybridised with two BamH I fragments from BC88, with sizes 
approximately 5.8 kb and 1.0 kb, respectively. 
3.2.2.1. Cloning of the BamH I fragments that hybridised with P001 
The 5.8 kb and —1.0 kb BamH I fragments that hybridised with P001 were 
cloned from BamH I sub-genomic libraries. BamH I digested DNA fragments 
approximately 4.5 to 7.0 kb were eluted from an agarose gel, ligated into plasmid 
pUCP19, and transformed into competent E. coli JM109. Similarly, BamH I 
fragments 0.2 to 2.0 kb were eluted, ligated into plasmid pZEr0-2.1, and transformed 
into E. coli TOP1OF'. Recombinant colonies (116) from the 5.8 kb library and 270 
colonies from the 1 kb library were screened with the P001 probe. Single clones from 
the 5.8 kb library (designated pTB001), and the 1 kb library (designated pTB004), 
exhibited strong hybridisation with this probe, while two clones from the latter 
library (pTB005 and pTB006), exhibited slightly weaker hybridisation signals. The 
—1 kb clones were all distinct from one another as determined by their different 
restriction enzyme digestion patterns following digestion with two restriction 
enzymes, Sau3A I and Msp I, which have four base pair recognition sequences. 
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Fig. 3.2. Southern hybridisation of Aeromonas strains probed with POOL 
Chromosomal DNA was digested with BamH I, transferred to nylon membrane and 
hybridised with P001 under high stringency conditions. DNA size markers (k DNA 
digested with Hind III, size in kilobases) are indicated to the left. 
Lane 1. A. veronii biovar sobria BC88 
Lane 2. 	A. veronii biovar sobria Ael 
Lane 3. A. hydrophila Ae6-W 
Lane 4. A. veronii biovar sobria Ae24 
Lane 5. A. veronii biovar sobria TAP 13 
Lane 6. A. caviae CA195 
1 	2 	3 	4 	5 	6 
23.13 
9.42 
6.56 
4.36 
2.32 
2.03 
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In order to allow subcloning of a smaller fragment of pTB001 for sequence 
analysis, Southern hybridisation analysis of various restriction enzyme digests was 
performed. The hybridising sequence was localised to a 1.5 kb EcoR UKpn I 
restriction enzyme fragment, and this fragment was subcloned into pGEM3zf(+), 
designated pTB002, for sequence analysis. 
3.2.2.2. Sequence analysis 
Nucleotide sequences of pTB004, pTB005 and pTB006 were determined for 
both strands using M13 forward and reverse primers. In all cases, no sequences 
homologous to the N-terminus of the Bfp subunit protein were identified. Similarly, 
no sequences corresponding with P001 were found. This indicates that probe P001 
was binding non-specifically to DNA from A veronii biovar sobria strains BC88 and 
Ae24, A. hydrophila Ae6-W, and A. caviae CA195. 
Good sequence data could not been obtained for the — 1.5 kb insert of pTB002, 
despite two separate attempts at sequencing this insert. The reason for this remains 
unclear, although this insert may have had a particularly GC-rich sequence, which is 
known to produce sequencing problems. As sequencing of this insert proved 
difficult, the entire 5.8 kb BamH I fragment contained in pTB001 was subcloned into 
the mobilisable CmR plasmid pBBR1MCS (Kovach et al., 1994), designated 
PTB003, and mobilised into A. veronii biovar sobria BC96 and A. caviae CA195. 
Both of these strains produce a serologically distinct Bfp pilus, and an intact copy of 
the Bfp pilin gene contained in plasmid pTB003 would presumably be expressed by 
these strains. No expression of the Bfp subunit protein was detected by western blot 
analysis. 
The insert of pTB004 was 1239 bp. Sequence analysis identified one open 
reading frame (ORF), which exhibited limited homology with hypothetical proteins 
from E. coli (32% identity and 47% similarity across 162 amino acids) and 
Helicobacter pylori (39% identity and 54% similarity across 103 amino acids), and 
with a cardiolipin synthase from E. coli (33% identity and 53% similarity across 101 
amino acids). 
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The insert of pTB005 was 692 bp, and contained a 302 bp region that encoded 
a 100 amino acid sequence which exhibited homology with ATP synthase proteins 
UncD from E. colt (87% identity and 97% similarity to amino acids 347 to 446), and 
AtpD from Haemophilus influenzae (88% identity and 94% similarity). 
The insert of pTB006 was 735 bp. The first 103 bp encoded a 33 amino acids 
sequence which exhibited 96% identity and 100% similarity with the C-terminal 
region (amino acids 304 to 336) of the L-allo-threonine aldolase from A. jandaei, and 
40% identity and 61% similarity with a similar enzyme from Pseudomonas 
aeruginosa. 
In summary, the degenerate probe P001 was not specific for the bfp gene(s) 
and use of this probe was not pursued further. 
3.2.3. Vibrio cholerae mshA and Pseudomonas aeruginosa pilA probes 
Digests of chromosomal DNA from A. veronii biovar sobria BC88 were 
examined by Southern hybridisation with the V. cholerae mshA and P. aeruginosa 
pilA probes. Digests of chromosomal DNA from P. aeruginosa PA01 and V. 
cholerae 01 El Tor H1 were includes as positive controls for the appropriate probe. 
Hybridisation was performed under high and low stringency conditions. No 
homologous sequences in A. veronii biovar sobria BC88 were identified using these 
probes. 
3.2.4. Aeromonas hydrophila Ah65 tapA probe 
Various digests of chromosomal DNA from A. veronii biovar sobria BC88 
were also examined by Southern hybridisation with the A. hydrophila Ah65 tapA 
probe. This probe hybridised with a single, -4.0 kb BamH I fragment (Fig. 3.3, lane 
1). Therefore, BamH I digested DNA fragments of sizes 0.5 to 2 kb were eluted from 
an agarose gel, ligated into the plasmid pUCP19 and transformed into E. colt strain 
JM109. Approximately 300 recombinant colonies were screened with the tapA probe, 
and this probe hybridised strongly to one clone, which was designated pTB011. 
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Fig. 3.3. Southern hybridisation of A. veronii biovar sobria BC88 probed with 
tapA cloned from A. hydrophila Ah65. 
Chromosomal DNA was digested with the restriction enzymes listed below, transferred to 
nylon membrane and hybridised with digoxigenin-labelled tapA under high stringency 
conditions. DNA size markers (?. DNA digested with Hind III, size in kilobases) are 
indicated to the left. 
Lane 1. BamH I 
Lane 2. Hind III 
Lane 3. EcoR I 
Lane 4. Pst I 
Lane 5. 	Sac I 
Lane 6. Kpn I 
1 	2 	3 	4 	5 	6 
23.13 
9.42 
6.56 
4.36 
2.32 
2.03 
A restriction map of pTB011 was generated using the enzymes BamH I, Hind 
III, Pst I, EcoR I, Kpn I and Sac I. The insert contained in pTB011 possessed single 
Pst I and Kpn I sites, and these appeared to be in similar positions to those of the A. 
hydrophila tapA clone, pCP1065. Therefore, three restriction fragments (1 kb BamH 
I, pTB012; 0.5 kb BamH I-Pst I, pTB013; and 0.5 kb Pst I-BamH I, pTB014) were 
subcloned into pGEM®-3zf(+) for sequence analysis. 
3.2.4.1. Sequence analysis 
Nucleotide sequences were determined for pTB012, pTB013, and pTB014, 
using M13 forward and reverse sequencing primers. Subsequent sequence alignments 
identified a single complete (453 bp) open reading frame and one partial (321 bp) 
open reading frame (Fig. 3.4), which exhibited high homology with tapA and tapB, 
respectively, from A. hydrophila Ah65 (Pepe et al., 1996). These open reading 
frames were, therefore, also designated tapA and tapB (submitted to 
EMBL/Genbank/DDBJ Data Libraries under accession number U81377). 
A sequence resembling a consensus sigma 54 (554)-dependent (RpoN-
dependent) promoter was located approximately 200 bp upstream of tapA. The tapA 
and tapB ORFs would both be transcribed in the same direction. This orientation is 
the same as the organisation of the pilus gene clusters of A. hydrophila and V. 
cholerae, but was different to the pilus gene cluster possessed by P. aeruginosa 
(Johnson etal., 1986; Pepe etal., 1996; Fullner and Mekalanos, 1999). 
3.2.4.2. Amino acid sequence comparisons 
The sequence of pTB012 was used to derive amino acid sequences of the tapA 
and partial tapB open reading frames. When compared, it was seen that the tapA gene 
from strain BC88 encoded a protein that was clearly different from the purified Bfp 
pilin (Fig. 3.5). The TapA proteins from A. veronii biovar sobria BC88 and A. 
hydrophila Ah65 were more closely related to the "classical" type IV pilin proteins 
of Pseudomonas syringae, Dichelobacter nodosus, and Pseudomonas aeruginosa, 
than they were to the Aeromonas Bfp pilin proteins (Fig. 3.5). 
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Fig. 3.4. Genetic map of the 1.0 kb BamH I fragment contained in pTB012. 
The direction of transcription is indicated by the direction of the arrowheads for the open 
reading frames. Relevant restriction sites are also shown. 
co 
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Fig. 3.5. Amino acid sequence comparison of A. veronii biovar sobria BC88 
TapA with type IV prepilins from other bacteria. 
Residues conserved in all sequences are shaded black. Conserved residues unique to each 
group are shaded grey. Sequences of Bfp pilin proteins were generated by N-terminal 
amino acid sequencing of purified proteins. Sequences of "classical" type IV pilin and Tap 
pilin proteins were derived from DNA sequences. Species abbreviations and the pilin 
subunit designations are as follows: 
"Classical" type IV pili; Ps, Pseudomonas syringae DC3000, PilA (Raineri et al., 
unpublished); Dn, Dichelobacter nodosus 351, FimA (Hoyne et al., 1989); Pa, 
Pseudomonas aeruginosa P1, PilA (Pasloske et al., 1988). 
Tap pili; Avbs, A. veronii biovar sobria BC88, TapA; Ah, A. hydrophila Ah65, TapA (Pepe 
et al., 1996); As, A. salmonicida A449, SfpA (Lutwyche etal., unpublished). 
Bfp pili; Avbs BC88, A. veronii biovar sobria BC88, Sfp (Kirov and Sanderson, 1996); Ac 
CA195, A. caviae CA195, Cfp (Kirov et al., 1998); As Ae24, 'A. sobria' Ae24 (Hokama 
and Iwanaga, 1992); As TAP 13, 'A. sobria' TAP 13 (Iwanaga and Hokama, 1992); As Ael, 
'A. sobria' Ael (Hokama and Iwanaga, 1991); Ah Ae6, A. hydrophila Ae6 (Hokama et al., 
1990); At 1220, A. trota 1220 (Nakasone et al., 1996). 
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The TapA and Bfp pilin proteins also appear to have different molecular 
weights. Values published for the Bfp pilins have ranged from 19 to 23 kDa, and this 
protein from A. veronii biovar sobria strain BC88 had a molecular weight of 21 lcDa 
(Kirov and Sanderson, 1996). The molecular weight of TapA from this strain 
(calculated from its derived amino acid sequence) was estimated at — 17 1cDa, similar 
to the molecular weight estimated for TapA from A. hydrophila. The size of the latter 
was confirmed by western blotting with A. hydrophila TapA antiserum obtained 
from Dr. M. S. Strom, Northwest Fisheries Science Center, Seattle, U.S.A. (section 
2.12; Fig. 3.6). This antiserum also recognised an — 17 IcDa protein from whole cell 
lysates of A. veronii biovar sobria TAP13. Slight reactivity was observed for an — 17 
IdDa band A. veronii biovar sobria Ae24, suggesting that there may be significant 
immunological cross reactivity between TapA proteins and that this cross reactivity 
is not confined to species-specific boundaries. Unfortunately, western blots of whole 
cell lysates of A. veronii biovar sobria BC88 grown under the same conditions did 
not react with this antiserum. 
The pilin subunit protein encoded by tapA (TapA) consisted of 151 amino 
acids, nine more than the A. hydrophila TapA, and exhibited extensive homology 
with type IV prepilin proteins from A. hydrophila (51% identity, 67% similarity), A. 
salmonicida (55% identity, 66% similarity), Pseudomonas syringae (45% identity, 
56% similarity), Dichelobacter nodosus (38% identity, 53% similarity),and 
Pseudomonas aeruginosa (39% identity, 50% similarity) (Fig. 3.7). Homology was 
highest in the N-terminal regions as is characteristic of these proteins. The prepilins 
from A. veronii biovar sobria and Pseudomonas aeruginosa exhibited 75% identity 
and 87% similarity in the first 41 amino acids. 
The N-terminal region of tapA from strain BC88 contained a consensus type IV 
leader peptidase/N-methyltransferase cleavage site (Fig. 3.7, arrow). The first six 
amino acids encode the putative leader sequence that is presumably cleaved from this 
protein. The resulting N-terminal phenylalanine would be methylated to produce the 
mature pilin (Strom and Lory, 1993; Tennent and Mattick, 1994). The primary amino 
acid sequence of TapA contains a total of four cysteine residues at positions 56, 65, 
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Fig. 3.6. Western blot analysis of Aeromonas strains with A. hydrophila Ah65 
TapA antiserum. 
Whole cell lysates were separated by SDS-PAGE and transferred to nitrocellulose where 
they were reacted with the A. hydrophila Ah65 TapA antiserum. This antiserum was 
prepared against a recombinant TapA protein as described in section 5.5.1.) Molecular 
weight markers (in kilodaltons) are indicated to the left. The 17 IcDa protein corresponding 
to the TapA protein is indicated to the right with an arrow. 
Lane 1. 	A. veronii biovar sobria BC88 
Lane 1. 	A. veronii biovar sobria Ael 
Lane 2. A. hydrophila Ae6-W 
Lane 3. A. veronii biovar sobria Ae24 
Lane 4. A. veronii biovar sobria TAP 13 
Lane 5. A. caviae CA195 
Lane 6. A. hydrophila Ah65 
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Fig. 3.7. Amino acid sequence comparison of A. veronii biovar sobria BC88 
TapA with type IV prepilins from other bacteria. 
The alignment was generated using ClustalW software. Residues conserved with the A. 
veronii biovar sobria BC88 TapA are shaded black. The predicted cleavage site where the 
pilin is cleaved and N-methylated to generate the mature pilin is indicated with an arrow. 
Species abbreviations and the pilin subunit designations are as follows: 
Avbs, A. veronii biovar sobria BC88, TapA; Ah, A. hydrophila Ah65, TapA (Pepe et al., 
1996); As, A. salmonicida A449, SfpA (Lutwyche et al., unpublished); Ps, Pseudomonas 
syringae DC3000, PilA (Raineri et al., unpublished); Dn, Dichelobacter nodosus 351, 
FimA (Hoyne etal., 1989); Pa, Pseudomonas aeruginosa P1, PilA (Pasloske etal., 1988). 
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139 and 149, suggesting that this protein is likely to form two separate intra-chain 
disulphide bridges, of similar size and location to those present within the D. 
nodosus class II pilins (Mattick et al., 1991). 
The partial sequence of tapB cloned from A. veronii biovar sobria (representing 
approximately 20% of tapB from strain Ah65) encoded 107 amino acids. This amino 
acid sequence was virtually identical (98% identity, 98% similarity) to the 
corresponding region of TapB from A. hydrophila and A. salmonicida (Fig. 3.8). 
3.2.4.3. Conservation of the tap gene cluster in Aeromonas 
The entire tap cluster appeared to be well conserved between A. veronii biovar 
sobria BC88 and A. hydrophila Ah65. For both strains, tapA and the 5' end of tapB 
were located on 1 kb BamH I fragments, and both genes were orientated in the same 
direction and appeared to possess a putative .554-dependent promoter upstream of 
tapA. To determine whether the rest of the tap cluster was also present, Southern 
hybridisation was employed to detect the presence of tapD, which lies at the distal 
end of the tap cluster. Like A. hydrophila Ah65, tapD was detected on a 2.7 kb Pst I 
restriction fragment under high stringency hybridisation conditions, suggesting that 
the entire tap gene cluster is likely to be encoded on the BC88 genome. 
Other strains of Aeromonas known to express Bfp pili were obtained from Dr. 
M. Iwanaga, University of Ryukus, Ryukus, Japan (Hokama et al., 1990; Hokama 
and Iwanaga, 1991; Hokama and Iwanaga, 1992; Iwanaga and Hokama, 1992). These 
strains, and A. caviae CA195 (Kirov et al., 1998), were also examined by Southern 
hybridisation for sequences homologous to the tapA and tapD genes to determine 
whether these genes may be widespread in Aeromonas species. Both probes 
hybridised to DNA from these strains at high stringency, although unlike strain 
BC88, some degree of restriction fragment length polymorphism was observed, and 
this did not appear to be species-related. For one of the five Bfp-positive strains 
examined, A. veronii biovar sobria Ae24, the probes hybridised to restriction 
fragments of identical size to fragments from A. hydrophila Ah65 and A. veronii 
biovar sobria BC88 (Fig 3.9, lane 4). 
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Fig. 3.8. Amino acid sequence comparison of A. veronii biovar sobria BC88 
TapB with homologous proteins from other bacteria. 
The alignment was generated using ClustalW software. Residues conserved with the A. 
veronii biovar sobria BC88 TapB are shaded black. Species abbreviations and the pilin 
subunit designations are as follows: 
Avbs, A. veronii biovar sobria BC88, TapB; Ah, A. hydrophila Ah65, TapB (Pepe et al., 
1996); As, A. salmonicida A450, TapB (Pepe and Strom, unpublished); Pa, Pseudomonas 
aeruginosa PAK, PilB (Nunn et al., 1990). 
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Ah : EILDS KALADECELEYGVPLLDLAAF DLAE I PnEYLNFJKLIEKHH`v • 91 
As EILDSKALADFCELEYGVPLLDLAAFDLAEI PQKYLNOKLIEKHEV • 91 
Pa : KLVSGL A.L.A EL SAEQFCIAYCDLI SLDRE SF PRDAI SE KL RQHRv • 92 
100 
Avbs : LPIYTQGHTLYIAMSDP 	: 	108 
Ah L PIYT (TIGHT LYIANSDP 	: 	108 
As L PITT QGHT LYI.A.MSDP 	: 	108 
Pa : I PLTATRRRI KLFVGI SD • 	: 	109 
Fig. 3.9. Southern hybridisation of Aeromonas strains probed with A. 
hydrophila Ah65 tapA and tapD gene probes. 
a. BamH I digests probed with tapA. b. Pst I digests probed with tapD. DNA size markers 
(X DNA digested with Hind III, size in kilobases) are indicated to the left. 
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3.3. Cloning of the N-terminal region of a gene encoding the Bfp 
pilin protein 
3.3.1. Construction of cosmid libraries 
Cosmid libraries enable large regions 	40 kb) of chromosomal DNA to be 
cloned, and, therefore, individual cosmid clones are likely to encode full copies of 
desired gene(s) along with the accessory genes required for expression in a 
heterologous host. Initially, a cosmid library was constructed from A. veronii biovar 
sobria BC88 DNA with the aim to identify Bfp-expressing clones with Bfp-specific 
antiserum following transfer of the library to an Aeromonas strain expressing a 
serologically distinct Bfp pilus. Clones containing bfp would more likely be detected 
in an Aeromonas strain than in E. coli, since all of the genes needed for expression 
would already be present. Therefore, a cosmid vector capable of transfer into, and 
stable maintenance in, an Aeromonas recipient was constructed. 
3.3.1.1. Construction of pTB023 
The cosmid vector pTB023 is a chloramphenicol (Cm1) resistant, mobilisable 
derivative of pHC79. The construction of pTB023 is depicted in Fig. 3.10. This 
vector was constructed in essentially the same manner as pPM2101 (Sharma et al., 
1989), except that the ampicillin resistance gene (bla) was deleted and replaced with 
a gene encoding chloramphenicol resistance. 
The bla gene was deleted from pHC79 by long range PCR (ExpandTM Long 
Template PCR System, Boehringer Mannheim) using primers P006 and P007 
(Appendix 7). The use of these primers resulted in the introduction of Pst I sites at 
either end of the PCR product, which were used to recircularise the plasmid lacking 
bla, creating pTB019. The mob region from pSUP201-1 (Simon et al., 1983), 
required for mobilisation into recipient bacteria by conjugation, was excised with 
BamH I, end-filled with the Klenow fragment of DNA polymerase I, and inserted 
into the end-filled EcoR I site of pTB019. The resulting plasmid, designated pTB020, 
was selected by its ability to be mobilised from E. colt S17-1 into E. colt SM10. The 
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Fig. 3.10. Construction of pTB023. 
All steps are described in full in section 3.3.1.1. 
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Cm1R vector pTB023 was produced by excising a cat gene cassette from pTB022 as a 
Psi' I fragment and cloning into the Pst I site of pTB020. pTB022 was constructed by 
excising the cat cassette from pBSL121 with BamH I and cloning into the Bgl II site 
of pLitmus29. The Cm1R cassette could then be excised as an —1 kb Pst I fragment 
that lacked an internal BamH I site. 
3.3.1.2. Library construction and mobilisation into Aeromonas. 
Preparation of vector and insert DNA, packaging and transduction were 
performed as described in section 2.9. E. coli S17-1 was used as a host strain for the 
library in order to allow transfer to heterologous recipient bacteria. 
Construction of a cosmid library in pTB023 produced — 1500 cosmid clones of 
which 672 Cm1R/Tets clones were selected for analysis. Initially, 12 cosmids were 
mobilised into each of the Aeromonas strains from which Bfp had been purified (A. 
veronii biovar sobria strains Ael, Ae24 and TAP 13, A. hydrophila Ae6 and A. caviae 
CA195) as well as into A. hydrophda Ah65. Transfer of all 12 cosmids was only 
observed when Ah65 was the recipient. Therefore, Ah65 was chosen for large scale 
screening of the cosmid library. 
Individual cosmids mobilised into Ah65 were replica plated onto nitrocellulose 
membranes and screened with a Bfp antiserum. This antiserum had been absorbed 
six times to whole cell lysates of Ah65 immobilised onto nitrocellulose membranes 
(see section 2.13.5). The resulting serum retained activity against a 21 lcDa band in 
BC88 and purified B fpBC88 protein, but exhibited no reactivity with a similar sized 
band from Ah65. This antiserum was used to screen the cosmid library in Ah65 for 
clones expressing Bfp. No Bfp-positive clones were identified using this procedure. 
In order to detect the bfp gene(s) in the cosmid library constructed above, an 
alternative strategy was used. The N-terminal region of a gene encoding the Bfp pilin 
protein was cloned, for use as a probe, using degenerate PCR primers based on the 
published N-terminal sequence of this protein (Kirov and Sanderson, 1996). 
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3.3.2. Cloning of the 5' end of the bfp subunit gene by PCR 
The entire N-terminal amino acid sequence of the Bfp pilin was used to derive 
the corresponding degenerate DNA sequence, and this DNA sequence was used to 
construct a series of forward and reverse degenerate oligonucleotide primers for PCR 
amplification of BC88 DNA. In the first instance, all possible combinations of 
forward and reverse primers were used in 40 cycles of PCR (94°C denaturation, 30 s; 
35°C annealing, 30 s; 60°C extension, 4 min). PCR products were obtained for all 
primer combinations. 
The N-terminal amino acid sequence of the Bfp pilin (31 amino acids) would 
be encoded by a 93 bp DNA sequence. Depending on the primers used in each 
reaction, a Bfp-specific PCR product would have an expected size range of 56 - 83 
bp. As the use of primers P019 and P022 appeared to give the best results, these 
primers were resynthesised with the 5' restriction enzyme sites Hind III (P023) or 
Xba I (P024). The above PCR reaction was repeated with these primers and the 
product was cloned into the Hind Inaba I sites of pZEr0-2.1, generating pTB037, 
for sequence analysis. The sequence of insert contained in pTB037 is given in Fig 
3.11. The translated sequence of the insert contained in pTB037 corresponded almost 
exactly to the N-terminal sequence of the purified Bfp pilin protein. The only 
difference was in the coding for a F residue at position 25 in place of a L. However, 
this sequence was in the area encoded by the degenerate primer P024, so this 
substitution was not deemed to be significant. 
Hence, the above procedure resulted in the cloning of a small region of a gene 
encoding the Bfp pilin. However, due to time constraints for this thesis, this could 
not be pursued further. 
In summary, the results presented in this chapter have described the cloning of 
part of a type IV pilus gene cluster from A. veronii biovar sobria BC88. The pilin 
gene (tapA) encoded a protein distinct to that expressed by this strain (Bfp). The tapA 
and tapD genes were also identified in other strains from which Bfp pili had been 
purified, demonstrating that Aeromonas species associated with gastroenteritis have 
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Fig. 3.11. Sequence of pTB037. 
pTB037 contains a 78 bp insert generated by PCR amplification of A. veronii biovar sobria 
BC88 DNA using primers P023 and P024. The unique sequence data not encoded by P023 
and P024 is shown in bold. The predicted amino acid sequence encoded by the insert in 
pTB037 is also shown. Note that this sequence is identical to the published N-terminal 
amino acid sequence of the Bfp pilin (Kirov and Sanderson, 1996). 
Bfp N-terminal 
sequence MTL I ELV I V I I I L GI L AV T A A PK FLN 
ATG ACI YTI ATH GAR YTI GTI ATH GTI ATH ATH ATH YTI GUI ATH YTI GCI OTT AC! GCI GCI CCI AAR TTY YTI AAY 
	 • 	 • 	  
P023 P024 
  
pTB037 sequence ATGACG CTG ATC GAG CTG ATC GTGATC ATC ATT CTGGGT ATT CTGGCGGTCACC GCC GCC CCC AAG TTT TTC AA 
MT L I EL VI VI I IL GI LAY TA A PK F F 
the potential to express two distinct families of type IV pili. Finally, the cloning of a 
small region of the bfp pilin gene should allow the cloning of the entire bfp gene 
cluster in the near future. 
3.4. Discussion 
The results in this chapter have demonstrated that Aeromonas species 
• associated with gastroenteritis encode two distinct families of type IV pili. The genes 
encoding Tap pili were cloned from A. veronii biovar sobria BC88, a strain from 
which the Bfp pili had been purified. The predicted amino acid sequence of tapA was 
different from the N-terminal sequence of the Bfp pilin, demonstrating that the tap 
gene cluster could not be encoding the pili purified from this strain. In addition, other 
strains from which Bfp pili had been purified (one A. hydrophila, one A. caviae, and 
three A. veronii biovar sobria strains) also possessed the tap gene cluster, as 
determined by Southern hybridisation. The cloning of a small region of the bfp gene 
from A. veronii biovar sobria BC88 further demonstrates that this strain possesses 
genes encoding two distinct families of type IV pili, Bfp and Tap. 
The N-terminal amino acid sequences of the TapA and Bfp pilin proteins show 
that they are both subunits of type IV pili. However, both pilin proteins are 
characterised by certain amino acid residues unique to each family. In addition, the 
TapA proteins appear to be smaller than Bfp pilin proteins, as determined by western 
blotting and comparison of molecular masses predicted from sequence data. 
However, such size differences could also be accounted for by different post-
translational glycosylation patterns (Virji et al., 1993). 
The genetic organisation of the tap gene clusters from A. veronii biovar sobria 
and A. hydrophila are very similar. For both clusters, the prepilin gene was coupled 
to a gene encoding a nucleotide-binding protein homologous to PilB from 
Pseudomonas aeruginosa. The layout of the tap cluster is very similar to gene 
clusters cloned from Vibrio vulnificus (Paranjpye et al., 1998), V. cholerae (Fullner 
and Mekalanos, 1999) and E. coli (Whitchurch and Mattick, 1994). This, and the 
observations that the tapA and tapD genes from different species of Aeromonas were 
74 
often present on identically-sized restriction enzyme fragments, and that TapA 
proteins from different species are occasionally antigenically cross-reactive, suggests 
that they have been acquired by horizontal gene transfer. 
Upstream of tapA from both A. veronii biovar sobria BC88 and A. hydrophila 
Ah65 was a sequence resembling a a54-dependent promoter. This type of promoter 
is responsible for transcription from the P. aeruginosa pilA gene, so it is possible that 
this promoter is also responsible for tapA expression by Aeromonas. However, the 
a54-dependent promoter upstream of the N. gonorrhoeae pilE gene is not active 
because this species encodes a dysfunctional rpoN gene, encoding sigma factor 54 
(Laskos et al., 1998). The potential a-54 dependent promoter sequence upstream of 
tapA differs somewhat from the consensus sequence for a54-dependent promoters, 
which have been derived by comparing the sequences of numerous a54 dependent 
promoters from members of the Enterobacteriaceae (Wang and Gralla, 1998). This is 
not unexpected, however, since Aeromonas is significantly diverged phylogenetically 
from the Enterobacteriaceae. Indeed, a54-dependent promoters often diverge 
considerably from the above consensus sequence, even within the Enterobacteriaceae 
(Wang and Gralla, 1998). It is, therefore, unknown, and impossible to predict, 
whether, this promoter is responsible for the expression of tapA in Aeromonas 
without the use of expression assays such as primer extension analysis. It is equally 
possible that the transcription initiation site lies upstream of the BamH I site 
proximal to tapA and would, thus, not have been identified by the sequencing 
described in section 3.2.5.1. 
Bfp pili have not been genetically characterised. Several approaches were 
investigated in this chapter in an attempt to genetically characterise this structure 
from A. veronii biovar sobria BC88. However, traditional methods such as 
transposon mutagenesis and the use of DNA probes were not successful. Two probes 
used in this study, the degenerate oligonucleotide P001 and the N-terminal region of 
mshA from V. cholerae, were designed in reference to the N-terminal amino acid 
sequence of the purified Bfp pilin protein. However, these probes failed to bind to the 
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corresponding region of the bfp subunit gene. This result is likely to reflect 
differences in codon usage between the bfp gene and the mshA gene, and the 
Aeromonas codon usage data used in the design of P001. Comparison of the 
sequence obtained for the cloned N-terminal region of bfp with the corresponding 
region of mshA demonstrates this to be the case, with codon mismatches for 9 of the 
13 amino acids encoded by the sequenced region. Unfortunately, the degenerate 
probe sequence could not be compared in this manner since this probe was designed 
from amino acids 19 to 25 of the Bfp N-terminal amino acid sequence, which resides 
in the region encoded by the degenerate PCR primer P024 in plasmid pTB037. 
The other method used to clone the bfp gene(s) involved the screening of a 
cosmid DNA library with a Bfp-specific antiserum (Kirov and Sanderson, 1996) 
following mobilisation into A. hydrophila Ah65. However, screening of the library in 
this host background did not identify clones expressing the Bfp pilin, indicating that 
the bfp gene(s) were not efficiently expressed in this strain. Unfortunately, the 
cosmid library could not be efficiently mobilised into an Aeromonas strain known to 
express an antigenically distinct Bfp pilus, possibly due to the presence of an S-layer 
or a restriction-modification system in these strains. 
The successful cloning of a small region of the bfp gene using a degenerate 
PCR technique should allow the identification of cosmid clones containing this gene. 
This may be accomplished by screening the cosmid library with this PCR product 
directly, or following the production of suitable DNA probes by inverse PCR using 
specific primers designed from the sequenced region. The subsequent sequencing 
and mutational analysis of this gene will allow the significance of Bfp pili in the 
pathogenesis of Aeromonas gastrointestinal disease to be established definitively. 
The role of the Tap pili in Aeromonas pathogenesis was completely unknown. 
Nothing was known about conditions that influence the expression and assembly of 
Tap pili. Their similarity to the "classical" type IV pilins of Dichelobacter nodosus, 
Neisseria gonorrhoeae and Pseudomonas aeruginosa, all of which are known to 
mediate attachment to epithelial cells (Strom and Lory, 1993), suggests, however, 
that Tap pili might also be colonisation factors for Aeromonas species. The cloning 
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of the tapA prepilin gene (described in this chapter) allowed the role of this pilus to 
be investigated further. The distribution of these genes is explored in chapter 4, in 
order to determine the use of this putative virulence factor as a marker of virulent 
strains. The expression of Tap pili, and ability of a tapA mutant strain of A. veronii 
biovar sobria BC88 to adhere to, and colonise, intestinal tissue is investigated in 
chapter 5. 
, 
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4.1. Introduction 
4.2. Prevalence of the tap cluster in hybridisation group reference strains 
4.3. Distribution of the tap cluster in Aeromonas isolates from different sources 
4.4. Hybridisation with tapA differentiated clinical and environmental isolates of 
Aeromonas veronii biovar sobria 
4.5. Sequencing of the tapA-proximal region 
4.6. Discussion 
4.1. Introduction 
The aim of the experiments described in this chapter was to examine the 
distribution of the tap gene cluster, as a first step towards evaluating the significance 
of these genes in Aeromonas species. The distribution of the genes located at either 
end of the tap cluster (tapA and tapD) was determined for the majority of 
hybridisation group reference strains (HG1 to HG12 and HG17), and clinical and 
environmental isolates of the three species most commonly associated with human 
gastrointestinal disease. 
4.2. Prevalence of the tap cluster in hybridisation group reference 
strains 
As described in section 1.2.3, of the 17 hybridisation groups currently 
recognised, only three are commonly associated with human gastrointestinal disease, 
and several have not been isolated from human clinical specimens (see Table 1.1.). 
Initially, to determine the distribution of the tap cluster in Aeromonas, the presence 
of tapA and tapD was investigated in representative members of each of the most 
common hybridisation reference groups. These strains included hybridisation groups 
(HG1 to HG12), and a newly described species, A. popoffii HG17. 
Digoxigenin-labelled probes were prepared by PCR amplification of tapA 
(contained in plasmid pCP1065) and tapD (contained in pCP1121) from A. 
hydrophila Ah65 (Fig. 4.1.), as described in section 2.10.2. Since results described in 
section 3.2.5.3. suggested that tapA was preferentially localised on a 1.0 or 1.2 kb 
BamH I restriction enzyme fragment, and tapD on a 2.7 or 3.9 kb Pst I fragment, 
these enzymes were again chosen to prepare the chromosomal DNA digests. 
Southern hybridisation with the tapA and tapD probes was performed under 
conditions of both low and high stringency as described in section 2.11.1. Results are 
shown in Fig. 4.2. 
The tapA and tapD probes reacted with DNA from all strains examined under 
low stringency conditions. Fig. 4.2a shows hybridisation with tapA at low stringency. 
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Fig. 4.1. Schematic representation of the tap gene cluster of A. hydrophila 
Ah65. 
The regions cloned in plasmids pCP1065 and pCP1121 are indicated. Horizontal lines 
below tapA and tapD indicate the areas used as probes in hybridisation assays. Numbers in 
parentheses are the nucleotide residues at the start and end of each probe sequence. 
Relevant restriction sites are also shown. 
tapD tapC 
BamH I 	Pst I 	BamH I 	 Pst I 	 Pst I 
tapA tapB 
pCP1065 	 pCP1121 
tapA probe 	 tapD probe 
	 i 
4448 bp 
Fig. 4.2. Southern hybridisation of genomic DNA from Aeromonas reference 
strains. 
a. BamH I digests probed with tapA under low stringency conditions. b. Psi' I digests 
probed with tapD under high stringency conditions. High and low stringency hybridisation 
results for each strain are also shown below each lane. Molecular weight markers (? ■, DNA 
digested with Hind III) are indicated to the left. Defined bands were observed with both 
probes for each strain tested despite some background signal. 
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However, when this experiment was repeated under conditions of high stringency, 
only 6 of 14 strains showed detectable levels of hybridisation with the tapA probe. In 
contrast, all strains hybridised with tapD at high stringency, as shown in Fig. 4.2b. 
As described in chapter 3, the tapA probe again preferentially hybridised with 
1.0 kb (HGs 2, 3, 8, 10, 11 and 17) or 1.2 kb (HGs 4, 5a, 5b and 6) BamH I 
restriction fragments. Similarly, the tapD probe preferentially hybridised with 2.7 kb 
(HGs 1, 2, 8 and 10) or 3.3 kb (HGs 3, 5a, 5b and 7) Pst I fragments. 
4.3. Distribution of the tap cluster in Aeromonas isolates from 
different sources 
The results described above indicated that the tap cluster might be widely 
distributed in Aeromonas species irrespective of their association with human 
disease, since all hybridisation groups appeared to possess tapA and tapD 
homologous sequences. To investigate this further, strains from our culture collection 
were also surveyed for the presence of tapA and tapD. Initially, 71 strains were 
examined in the same manner as described for the reference strains. Species 
commonly associated with human diarrhoea (A. veronii biovar sobria, n = 22; A. 
hydrophda, n = 24; A. caviae, n = 22; and A. trota n = 3) were chosen from clinical 
(diarrhoeal faeces) and environmental sources (n = 42 and n = 29, respectively). 
These strains were predominantly Australian isolates (n = 57), but were from several 
widely separated regions (Western Australia, South Australia, Tasmania and 
Queensland). The remaining fourteen isolates (nine clinical and five environmental) 
were from Japan, Thailand, the United States and Peru. Results of this screening are 
summarised in Table 4.1. 
Both the tapA and tapD probes hybridised with DNA from all strains under 
low stringency conditions, irrespective of their source or geographical origin. 
However, as for the reference strains, only tapD hybridised with DNA from all 
strains at high stringency. Species-associated differences in the stringency conditions 
that allowed hybridisation with the tapA probe were also observed, and these were 
consistent with results obtained with the reference strains. DNA from all A. veronii 
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Table 4.1. Occurrence of tap genes in Aeromonas culture collection strains. 
Species' / source No. tested No. with tapA No. tested No. with tapD 
Low" High" Highb' 
A. veronii biovar sobria 
Clinical 12 12 12 7 7 
Environmental 10 10 10 7 7 
A. hydrophila 
Clinical 11 11 11 8 8 
Environmental 13 13 13 10 10 
A. caviae 
Clinical 16 16 0 10 10 
Environmental 6 6 0 5 5 
A. trota 
Clinical 3 3 3 3 3 
Environmental - - - - 
Total 71 71 49 50 50 
a Species determined according to the biochemical criteria of Popoff and Veron (1976). 
b Low, low stringency hybridisation; High, high stringency hybridisation. 
DNA from all strains hybridised with the tapD probe under both low and high stringency conditions. 
biovar sobria and A. hydrophila isolates hybridised with tapA at high stringency, but 
DNA from the 15 A. caviae isolates failed to do so. 
Species-associated differences were also observed in the fragment sizes to 
which tapA and tapD hybridised, especially for clinical isolates. For clinical isolates 
of A. veronii biovar sobria and A. hydrophila, tapA was most often detected on a 1.0 
kb BamH I fragment and tapD on a 2.7 kb Pst I fragment. In contrast, for A. caviae 
isolates, these genes were most often found on a 1.2 kb BamH I fragment and a 3.9 
kb Psi' I fragment, respectively (Table 4.2). This suggests that there may be two 
separate lineages of the tap cluster, one possessed by A. veronii biovar sobria and A. 
hydrophila and another possessed by A. caviae strains. 
4.4. Hybridisation with tapA differentiated clinical and 
environmental isolates of Aeromonas veronii biovar sobria 
The wide distribution of the tap gene cluster in Aeromonas species suggested 
its ability to be used as a marker of pathogenic strains might be limited, since both 
clinical and environmental strains appeared to possess these genes. However, 
hybridisation with the tapA probe did appear to differentiate clinical and 
environmental isolates of A. veronii biovar sobria (Fig. 4.3). For 10 of 12 clinical 
isolates in this initial screening, tapA localised on a 1.0 kb BamH I fragment, 
whereas it hybridised to a larger fragment (4.8 — 9.0 kb) for eight of 10 
environmental isolates (Fig. 4.3a). Similar differentiation based on the fragment sizes 
to which tapD hybridised were also observed (Fig. 4.3b). 
The tapA-homologous restriction enzyme fragments (— 1.0 kb) from clinical A. 
veronii biovar sobria did not appear to be identical, as slight differences in the size of 
each band were apparent. In an attempt to account for such differences, DNA from 
each strain was amplified with primers designed to flank the initiation and 
termination codons of the tapA open reading frames (based on sequences from A. 
veronii biovar sobria BC88 and A. hydrophila Ah65). PCR was performed using 
primers P004 and P011 in 25 cycles of denaturation (94°C, 40 s), annealing (55°C, 
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Table 4.2. Summary of fragment sizes to which tapA and tapD probes 
hybridise 
Species/source tapA tapD 
No. tested 1.0 kb 1.2 kb No. tested 2.7 kb 3.9 kb 
A. veronii biovar sobria 
Clinical 12 10 0 7 5 0 
Environmental 10 2a 0 7 2 0 
A. hydrophila 
Clinical 11 5 3 8 5 0 
Environmental 13 5 1 10 5 0 
A. caviae 
Clinical 16 3 8 10 0 8 
Environmental 6 2 3 5 0 3 
a  For environmental isolates of A. veronii biovar sobria, the tapA probe hybridised to a 9 kb BamH I 
fragment (see Fig. 4.3.). 
Fig. 4.3. Southern hybridisation of genomic DNA from clinical and 
environmental isolates of A. veronii biovar sobria. 
a. BamH I digests probed with tapA. PCR results using primers flanking the initiation and 
termination codons of the tapA open reading frame (P004 and P011) are indicated below 
the Southern hybridisation results. b. Psi I digests probed with tapD. Hybridisation was 
performed under high stringency conditions. Molecular weight markers (X DNA digested 
with Hind III) are indicated to the left. 
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40 s) and extension (72°C, 1 min). Results of this experiment are shown below the 
Southern hybridisation results in Fig. 4.3a. 
Comparison of the Southern hybridisation and PCR results demonstrates that 
the size variations of the — 1 kb restriction enzyme fragments correspond to size 
differences in the tapA open reading frames. 
The observation that the tapA probe appeared to differentiate clinical and 
environmental isolates of A. veronii biovar sobria was of particular interest since this 
has the potential to be exploited as a marker pathogenic strains of this species. 
Therefore, a more detailed survey for the presence of tapA in isolates of A. veronii 
biovar sobria from a variety of clinical and environmental sources was undertaken, in 
collaboration with Mr. Gerald Murray (BScHons student, Discipline of Pathology, 
University of Tasmania). Results of BamH I restriction fragment sizes which 
hybridise with tapA are summarised in Table 4.3. 
The clinical isolates tested were from diarrhoeal (n=20) and non-diarrhoeal 
(n=19) stool specimens, as well as six other clinical specimens (e.g. ulcer, blood, 
wound). Ten animal isolates were also included, which included six anal swabs from 
koi carp and long neck tortoise. The remaining four animal isolates were from fish 
and shellfish. A total of 26 environmental A. veronii biovar sobria isolates were 
tested, and these were from various surface water sources. The incidence of tapA 
localised on a 1 kb BamH I fragment was higher for the isolates from diarrhoeal 
stools (85%) when compared to non-diarrhoeal (63%) and environmental (50%) 
isolates. The incidence in extraintestinal (83%) and animal (90%) isolates was also 
high, although comparatively few isolates were tested in each of these groups. It was 
reasoned that the lower incidence in environmental isolates may reflect inaccurate 
species determination (using biochemical typing results from the laboratory database 
prior to 1990). However, when examination of environmental isolates was restricted 
to those which had been classified by genotyping methods, the incidence only rose 
slightly to 67% (10 of 15), which is similar to the incidence for isolates from non-
diarrhoeal stools. 
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Table 4.3. Summary of A. veronii biovar sobria BamH I fragment sizes to 
which the tapA probe hybridises 
Source No. tested BamH I fragment size (kb) 
0.5 0.9- 1.1 1.2 2.4 4.0 8.0-9.0 
Clinical 
Diarrhoeal stools 20 17 - 1 1 1 
Non-diarrhoeal stools 19 - 12 2 1 2 2 
Extra-intestinala 6 - 5 1 
Animalb 10 9 - 1 
Environmental 26 1 13 2 10 
a 	Extraintestinal isolates were from blood (n=4), a wound (n=1), and an ulcer (n=1). 
b Animal isolates were from skin (n=4) or anal (n=6) swabs from aquatic organisms. 
C 	Environmental isolated were all from fresh surface water. 
4.5. Sequencing of the tapA-proximal region 
The observed restriction fragment length polymorphism is consistent with 
nucleotide sequence differences within the region encompassing tapA. Such 
differences may include the presence of important virulence determinants in clinical 
strains, variations in genes or promoter sequences responsible for Tap pilus 
expression, or minor differences within TapA, which may or may not have functional 
relevance. To investigate these possibilities, the region immediately upstream of 
tapA from strain BC88 was sequenced (This work was done in collaboration with 
Mr. Gerald Murray, BScHons student, Discipline of Pathology, University of 
Tasmania. Mr Murray performed all of the experiments involved in the subcloning 
and sequencing of fragments from pTB032 under the supervision of the candidate. 
Analysis of the sequence data and subsequent conclusions was performed by the 
candidate.) 
A BC88 genomic library constructed in the cosmid vector pTB023 
(construction described in section 3.3.1.) was screened for sequences homologous 
with the tapA and tapD probes used in section 4.2.2. Four positive clones were 
identified and one of these, designated pTB032, was chosen for further analysis. 
Southern hybridisation of pTB032 following various restriction digests demonstrated 
that an — 3.3 kb Pst I fragment would contain — 2.8 kb of unsequenced DNA 
upstream of tapA. This region was subcloned as a 3.3 kb Psi' I fragment from 
pTB032 into pZEr0-2.1, designated pG01. Next, a series of subclones were 
generated to allow sequencing of the entire 3.3 kb Pst I fragment contained in pG01, 
as depicted in Fig. 4.4. Nucleotide sequences were generated for each of these clones, 
and gaps were filled by sequencing directly off pG01 using primers as indicated in 
Fig. 4.4. A graphical representation of the entire 3396 bp Pst I fragment contained in 
pG01 is also given in Fig. 4.4. No open reading frames that would encode other 
putative virulence factors, or other proteins involved in the expression or assembly of 
bacterial pili, were identified. 
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Fig. 4.4. Sequencing of the tapA-proximal region from A. veronii biovar 
sobria BC88. 
The regions contained in plasmids pG01, pG02 and pG03 are indicated below the gene 
map. Arrows below the map represent individual sequencing runs. PCR primers (GM1 to 
GM4) used to fill sequence gaps are indicated. Relevant restriction sites are also indicated. 
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Immediately upstream of tapA is a small open reading frame (ORF) that 
exhibits homology with nadC from Salmonella typhimurium. However, the protein 
encoded by this ORF would be truncated and contains only the 3' 67 amino acids of 
NadC. Upstream of nadC is another ORF, transcribed in the opposite direction, 
which exhibits homology with ampD from E. coli. Downstream of ampD, is a partial 
ORF exhibiting homology with the 5' end of pdhR from E. coli. Interestingly this 
gene organisation is very similar to that published for the pi/A-proximal region of V. 
cholerae, which also contains ampD and a truncated nadC (Fullner and Mekalanos, 
1999). 
To determine whether pdhR is also present upstream ofpilA in this organism, a 
search of the unfinished V. cholerae genome sequence (http://www.tigr.org ) was 
conducted for sequences encoding proteins homologous with the N-terminal region 
of tapA. A BLASTX search with this sequence was then conducted and the resulting 
protein coding regions compared with those found for strain BC88. A graphical 
representation of these results is shown in Fig. 4.5. What is immediately apparent 
following this analysis is that there appears to be an approximately 5 kb region of 
DNA present in V. cholerae that is absent from A. veronii biovar sobria BC88. This 
region encodes 5 separate open reading frames, all of which would encode proteins 
homologous to proteins that perform housekeeping functions. 
Another possibility considered to account for the differences in hybridisation 
patterns between clinical and environmental isolates of A. veronii biovar sobria was 
the presence of promoter sequences upstream of tapA. Therefore, the region spanning 
the termination codon of nadC and the initiation codon of tapA was screened for 
potential promoter sequences. Sigma 54-dependent and a70-dependent promoters 
were identified using software from the Department of Biochemistry and Molecular 
Biology, Pennsylvania State University (http://www.bmb.psu.eduiforml.html ) and 
NNPP software at the Lawrence Berkley Laboratory, University of California 
(http://www-hgc.lbl.gov/projects/promoter.html),  respectively. In this region, one 
potential a54-dependent promoter, as described in chapter 3 (section 3.2.5.1.), and 
83 
Fig. 4.5. Comparison of the tapA proximal region of A. veronii biovar sobria 
BC88 with the pilA proximal region of Vibrio cholerae. 
The 5 kb region containing five open reading frames, which appears to be unique to V. 
cholerae, is indicated. 
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two potential a70-dependent promoters were identified (see Fig. 4.6). However, the 
presence of a putative NifA binding site, required for activation of a54-dependent 
promoters, was not identified upstream of the potential a54-dependent promoter. 
In summary, the results presented in this chapter have demonstrated that the 
tap gene cluster is widely distributed in the genus Aeromonas. All strains examined, 
irrespective of their species or source of isolation, possessed the tap cluster. The 
interesting finding that the tapA probe hybridised with an — 1 kb BamH I fragment 
from clinical isolates of A. veronii biovar sobria more frequently than it hybridised 
with a similarly-sized BamH I fragment from environmental isolates is being 
investigated further in our laboratory (Mr. G. Murray, BScHons). Sequencing of the 
tapA-proximal region did not identify other genes involved in virulence, pilus 
assembly, or expression, suggesting that this difference was not due to the presence 
of upstream genes conferring virulence. Three potential promoter elements were also 
identified, including one a54-dependent promoter, which are most often responsible 
for the expression type IV prepilin genes. Studies are in progress investigating the 
sequence differences in the tapA proximal region from environmental isolates of A. 
veronii biovar sobria. 
4.6. Discussion 
The Aeromonas tap gene cluster encodes a putative type IV pilus that exhibits 
high homology with pilus gene clusters of several Gram-negative bacteria. For many 
of these organisms, type IV pili are essential virulence factors that mediate adhesion 
to epithelial cells. As an initial attempt to determine the significance of the tap gene 
cluster in Aeromonas species, the presence of the genes located at either end of this 
cluster was determined for a variety of strains representing species pathogenic and 
non-pathogenic for humans, and strains isolated from clinical and environmental 
sources. Results presented in this chapter have established that the tap gene cluster is 
widely distributed in Aeromonas species. All hybridisation group reference strains, 
and clinical and environmental isolates of gastroenteritis-associated species, isolated 
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Fig. 4.6. Nucleotide sequence of the nadC-tapA intergenic region from A. 
veronii biovar sobria BC88 showing putative promoter sequences. 
P1 and P2 represent conventional o70-dependent promoters while P3 represents a a54- 
dependent promoter. Predicted transcription start points from each promoter are indicated 
with arrows below the sequence. A putative ribosomal binding site (AGGA) is underlined. 
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from various sources, possessed the tapA and tapD genes. In addition, other 
investigators have recently reported that this gene cluster is also present in the 
psychrophilic Aeromonas species, A. salmonicida (HG3), (Genbank accessions 
AF059248, AF003962, AF059249 and U95640). 
The widespread distribution of the tap gene cluster is consistent with the 
distribution of type IVA pilus genes in other bacteria. For the majority of bacteria for 
which this type of study has been conducted, the genes encoding pili were found to 
be widespread in both pathogenic and non-pathogenic species. For example, both 
virulent and benign isolates of Dichelobacter nodosus have been found to encode pili 
(Rood et al., 1997), and the genes encoding pili from Legionella pneumophila were 
found to be possessed by both the pathogenic (e.g. L. pneumophila, L. longbeachae) 
and non-pathogenic (e.g. L. erythra, L. spiritensis) Legionella species (Liles et al., 
1998). The exception to this rule are the members of the Neisseria genus. For these 
bacteria, sequences homologous to the pilin subunit gene (pilE) have only been 
found in the pathogenic species N. meningitidis and N. gonorrhoeae (Aho et al., 
1987; Wolff and Stern, 1995). Therefore, the fact that the tap cluster is present in 
both pathogenic and non-pathogenic species does not rule out that these genes may 
encode an important virulence factor for Aeromonas species. 
The observed differences in the stringency conditions and the restriction 
fragment sizes with which the tapA and tapD probes hybridised may also indicate 
that there are two separate lineages of the tap cluster. The clusters from A. 
hydrophila and A. veronii biovar sobria hybridise with a tapA probe from A. 
hydrophila Ah65 at high stringency, and most commonly have tapA and tapD 
localised on 1.0 kb BamH I and 2.7 kb Pst I restriction fragments, respectively. In 
contrast, the tap cluster from A. caviae strains is characterised by hybridisation with 
the A. hydrophila Ah65 tapA gene only under low stringency conditions, and strains 
of A. caviae most commonly have tapA and tapD localise to 1.2 kb BamH I and 3.3 
kb Psi' I restriction fragments, respectively. 
The sequence of tapD appears to be well conserved, as DNA from all isolates 
hybridised with a tapD probe under high stringency conditions. Such sequence 
85 
conservation is not unexpected, however, as the tapD gene encodes a protein with 
multiple enzymatic functions, which is likely to reside in the cytoplasmic membrane. 
In contrast, the sequences of tapA appear to be more variable, since strains of A. 
caviae hybridised with this probe only under low stringency conditions. If Tap pili 
are assembled on the cell surface, variation in tapA would presumably be driven by 
in vivo selection as are the pilin proteins of other Gram-negative pathogens, such as 
those belonging to the genus Neisseria (Seifert, 1996). 
Initial screening results indicated that the tapA probe may have potential for 
use as a marker of pathogenic strains. In these initial experiments, the tapA probe 
hybridised with an — 1.0 kb BamH I fragment from clinical isolates of A. veronii 
biovar sobria more frequently than it hybridised with an — 1.0 kb fragment from 
environmental isolates. The clinical strains examined were not a homogenous group 
as they came from diverse geographical regions and varied considerably in their 
exotoxic activities. Therefore, it is unlikely that the conservation in the clinical 
strains simply represents multiple isolations of a clonal organism. 
Further screening demonstrated that this difference was not as distinct as first 
thought. However, using genetically typed strains, diarrhoeal isolates almost always 
had tapA localised to an — 1.0 kb BamH I restriction fragment (85% tested) whereas 
this frequency was lower for environmental isolates (67% isolates tested). This 
finding needs to be investigated further using genetically typed strains of known 
source. It is possible that the results from the initial screening experiments may have 
been skewed by inaccurate species designation. In particular, some of the 
environmental isolates of A. veronii biovar sobria HG8/10 may have been 
inaccurately classified A. sobria HG7 strain. The methods used to speciate the 
majority of the strains used in this chapter involved several biochemical tests, which 
have been developed for clinical isolates, and environmental isolates do not always 
give reliable results when grown at 37°C. In order to clarify these possibilities, the 
environmental A. veronii biovar sobria strains used in this chapter have been sent to 
Dr M. Altwegg (University of Zurich, Zurich, Switzerland), to be genotyped. 
Unfortunately, the results of this testing are not yet available. 
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The observed restriction fragment length polymorphism between clinical and 
environmental isolates of A. veronii biovar sobria is consistent with nucleotide 
sequence differences within the region encompassing tapA. Such differences may 
have included the presence of important virulence determinants in clinical strains, or 
variations in genes or promoter sequences responsible for Tap pilus expression. 
Sequencing upstream of tapA from strain BC88 revealed that this region is very 
similar to the pi/A-proximal region of V. cholerae. However, based on this sequence 
data, it seems unlikely that differences upstream of tapA between clinical and 
environmental A. veronii biovar sobria could have accounted for the differences in 
hybridisation results. No ORFs upstream of tapA from strain BC88 resembled genes 
encoding virulence factors from other bacteria, or genes involved in the regulation of 
virulence factor expression. However, two genes identified did exhibit homology 
with genes encoding proteins involved in the regulation of expression of other gene 
systems. The ampD gene encodes a negative regulator of ArnpC beta-lactamase 
expression responsible for cephalosporin resistance in the Enterobacteriaceae, while 
pdhR encodes a transcriptional repressor of the pyruvate dehydrogenase complex. All 
identified ORFs would encode full length proteins with the exception of nadC, which 
encodes a quinolinate phosphoribosyl transferase involved in NAD biosynthesis. 
Again, the nature of this gene is identical to the nadC-homologous ORF from V. 
cholerae. The nadC genes from these two organisms are truncated, and only the C-
terminal 67 amino acids would be expressed by A. veronii biovar sobria BC88. 
Analysis of DNA sequence between nadC and tapA revealed the presence of 
one potential a54-dependent promoter and two potential a70-dependent promoters. 
The majority of type IV prepilin genes described to date are transcribed from 0 . 54- 
dependent promoters. However, while both of the a70-dependent promoters 
conformed reasonably well to the consensus sequence, giving scores of 0.99 (P1) and 
0.91 (P2), the sequence of the putative o -54-dependent promoter upstream of tapA 
(GGN ioAC) did not conform exactly to the consensus sequence for this class of 
promoter (GGN I0GC). Furthermore, a consensus sequence for the NifA binding site 
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(required for activation from a54-dependent promoters) was not found within the 
region 75 to 125 bp upstream of this potential a54-dependent promoter. It is 
interesting to note, however, that specific mutations have been identified that allow 
transcription from a54-dependent promoters in the absence of upstream regulatory 
sequences (Wang et al., 1997). One class of these mutants possessed a dysfunctional 
—12 promoter recognition sequence. It is, therefore, possible that the non-consensus — 
12 sequence in A. veronii biovar sobria BC88 allows transcription of tapA in the 
absence of an upstream NifA binding site. 
In summary, the tap cluster is widely distributed in the genus Aeromonas. This 
suggests that the tap gene cluster encodes a structure important for some aspect of 
the biology of these bacteria. Experiments described in chapter 5 will investigate 
whether Tap pili mediate adhesion to, and colonisation of, the gastrointestinal tract 
and factors influencing their expression. 
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5.1. Introduction 
The aim of this chapter was to determine whether Tap pili mediate binding to 
host tissues and whether these structures are involved in intestinal colonisation by 
Aeromonas species. This was accomplished by investigating the ability of wild-type 
(BC88) and tapA mutant (BC88tapA::0) strains to adhere to intestinal tissue cell 
lines, and assessing these strains in two animal models of gastrointestinal tract 
infection. Expression of Tap pili by BC88 was also investigated as part of these 
studies, and this necessitated the preparation of an antiserum against TapA from A. 
veronii biovar sobria BC88. 
5.2. Construction and in vitro characterisation of a Aeromonas 
veronii biovar sobria BC88tapA::C2 mutant strain 
A. veronii biovar sobria BC88tapA::Q was constructed by Dr. M. S. Strom, 
NVVFSC, Seattle, U.S.A. This strain was prepared by replacing the wild type copy of 
tapA with a copy that had been interrupted by insertion of the omega (Q) interpo son, 
encoding spectinomycin resistance. A 1.0 kb BamH I fragment (containing tapA) was 
isolated from pTB012 and inserted into the Bgl II site of the sacB suicide vector 
pEP185.2, producing pMS012. The Q interposon (from plasmid pUC19Q) was then 
inserted as a 2.1 kb Sma I fragment into the end-filled Pst I site of pMS012, 
producing pMS012Q. Plasmid pMS0120 was subsequently transformed into E. coli 
S17-1Apir and mobilised into A. veronii biovar sobria BC88 by conjugation, and 
transconjugants were selected on BHIA containing ampicillin and spectinomycin. 
Plasmid pEP185.2 requires the Apir gene product to replicate, and is therefore unable 
to replicate in Aeromonas. Selection of double recombinant strains, which possessed 
the tapA::C2 mutation with the suicide vector resolved from the chromosome, was 
confirmed by Southern hybridisation, using a digoxigenin-labelled 1.0 kb BamH I 
fragment (tapA) from pTB012 as a probe. 
The omega interposon creates a mutation with strong polar transcription and 
translation termination signals (Frey and Krisch, 1985). The tapA:S2 mutation lies 
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upstream of tapB, -C, and —D. The tapD gene product has been shown to be involved 
in extracellular protein secretion, including the secretion of at least one virulence 
factor, aerolysin. A mutation in tapD causes pleiotrophic secretion defects 
presumably due to a lack of processing of prepilin-like components of the type II 
secretion pathway (ExeG, -H, -I, and —J). Therefore, for the subsequent experiments 
involving BC88tapA:S2 (tapA mutant), it was necessary to establish whether the 
tapA:S2 mutation had polar downstream effects on the expression of tapD. This was 
accomplished by assaying extracellular toxic activities, since haemolytic, cytotoxic 
and enterotoxic activities are all mediated, at least in part, by aerolysin. These toxin 
assays were performed by Mr. A. Kelleher (BScHons 1998, Discipline of Pathology, 
University of Tasmania). The results are summarised in Table 5.1. 
BC88tapA:S2 (tapA mutant) produced wild-type levels of haemolytic, 
cytotoxic and enterotoxic activities. Therefore, the extracellular protein secretion of 
A. veronii biovar sobria BC88 did not appear to be affected by the tapA:S2 mutation. 
5.3. In vitro adhesion of BC88 and BC88tapA:S1 
In an initial attempt to determine whether Tap pili are required for adhesion of 
Aeromonas bacteria to human tissues, BC88 (wild-type) and BC88tapA::0 (tapA 
mutant) were assessed for their abilities to adhere to human intestinal tissue and to 
HEp-2 epithelial and Henle 407 intestinal cell lines. 
5.3.1. Adhesion to human intestinal tissue 
The ability of BC88 and BC88tapA:S2 to adhere to human intestinal tissue was 
assessed by measuring the adherence of A. veronii biovar sobria BC88 and 
BC88tapA:S2 strains to intestinal tissues obtained from routine biopsies at the Royal 
Hobart Hospital (Tasmania, Australia), followed by examination by light 
microscopy. These experiments were performed by Ms. A. Stimming (BMedSc, 
Discipline of Pathology, University of Tasmania). 
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Table 5.1. Toxin production by A. veronii biovar sobria strains 
BC88 (wild-type) and BC88tapA:S2 (tapA mutant) 
Strain Haemolytic titre' Cytotoxic titreb Enterotoxic activity' 
BC88 1024" 128" 0.087 
BC88tapA:S2 1024" 128" 0.085 
a 	Haemolytic activity expressed as the highest dilution of cell free culture supernatants 
causing lysis to rabbit erythrocytes. 
b 	Cytotoxic activity expressed as the highest dilution of cell-free culture supernatants 
causing 50% lysis to Vero cells. 
c 	Enterotoxic activity expressed as the ratio of intestinal weight to remaining body weight 
following administration of 100 la I cell free culture supernatant. A value above 0.075 was 
considered positive. 
d  The comparatively low cytotoxic titre is due to the methodology of the cytotoxin assay 
used. 
Both BC88 (wild-type) and BC88tapA:S2 (tapA mutant) appeared to adhere at 
similar levels to the microvillus brush border of the enterocytes, suggesting that the 
tapA:S2 mutation did not effect the ability of strain BC88 to adhere to human 
intestinal tissue. However, this assay was not performed so as to allow quantitative 
measurements of adhesion. Minor differences in adhesion would, therefore, not have 
been observed. 
5.3.2. Adhesion to HEp-2 and Henle 407 cell lines 
Quantitative adhesion to HEp-2 and Henle 407 (INT407) cell lines was 
assessed according to the protocol of Carrello et al. (1988). For these experiments, 
strains were grown under standard in vitro growth conditions (BHIB, 37°C, static), as 
described by Carrello et al. (1988). The results of these experiments are summarised 
in Table 5.2. 
No significant difference in the adhesion of BC88 (wild-type) and 
BC88tapA:S2 (tapA mutant) was observed to either HEp-2 (p=0.759) and Henle 407 
(p=0.129) cells. For these experiments, bacteria were grown under standard in vitro 
culture conditions. It has already been established in our laboratory that Tap pili 
either constitute a minor pilus population under these conditions, or that they are not 
assembled on the bacterial surface (Kirov and Sanderson, 1996). Hence, it was 
important to evaluate the colonisation of the intestinal tract in vivo by BC88 (wild-
type) and BC88tapA:S2 (tapA mutant), where it is possible that expression of Tap 
pili is induced. 
5.4. In vivo behaviour of BC88tapA::SI 
To establish whether the tapA:S2 mutation had any affect on the ability of 
strain BC88 to colonise the intestinal tract in vivo, BC88 (wild-type) and 
BC88tapA:S2 (tapA mutant) were assessed in infant mice (colonisation and 
competition experiments) and rabbits using the removable intestinal tie adult rabbit 
diarrhoeal (RITARD) model. 
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Table 5.2. Adhesion to epithelial and intestinal cell lines by A. veronii 
biovar sobria BC88 (wild-type) and BC88tapA:S2 (tapA mutant). 
Cell adherence' 
Strain HEp-2 Henle 407 
BC88 10.1 ± 0.7 13.3 ± 2.1 
tapA::0 11.1 ± 1.6 16.2 ± 1.3 
p = 0.759 	 p = 0.129 
a Adherence expressed as the mean number of bacteria per cell ± standard deviation. 
5.4.1. Colonisation of infant mice 
The infant mouse model of bacterial colonisation has been well established for 
use to examine the virulence and ability to colonise the intestine by strains of Vibrio 
cholerae (Attridge et al., 1993; Attridge et al., 1996; Fullner and Mekalanos, 1999). 
This model has also been used to measure the virulence of Aeromonas hydrophila 
(Wong et al., 1996) using the LD50 assay described for V. cholerae (Chaicumpa and 
Rowley, 1972). Results from the report by Wong et al. (1996) also indicated that 
Aeromonas bacteria may colonise the infant mouse intestinal tract at sub-lethal 
doses. 
Since the infant mouse model had not been used to assess colonisation by A. 
veronii biovar sobria, initial experiments were conducted to establish whether BC88 
(wild-type) and BC88tapA:S2 (tapA mutant) were capable of persisting in the infant 
mouse intestinal tract. These experiments involved the administration of each strain 
separately to groups of six BALB/c infant mice. At 24 h post infection, mice were 
sacrificed and bacteria were enumerated by plate counts. The results are summarised 
in Table 5.3. 
Both strains appeared to colonise at similar levels. The wild-type strain was 
retrieved at a level of 3.1 x 10 ± 4.4 x 10' (range: 4 x 10 6 to 9.6 x 107), compared to 
a level of 2.6 x 10 7 ± 2.0 x 107 (range: 4 x 106 to 4.8 x 107) for BC88tapA:S2 (tapA 
mutant). A high level of variation was observed for intestinal recoveries of each 
organism from individual mice and, consequently, no statistical difference in 
adhesion was observed. Therefore, to compare more accurately the ability of these 
strains to colonise the intestine, an alternative method was adopted. This involved 
administration of BC88 (wild-type) and BC88tapA:S2 (tapA mutant) simultaneously 
to individual mice (competition assay). This method is well established for assessing 
mutants defective in the production of putative colonisation factors of V. cholerae 
(Attridge et al., 1993; 1996). BC88 and BC88tapA::C2 were administered in 
competition to groups of six or seven infant mice according to the protocols of 
Attridge et al. (1993) and Fullner and Mekalanos (Fullner and Mekalanos, 1999). 
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Table 5.3. Infant mouse colonisation by A. veronii biovar sobria BC88 
(wild-type) and BC88 tapA:: 0 (tapA mutant)a 
Strain Inoculumb Recover?' 
BC88 1.4 x 10' 1.6 x 106 3.1 x 10 7 ± 4.4 x 10 7 
9.6 x 107 
6.0 x 10 7 
4.0 x 10 6 
4.0 x 10 6 
2.0 x 10 7 
BC88tapA:S2 2.1 x 10 7 2.8 x 10 7 2.6x 10'± 2.0 x 10 7 
4.8 x 10 7 
4.0 x 106 
8.0 x 106 
4.4 x 10 7 
2.4 x 10 7 
a 	Six mice were included in each test group. 
b  The inoculum was determined retrospectively by plate counts. 
, 	The recovery was calculated as the total number of bacteria recovered from intestinal tissue after 24 h 
± standard deviation. 
d  The recovery of strains BC88 and BC88tapA::0 were not statistically different (students t-test, p = 
0.78548). 
Comparative inoculation of BC88 and BC88tapA:n strains was repeated twice, and 
the results are indicated in Fig. 5.1. 
Fig. 5.1 shows the ratios of BC88 (wild-type) and BC88tapA::0 (tapA mutant) 
bacteria recovered from intestinal homogenates of individual mice (output ratio, 
represented as individual symbols), for each of two experiments. The input ratio for 
each experiment is indicated below each test group. For each experiment, the output 
ratios were very similar to the ratios present in the challenge inoculum, indicating 
that the tapA:S2 mutation did not decrease the ability of BC88 to colonise the infant 
mouse intestinal tract. 
5.4.2. Removable intestinal tie adult rabbit diarrhoeal (RITARD) model 
The BC88 (wild-type) and BC88tapA::Q (tapA mutant) strains were tested in 
the removable intestinal tie adult rabbit diarrhoea! (RITARD) model, as described by 
Pazzaglia et al. (1990). These experiments were performed by Dr. M. J. Albert 
(International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh). 
Nine rabbits each were challenged with BC88 and BC88tapA:S2, and five 
rabbits were challenged with a control organism, E. coli EC 101. Each animal was 
administered the appropriate bacterial strain at a dose of 10' ° organisms. Rabbits 
were observed for eight days for diarrhoeal symptoms and shedding of the test 
organism. Results are summarised in Table 5.4. 
No diarrhoeal symptoms were observed when the negative control strain, E. 
coli EC101, was administered to five rabbits in this experiment, or to 12 rabbits used 
as similar controls in other experiments. The BC88 wild-type strain caused 
diarrhoeal symptoms lasting for one to three days in six of nine rabbits. Hence, A. 
veronii biovar sobria BC88 is able to cause a mild, self-limiting gastrointestinal 
illness in rabbits. The BC88tapA:S2 (tapA mutant) strain produced diarrhoeal 
symptoms in four of nine rabbits. This difference cannot be considered significant 
due to the small number of test animals used in this experiment. The fact that four 
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Fig. 5.1. Colonisation of infant mice by BC88 (wild-type) and BC88tapil:S2 
(tapA mutant). 
Individual mice were fed mixed suspensions of wild-type and mutant bacteria. Input ratios 
are indicated below each test group (n=2). Each symbol represents the wild-type:mutant 
output ratio for bacteria recovered from the intestines of individual mice. 
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Table 5.4. Ability of A. veronii biovar sobria BC88 (wild-type) and 
BC88tapA:S2 (tapA mutant) to cause disease in the RITARD model 
Strain No. rabbits tested No. shedding Aeromonasa No. with diarrhoea 
BC88 9 7 6 
BC88tapA:S2 9 8 4 
E. coli 5 (12)b 0 0 
EC101 
a  All rabbits were monitored for eight days. Both BC88 and BC88tapA:n were shed for periods 
ranging from one to three days. 
I) 	Five rabbits were included as controls in this experiment; 12 control animals were from previous 
experiments conducted at the International Centre for Diarrhoeal Disease Research, Dhaka, 
Bangladesh (M. J. Albert, personal communication). 
rabbits administered BC88tapA::0 (tapA mutant) exhibited diarrhoea! symptoms 
indicates that possession of Tap pili is not essential for this process. 
Rabbits administered the wild-type and mutant strains were also assessed for 
faecal shedding of each test strain. Both strains were shed for periods ranging from 
one to five days, by seven of nine rabbits (BC88), or eight of nine rabbits 
(BC88tapA::Q). The results obtained also indicate that the tapA::S) mutation does not 
attenuate the virulence of A. veronii biovar sobria BC88 in this animal model. 
Hence, in vitro and in vivo studies suggest that Tap pili do not mediate 
adherence to epithelial and intestinal cell surfaces, and that they are not essential for 
colonisation of the intestinal tract. However, it is unclear whether the tap gene cluster 
encodes a pilus that is expressed and assembled on the bacterial cell surface. From 
the in vitro studies conducted in our laboratory, these pili are either not expressed, or 
constitute a minor pilus under standard in vitro culture conditions. Therefore, 
experiments were performed to investigate the assembly of Tap pili by A. veronii 
biovar sobria BC88. 
5.5. Expression and assembly of Tap pill by Aeromonas veronii 
biovar sobria BC88 
To investigate whether Tap pili are expressed, an antiserum against the protein 
encoded by tapA from A. veronii biovar sobria BC88 was produced. Since Tap pili 
have never been purified from the surface of Aeromonas species, a recombinant 
TapA protein was produced and used to raise a polyclonal rabbit antiserum, which 
could then used to assess TapA expression and assembly on the bacterial cell surface. 
To prepare a TapA antiserum, rabbits were immunised with a recombinant 
TapA protein, hereafter, r-TapA, produced by overexpression of tapA in E. coli 
BL21(DE3). To facilitate the identification and purification of r-TapA, this protein 
was fused to a His•tag sequence, which can be purified by affinity chromatography 
to divalent cations (see section 2.12). 
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5.5.1. Construction of a tapABC88 His•tag expression construct 
Initially, the entire tapA gene (including the type IV leader sequence) was 
incorporated into the r-TapA expression construct. The tapA open reading frame 
from A. veronii biovar sobria BC88 was amplified using primers P004 and P005, 
which contain engineered sites BamH I and EcoR V sites, respectively, to allow 
subsequent cloning into the expression vector pQE32 (Appendix 7). The resulting 
PCR product was digested with BamH I and EcoR V and cloned into pQE32. This 
construct, designated pTB025, was transformed into E. coli TOP10F' and cultures 
were induced with IPTG as described in section 2.12.1. However, upon induction of 
r-TapA expression from this construct, the cells appeared to lyse. This may have 
occurred as a result of toxicity associated with the type IV leader peptide. The 
toxicity of Neisseria gonorrhoeae PilE, following expression in E. coli, has been 
shown to be associated with the type IV leader peptide (Fyfe et al., 1993). 
Therefore, an alternative strategy was adopted, which involved producing a 
fusion protein that lacked the type IV leader peptide, followed by expression using 
the pET expression system. This system had been used successfully to prepare an 
antiserum against the C-terminal region of the A. hydrophila Ah65 TapA protein, and 
to demonstrate that this protein is expressed (Dr. M. S. Strom, personal 
communication). The pET system utilises an extremely strong expression system 
involving the T7 RNA polymerase. This system can be kept transcriptionally silent 
and, upon induction, produces the highest transcription levels of any commercially 
available expression system. The revised cloning strategy for production of the 
TapA-Hisetag fusion protein construct is indicated in Fig. 5.2. 
The tapA open reading frame from A. veronii biovar sobria BC88 was 
amplified using primers P013 and P014 (Appendix 7). P013 was designed so as to 
incorporate a Nde I site after the preTapA leader sequence, in order to remove this 
sequence following digestion with Nde I. The PCR product produced by this method 
was digested with Nde I and Bgl II, and cloned into the Nde I and BamH I sites of 
pET15b to produce pTB028. Expression from this construct would produce a fusion 
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Fig. 5.2. Cloning strategy for the construction of pTB028. 
The DNA sequences at the 5' and 3' ends of tapA used for the construction of primers P013 
and P014, respectively, are shown. Restriction sites incorporated to facilitate cloning are 
underlined. pTB028 was constructed by PCR amplification of tapA with P013 and P014 
and digesting the resulting PCR product with Nde I and Bgl II. The resulting DNA 
fragment was cloned into the Nde I and BamH I sites of pET15b, generating pTB028. The 
sequence of the r-TapA fusion protein is also indicated. The vector-derived His ■tag 
sequence is in bold font. 
CAAAT GAAGAAACAAT CGGGTT TT TACCCTTATTGAACTGAT GAT 
5 7 - TGAAGAAACAACATAT GT TT TACCCT TATTG- 3 
P013 
 
tapB  
 
... 
TAT T GCCCCAAATAAT GACCT CTAGCCCTAATAGCGGCCT GGCGT 
3' -GGTT TAT TACTGGAGAT CTAGAT TATC-5 ' 
P014 
I PCR amplify and clone into pET15b 
r-TapA MGSSHHHHHHSSGLVPRGSHMFTLIELMIVVAIVAILAAV 	CAGASNVNDYCPK 
protein containing an N-terminal Hisotag sequence, as shown in Fig. 5.2. The 
predicted sequence of this protein was confirmed by sequencing of the pTB028 
expression region, using a primer to the T7 promoter located upstream of tapA 
(Appendix 7). 
5.5.2. Identification of clones which express r-TapA 
Plasmid pTB028 was isolated and transformed into E. coli BL21(DE3), a strain 
that possesses the gene encoding T7 RNA polymerase under control of a lac 
promoter. Expression of T7 RNA polymerase occurs following addition of 1 mM 
IPTG to the growth medium and this, in turn, results in the expression of the TapA-
His•tag fusion protein from the 17 promoter. Six BL21 clones were grown and 
induced as described in section 2.13.1, and whole cell lysates were analysed for r-
TapA expression by SDS-PAGE. The results are shown in Fig. 5.3a. 
In Fig. 5.3a, lane 1 contains plasmid pCP1183 in E. coli BL21(DE3). This 
plasmid contains the region of tapA from A. hydrophila Ah65 encoding the C-
terminal 126 amino acids, fused to the His•tag sequence in pET15b (obtained from 
Dr. M. Strom), and was used as a positive control in all expression and purification 
studies described in this section. Lane 2 contains plasmid pET15b in E. coli 
BL21(DE3). This strain was used as a negative control in all expression experiments. 
Lanes 3 to 8 contain plasmid pTB028 in E. coli BL21(DE3). All pTB028 clones 
produced a 21 kDa protein following induction, as indicated by an arrow. This 
protein was absent in the negative control strain (lane 2). The molecular weight of 
this protein corresponds exactly to the predicted molecular weight of the r-TapA 
protein, as judged from the amino acid sequence. The identity of the 21 kDa protein 
was confirmed by western blot analysis with a tetra•His antibody (Qiagen, Hilden, 
Germany). Results are shown in Fig. 5.3b. This antibody is specific for four 
successive histidine residues, which are present within the Hisetag sequence. 
However, the level of expression was lower than that of the positive control plasmid 
pCP1183. 
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Fig. 5.3. Identification of r-TapA expression clones. 
a. SDS-PAGE analysis. b. Western blot analysis. His•tag proteins are detected with a 
tetra•His monoclonal antibody specific for four successive histidine residues. Molecular 
weight markers (size in kilodaltons) are indicated to the left. The 21 kDa protein (r-TapA) 
is indicated to the right with an arrow. 
Lane 1. 	BL21(DE3) containing pCP1183, positive control 
Lane 2. 	BL21(DE3) containing pET15b, negative control 
Lane 3. 	Individual BL21(DE3) clones containing pTB028 
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5.5.3. Optimisation of expression 
The levels of r-TapA expression were fairly low, as judged by SDS-PAGE 
analysis. Therefore, two factors known to influence the levels of protein expression 
in the pET system were investigated to determine whether the relative levels of r-
TapA production could be increased. These factors were the stability of the 
expression construct, and assessment of r-TapA expression in different E. coli host 
strains. 
Plasmid pTB028 was found not to be unstable in BL21(DE3) in the presence of 
100 ps/m1 carbenicillin. The use of three different host strains, E. coli strains 
BL21(DE3), BL21(DE3) (pLysS), and JM109(DE3) were also tested. Plasmid pLysS 
encodes T7 lysozyme, which is a repressor of residual T7 RNA polymerase-mediated 
expression and is often used to minimise baseline expression of toxic proteins in E. 
coli. The highest levels of expression were observed when E. coli BL21(DE3) was 
the host strain. Therefore, this strain was used for all subsequent experiments. 
5.5.4. Reduction of background protein expression 
Despite the experiments described above, the level of r-TapA expression in E. 
coli BL21(DE3) remained low. The r-TapA protein was estimated to be expressed at 
— 1 to 5% of the total cell protein in E. coli BL21(DE3), compared with — 30% for 
the positive control plasmid pCP1183. Since the experiments in section 5.3.1.3. 
failed to increase the amount of r-TapA produced, attempts were made to reduce the 
amount of background host cell protein production by inhibiting the host RNA 
polymerase with the antibiotic rifampicin. T7 RNA polymerase is unique in that its 
activity is not inhibited by rifampicin. Consequently, this antibiotic has been used to 
inhibit host cell protein production during T7 RNA polymerase protein expression 
(Tabor and Richardson, 1985). Expression of the T7 RNA polymerase enzyme in E. 
coli BL21(DE3) is under the control of the E. coli RNA polymerase enzyme, which 
is inhibited by rifampicin. Hence, a time course of expression was conducted where 
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200 g/m1 of rifampicin was added at various intervals following induction with 
IPTG. The results of this experiment are shown in Fig. 5.4. 
After induction, a 21 lcDa protein was observed in all cultures containing 
pTB028. However, the levels of background protein expression were much lower in 
those cultures to which rifampicin had been added. The relative level of r-TapA 
expression was highest when rifampicin was added 30 min after induction with 
IPTG. This condition was, therefore, used in all subsequent experiments. 
5.5.5. Purification of r-TapA 
The levels of r-TapA produced following the induction conditions described 
above were approximately five times lower than the protein levels observed 
following induction from the positive control plasmid pCP1183. Therefore, culture 
volumes were scaled up ten-fold to ensure that suitable amounts of this protein would 
be available for purification. Processing of the cell pellets following induction 
indicated that the r-TapA protein was contained within insoluble inclusion bodies. 
Consequently, purification was carried out under denaturing conditions (6 M 
guanidine hydrochloride). 
The His•tag purification procedure relies on the affinity of the amino acid 
histidine to divalent cations. The His•tag sequence binds reversibly to nickel ions 
immobilised on a NTA resin (Qiagen, Hilden, Germany) and, after unbound proteins 
are removed by washing, the target protein can be eluted by competition with the 
histidine analogue, imidazole. Attempts to purify the r-TapA protein using this 
approach, however, were unsuccessful due to the extremely insoluble nature of this 
protein when expressed in E. coli. The majority of r-TapA protein was not able to be 
dissolved following overnight incubation in 8 M urea or 6 M guanidine 
hydrochloride. 
The insoluble nature of r-TapA was eventually exploited to remove the 
majority of contaminating host proteins, and obtain a relatively pure protein 
preparation. This procedure involved incubating the insoluble fraction in increasing 
concentrations of urea (2, 4, 6, and 8M) using a slight modification of the protocol 
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Fig. 5.4. Reduction of background protein expression from r-TapA expression 
clones. 
Following induction with IPTG, 200 [tg/m1 rifampicin was added to inhibit host protein 
synthesis at the time points indicated and each culture was subjected to SDS-PAGE. 
Molecular weight markers (size in kilodaltons) are indicated to the left. The 21 kDa r-TapA 
protein is indicated to the right with an arrow. Note the reduced levels of background 
proteins in lanes 4-9. 
Lane 1. 	BL21(DE3) pTB028 uninduced 
Lane 2. 	BL21(DE3) pTB028 induced 
Lane 3. 	BL21(DE3) pTB028 induced, rifampicin added after 4 h induction 
Lane 4. 	BL21(DE3) pTB028 induced, rifampicin added after 15, 30, 60, 90, 120, and 
180 mm induction, respectively 
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described by Reischl (1998) (section 2.13). The results of this experiment are shown 
in Fig. 5.5. 
In Fig. 5.5, lane 1 contains the soluble protein fraction. Lanes 2 to 5 contain 
fractions successively solubilised in 2, 4, 6 and 8 M urea, and lane 6 contains the 
insoluble fraction. A 21 lcDa protein band was apparent in all lanes, and the 
concentration of this protein was highest in the 8M urea-insoluble fraction. This 
protein was isolated by SDS-PAGE and used to immunise New Zealand white 
rabbits, according to the protocol outlined in section 2.13.4. 
In summary, the pET expression system was used to produce a relatively pure 
preparation of a recombinant TapA protein. New Zealand white rabbits were 
immunised with this protein. For the initial challenge, 100 [tg of r-TapA was 
emulsified in Freund's complete adjuvant and administered to each of three rabbits 
subcutaneously (sc). Subsequent challenges (100 [tg r-TapA emulsified in Freund's 
incomplete adjuvant) were administered sc at days 21, 35 and 49. Test bleeds were 
obtained at days 28, 42 and 56, and assessed for reactivity against whole cell lysates 
of A. veronii biovar sobria BC88 and E. coli BL21(DE3) (pTB028). 
5.5.6. Antiserum characterisation 
Test bleeds (— 5 ml; section 5.5.5) were obtained and tested for reactivity by 
western blotting. Although these bleeds indicated that the rabbits were responding 
with a good immune response, the unabsorbed antiserum exhibited high reactivity 
against a wide range of antigens from both strains tested. Consequently, specific 
reactivity against TapA was not readily observed. Therefore, it was decided to absorb 
each antiserum against an acetone powder of BC88tapA:S2 as described in section 
2.13.5. Results of western blots, using this absorbed antiserum, against whole cell 
lysates of A. veronii biovar sobria BC88 and BC88tapA:S2 are shown in Fig. 5.6. 
Of the three rabbits immunised with r-TapA, one produced a good level of 
reactivity against TapA. This antiserum reacted with a strong protein band from 
BC88, 20.5 IcDa is size, which is absent in the BC88tapA:S2 lane (Fig. 5.6). This 
99 
Fig. 5.5. Semi-purification of r-TapA by removal of contaminating proteins. 
SDS-PAGE analysis of partially-purified r-TapA fractions. Contaminating proteins were 
removed following successive solubilisation in urea by a modification of the procedure of 
Reischl (1998). Molecular weight markers (size in kilodaltons) are indicated to the left. The 
21 kDa r-TapA protein is indicated to the right with an arrow. 
Lane 1. BL21(DE3) pTB028 uninduced 
Lane 2. BL21(DE3) pTB028 induced 
Lane 3. 	soluble fraction 
Lane 4. 	2 M urea-soluble fraction 
Lane 5. 	4 M urea-soluble fraction 
Lane 6. 	6 M urea-soluble fraction 
Lane 7. 	8 M urea-soluble fraction 
Lane 8. 	8 M urea-insoluble fraction 
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Fig. 5.6. Western blot analysis of whole cell lysates of BC88 (wild-type) and 
BC88tapA::0 (tapA mutant) with the r-TapA antiserum. 
The r-TapA antiserum was absorbed four times against an acetone powder of BC88tapA:S2 
(tapA mutant). Note a 21.5 I(Da protein present in BC88 (lane 1) and absent in 
BC88tapA:S2 (lane 2). The observed laddering effect of this protein may be due to altered 
glycosylation states, or some chemical property of the TapA amino acid sequence. 
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demonstrates both that the TapA antiserum is specific for TapA, and that tapA is 
expressed by A. veronii biovar sobria BC88. However, the size of the TapA protein 
(20.5 l(Da) was higher than that predicted by the gene sequence (17 lcDa). This 
discrepancy may have been caused by some chemical property of the TapA primary 
amino acid sequence, causing some effect on charge or folding. Alternatively, the 
slower apparent migration of TapA may have been caused by alternate glycosylation 
states of this protein. The primary amino acid sequence of TapA does contain two 
possible N-linked glycosylation sites at residues 32 and 118. These possibilities may 
also account for the slight laddering effect of this protein, which is visible in Fig. 5.6, 
lane 1. 
5.5.7. Electron microscopic examination of Tap pilus assembly 
Previous studies in our laboratory have demonstrated that almost all pili 
expressed on the surface of A. veronii biovar sobria BC88 when grown under 
standard in vitro culture conditions (TSBY, 22°C, 48 h) are Bfp pili (Kirov and 
Sanderson, 1996). However, Kirov and Sanderson (1996) also documented 
conditions (TSAY, 22°C, 48 h) where a significant proportion of the pilus structures 
were distinct from Bfp pili. Therefore, A. veronii biovar sobria BC88 (wild-type) and 
BC88tapA:S2 (tapA mutant) were grown under the different conditions examined 
above, and examined by immune electron microscopy using the TapA antiserum. A 
variety of dilutions of this antiserum were assessed (1:10, 1:100 and 1:1000), and a 
1:100 dilution of Bfp antiserum (Kirov and Sanderson, 1996) served as a positive 
control. The results of this experiment are shown in Fig. 5.7. 
Fig. 5.7 shows immunogold electron microscopic examination of A. veronii 
biovar sobria BC88 (wild-type) and BC88tapA:S2 (tapA mutant), grown on TSAY at 
22°C for 48 h, stained with a 1:10 dilution of the TapA antiserum. No labelling of 
pilus structures was detected with this antiserum. The Bfp antiserum, however, 
labelled pili on the surface of both BC88 and BC88tapA::Q. 
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Fig. 5.7. Immunogold electron microscopic analysis of Tap pilus assembly by 
A. veronii biovar sobria BC88. 
A. veronii biovar sobria BC88 (wild-type) was grown on TSAY for 48 h at 22°C and 
stained with the appropriate antiserum preparation. a. 1:100 dilution of Bfp antiserum. 
Arrows indicate immonogold labelling of a Bfp pilus. b. 1:10 dilution of r-TapA antiserum. 
Bar represents 0.5 1.1m. Note the absence of staining with the r-TapA antiserum. 
b. 
5.6. Discussion 
The experiments outlined in this chapter have described the construction of an 
isogenic tapA mutant strain of A. veronii biovar sobria BC88, and the evaluation of 
this strain using in vitro models of adhesion and in vivo models of intestinal 
colonisation. 
Adhesion to cell lines has been shown to correlate with enteropathogenicity for 
Aeromonas species, and this is thought to reflect a strains ability to colonise the 
intestinal tract (Kirov et al., 1995a). The tapA:S2 mutation did not attenuate A. 
veronii biovar sobria BC88 in any of the in vitro adherence models tested. BC88 
(wild-type) and BC88tapA::S2 (tapA mutant) adhered to human intestinal tissue, 
HEp-2 epithelial cells, and Henle 407 intestinal cells at similar levels and the 
differences in adhesion were not statistically significant. However, given that Tap 
pili do not appear to be assembled under in vitro culture conditions, this observation 
is not unexpected. A. veronii biovar sobria BC88 has been the subject of intensive 
investigations in our laboratory with respect to its filamentous surface structures. 
Immunoelectron microscopy has revealed that the vast majority of pili expressed by 
this strain are label with Bfp antiserum (Kirov and Sanderson, 1996). However, a 
small proportion (< 2%) of the bacterial proportion produced an immunologically 
distinct pilus, which was also present in very low numbers (<3 per cell on average) 
(Kirov and Sanderson, 1996). Whether these unlabelled pili are Tap pili remains to 
be determined. If so, Tap pili would constitute a minor pilus when bacteria are grown 
under standard in vitro culture conditions. 
The widespread conservation of the tap gene cluster suggests that Tap pili play 
some role in the biology of Aeromonas bacteria, such as in the adhesion to inorganic 
substrates and the formation of biofilms in environmental niches. Tap pili may also 
be involved in adhesion to cells, despite the observations discussed above, where 
their low level of expression in vitro, and the presence of expressed Bfp, masks the 
effect of the tapA::12 mutation. Another possibility is that the Tap pilus, while not 
important for adhesion to epithelial or intestinal cells, is a colonisation factor by 
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mediating bacterium-bacterium adhesion and microcolony formation. This property 
has been attributed to type IV pili, but primarily to those of the type IVB pili 
represented by the Vibrio cholerae TCP, enteropathogenic E. coli BFP, and 
enterotoxigenic E. coli Longus pilus. 
The effect of the tapA:S2 mutation was, therefore, assessed in two in vivo 
models of intestinal infection to further investigate its possible role as a colonisation 
factor. The rabbit (RITARD) model used is one of two models of Aeromonas 
gastrointestinal disease reported to mimic diarrhoeal symptoms (Pazzaglia et al., 
1990). The RITARD model is a complex model involving surgical administration of 
the test strain directly into the intestines of test animals and, as such, makes the 
testing of large numbers of animals difficult and expensive. Hence the relatively few 
animals able to be investigated in these studies. 
The infant mouse model is often used to investigate the colonisation factors of 
Vibrio cholerae (Attridge et al., 1993; Attridge et al., 1996; Fullner and Mekalanos, 
1999). This model has also been applied to the measurement the virulence of 
Aeromonas species by determining a 50% lethal dose (LD„) as described by Wong et 
al. (1996). Wong et al. (1996) demonstrated that a strain of A. hydrophila (strain A6) 
was able to persist in the infant mouse intestine for considerable periods of time 
following administration at a level corresponding to 0.4 LD 50 units. Based on this 
report, it was decided to investigate the colonisation of BC88 (wild type) and 
BC88tapA:S2 (tapA mutant) using this infant mouse model. However, due to the 
availability of BALB/c mice, these were substituted for the Swiss-Webster mice used 
by Wong et al. (1996) and Attridge et al. (1993; 1996). 
Initial experiments with infant mice involved the administration of BC88 (wild 
type) and BC88tapA:S2 (tapA mutant) strains separately to individual mice. These 
experiments were primarily designed to determine whether A. veronii biovar sobria 
BC88 could colonise BALB/c mice at similar levels as A. hydrophila A6 in Swiss-
Webster mice. However, it was also designed so that major defects in the 
colonisation of the intestinal tract by BC88tapA:S2 strain would be detected. Results 
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indicated that BC88 could persist in BALB/c mice for periods greater than 24 h, 
since the output levels of both BC88 and BC88tapA:S2 strains 24 h post-inoculation 
was similar to their input levels. This experiment, therefore, did not detect any 
differences between the recovery of BC88 (wild-type) and BC88tapA::C2 (tapA 
mutant) from the mouse intestinal tract. 
An infant mouse competition assay was used in order to make a better 
comparison of the ability of BC88 (wild type) and BC88tapA:S2 (tapA mutant) to 
colonise intestinal tissue. Again, this approach indicated that the tapA:S2 mutation 
did not attenuate colonisation of the intestinal tract by A. veronii biovar sobria BC88. 
The results obtained for this assay supported the results observed for the RITARD 
model, in that Tap pili are either not expressed in sufficient levels, or do not function 
as intestinal colonisation factors. 
The tap genes represent a conserved gene cluster whose components are 
necessary for extracellular protein secretion. The putative prepilin gene, tapA, 
encodes a full length protein of 151 amino acids which contains all the features 
currently recognised to be essential for assembly into surface pili. Furthermore, the 
tapA genes from both A. hydrophila Ah65 and A. veronii biovar sobria BC88 are 
expressed as determined by western blot analysis using antisera raised against 
recombinant TapA proteins. However, Tap pili do not appear to be assembled in 
large numbers on the surface of either A. veronii biovar sobria BC88 (section 5.5.7) 
or A. hydrophila Ah65 (Dr. M. S. Strom, personal communication), at least under 
standard in vitro culture conditions. It seems unlikely that Tap pili are not assembled 
by Aeromonas species, since it is likely that expression of TapA would be selected 
against if this protein was of no use to the cell. 
The assembly of Tap pili on the bacterial surface may be regulated by the 
expression, or phase variation, of an accessory gene required for assembly, as 
previous studies in our laboratory demonstrated that non-Bfp pili are expressed when 
the in vitro growth conditions are altered. However, despite growing BC88 under 
these latter conditions, no Tap pili could be identified. 
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It cannot be discounted, however, that the TapA antiserum does not recognise 
TapA in its native conformation, and that the B 11,-distinct  pili described above are in 
fact Tap pili. The TapA antiserum was prepared using a denatured recombinant 
protein purified by SDS-PAGE, and it is possible that the epitopes recognised by this 
serum are unnatural or sequestered in the assembled pilus structures. Furthermore, it 
is possible that the His•tag sequence, or the absence of disulphide bonds, in the 
recombinant proteins may have altered their folding when compared with the native 
proteins. It would be useful to check the reactivity of this antiserum against native 
TapA by enzyme-linked immunosorbant assay, or by western blotting following 
native polyacrylamide gel electrophoresis. 
In summary, the results presented in this chapter have explored the function 
and expression the prepilin gene, tapA, encoded by the tap gene cluster. The 
evidence thus far suggests that this gene does not encode a pilus as significant in 
adhesion and colonisation as the Bfp pilus. In this respect, it appears that the tap gene 
cluster is similar in both structure (chapter 4) and function (chapter 5) to the pil gene 
cluster recently identified in Vibrio cholerae, which also had no role in adhesion or 
colonisation of infant mice. 
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6.1. Introduction 
Bacteria belonging to the genus Aeromonas are ubiquitous in the aquatic 
environment and have been linked to serious invasive diseases of both humans and 
animals. Although the subject of some controversy, some strains of Aeromonas 
bacteria are also believed to be primary gastrointestinal pathogens of humans. There 
is, however, no method currently available to identify these enteropathogenic strains. 
Although accurate species determination of an isolate is important, this identification 
alone is not sufficient. It is likely that only a subset of the three most common 
diarrhoea-associated species, A. hydrophila HG1, A. caviae HG4 and A. veronii 
biovar sobria HG8/10 possess the combinations of virulence factors that allow them 
to cause disease. Much effort has centred on elucidating the varied virulence 
mechanisms possessed by Aeromonas bacteria in an effort to identify characteristics 
that may be useful for the identification of pathogenic strains. 
For other enteropathogenic bacteria, type IV pili are often the primary bacterial 
structures mediating colonisation of intestinal tissues (Attridge et al., 1996; 
Donnenberg et al., 1997). At the commencement of the studies described in this 
thesis, very little was known about Aeromonas intestinal colonisation factors. Type 
IV pili had been purified from several diarrhoea-associated strains, and there was 
some indirect evidence that these structures mediated bacterial adhesion to 
enterocytes. The overall aim of this thesis, therefore, was to expand studies in this 
area by studying the genetics and function of Aeromonas type IV pili. 
6.2. Aeromonas species associated with gastrointestinal disease 
possess two distinct families of type IV pili 
The initial aim of this thesis was - to clone the genes encoding the bundle-
forming pilus (Bfp) expressed by a diarrhoea-associated Aeromonas strain (BC88). 
To accomplish this, a number of probes were used to identify genes encoding pili by 
Southern hybridisation. One probe was a type IV prepilin gene, tapA, recently cloned 
from a strain of A. hydrophila (Pepe et al., 1996). The use of this probe resulted in 
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the cloning of genes encoding a second family of type IV pili from A. veronii biovar 
sobria BC88. The cloning of the tap gene cluster from this strain, which was known 
to express Bfp pili (Kirov and Sanderson, 1996), clearly established that there are 
two families of type IV pili in Aeromonas species. This finding helped to resolve 
confusion in the literature between the tap cluster and the purified Bfp pili, and 
raised questions regarding the function(s) of these two families of pili. The cloning 
of the tap gene cluster from BC88 also allowed the production of an isogenic tapA 
mutant strain, which was used to analyse the function of this family of pili at the 
genetic level. 
The four genes that comprise the tap cluster are all transcribed in the same 
direction. However, these genes do not appear to form an operon. The intergenic 
space between tapB and tapC is quite large (Pepe et al., 1996), and a polar mutation 
constructed in tapA had no effect on protein secretion, an affect that would have been 
clearly visible if tapD was affected by this mutation. Expression of tapA is probably 
driven from one of the three promoters (one a54 and two a70) identified upstream of 
this gene in A. veronii biovar sobria BC88. For the majority of type IV pilus systems 
(e.g. P. aeruginosa and D. nodosus), expression of the pilin gene is initiated from a 
single a54-dependent promoter (Johnson et al., 1986; Thony and Hennecke, 1989). 
However, for strains of N. gonorrhoeae, a a70-dependent promoter appears to 
mediate pilE expression (Fyfe et al., 1993). Primer extension analysis could be used 
to map the transcription start site and determine which of these potential promoter 
sequences is responsible for tapA expression. 
The organisation of the tap cluster, and the flanking DNA regions, bears 
striking similarity to the clusters from V. vulnificus, V. cholerae, and E. coli (Fig. 
6.1). The presence and orientation of genes upstream of tapA suggests that the tap 
cluster may have arisen by lateral transfer. This theory is supported by the fact that 
sequence similarities in type IV pilin proteins do not fit into taxospecies 
classification (Spangenberg et al., 1997). 
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Fig. 6.1. Organisation of representative pilus gene clusters from various 
bacteria. 
The organisation of each gene cluster was assembled from sequences submitted to the 
Genbank database as follows: A. hydrophila Ah65 (U20255), A. salmonicida A450 
(AF059248 and AF059249), V. vulnificus M06-24 (AF070934), E. coli K12 (AE000120, 
L28105, and D26562), and P. aeruginosa PAK (M32066 and M14849). Similar genes are 
shaded in a similar manner. Genes not shaded do not exhibit homology with any of the 
other genes shown. 
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6.3. Distribution of the tap gene cluster 
The tap gene cluster was found to be widely distributed in Aeromonas isolates 
representing species both pathogenic and non-pathogenic to humans, and in isolates 
from clinical and environmental sources. This finding possibly argues against a role 
for these pili in virulence. However, type IV pilus genes from other pathogenic 
bacteria may, or may not, be present in non-pathogenic isolates. In D. nodosus (Rood 
et al., 1997) and Legionella species (Liles et al., 1998), genes encoding type IV pili 
are widely distributed among pathogenic and non-pathogenic isolates, whereas in 
Neisseria species (Aho et al., 1987; Wolff and Stern, 1995), V. cholerae (Karaolis et 
al., 1998), and E. coli (Sohel et al., 1996) they are limited to pathogenic strains. 
Therefore, the widespread distribution of the tap cluster does not discount the 
possibility that these genes encode a pilus important in the pathogenesis of 
Aeromonas infections. 
Differences in the hybridisation results of the different species examined 
suggests that there may be two lineages of the tap gene cluster. The tap clusters from 
A. hydrophila and A. veronii biovar sobria appear to be more closely related to each 
other than they are to the tap cluster from A. caviae. This situation is reminiscent of 
that of Dichelobacter nodosus. Strains of D. nodosus possess either Class I or Class 
II pili. These classes are defined by both sequence conservation within the pilin 
subunit, and gene organisation with respect to other pilus biogenesis proteins (Hobbs 
et al., 1991; Mattick et al., 1991). Although it is likely that the TapA proteins from 
all Aeromonas species exhibit significant sequence divergence outside species 
boundaries, the organisation of the tap cluster may also vary between these two 
groups. This idea could be confirmed by cloning and sequencing the tap cluster from 
A. caviae, since, to my knowledge, no investigations of this type have yet been 
conducted. (There are no sequences in the Genbank database corresponding to the 
tap cluster from A. caviae.) 
Despite the above results, which suggested that the tap gene cluster would not 
prove useful as a marker of pathogenic strains, preliminary results did indicate that 
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hybridisation with a tapA probe may differentiate clinical and environmental isolates 
of one species, A. veronii biovar sobria. For clinical isolates of this species, the tapA 
gene tended to be present on an — 1 kb BamH I fragment more frequently than it was 
for environmental isolates. However, subsequent analysis using genetically-typed 
strains indicated that the distinction between clinical and environmental isolates was 
not as great as first thought. Approximately 85% of diarrhoeal strains had tapA 
localised to an — 1 kb BamH I fragment, while in non-diarrhoeal and environmental 
isolates, this frequency was around 67%. Hence, although the tapA probe has 
identified two distinct populations of A. veronii biovar sobria strains (tapA on an — 1 
kb BamH I fragment, and tapA on a larger fragment), the significance of this 
observation, and ability to characterise pathogenic A. veronii biovar sobria is unclear 
at present and is being further studied in our laboratory (Mr. Gerald Murray, 
BScHons 1999). 
6.4. Expression of Tap pili 
Experiments described in this thesis suggest that Tap pili are likely to be 
assembled into surface pili, since all of the genes that comprise the tap cluster encode 
functional proteins. The tapA genes from both A. veronii biovar sobria BC88 (this 
study) and A. hydrophila Ah65 (Dr. M. S. Strom, personal communication) were 
shown to be expressed using polyclonal rabbit antisera. Moreover, tapB, -C, and —D 
from Ah65 have been shown to complement corresponding pil mutations in P. 
aeruginosa (Pepe et al., 1996). However, immune electron microscopic analysis 
could not demonstrate Tap pili directly on the surface of BC88, indicating that these 
pili are either expressed at very low levels under standard in vitro growth conditions, 
or they are not expressed under these conditions. 
Conditions that favour the assembly of Tap pili on the surface of Aeromonas 
bacteria remain to be defined. As expression of TapA was detected under standard in 
vitro culture conditions, the regulation of Tap pilus expression is most likely 
mediated by expression of another protein. This may occur at the level of 
transcription, or by phase variation as is the case for Neisseria gonorrhoeae. 
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Expression of pili by N. gonorrhoeae is subject to phase variation of Pi1C, a protein 
required for pilus assembly and/or translocation across the outer membrane. 
Expression of Pi1C is controlled at the translational level by frameshift mutations in a 
run of G residues positioned in the region encoding the signal peptide. This variation 
in Pi1C expression results in pilus phase variation independent of the pilus subunit 
(PilE) (Jonsson et al., 1991). 
If expression of Tap pili is regulated at the level of transcription, the growth 
conditions under which these pili are assembled remain to be defined. Growth 
conditions, shown in a previous study (Kirov and Sanderson, 1996) to result in the 
expression of surface pili distinct to Bfp, did not appear to influence the expression 
of Tap pili on the bacterial surface. Therefore, it is likely that another defined in vivo 
or environmental growth condition is required. Electron microscopic examination of 
bacteria recovered from biofilms, or following intestinal passage, may identify these 
conditions. 
Wild-type and tapA mutant strains were examined for their ability to colonise 
the gastrointestinal tract in two animal models, where conditions might be expected 
to favour expression of Tap pili if they are indeed important intestinal colonisation 
factors. If Tap pili were assembled on the bacterial surface under these conditions, 
however, results indicated that they are unlikely to be the primary structures 
mediating intestinal colonisation. It is also possible that assembly of Tap pili is 
down-regulated during in vivo passage, since electron microscopic analysis of 
clinical and environmental strains of A. veronii biovar sobria have demonstrated that 
environmental strains possess far more filamentous surface structures when 
compared to clinical isolates (Kirov et al., 1995b). 
It is interesting to note that assembled pili encoded by the tap-homologous 
gene clusters from Vibrio species and E. coli, described above, have not been 
detected. As these clusters all have a similar genetic organisation, it is possible that 
the assembly of their encoded gene products into pili is mediated by a common 
mechanism. Hence, further studies aimed at elucidating the conditions necessary for 
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assembly of Tap pili may shed light on the assembly and role in virulence of similar 
structures encoded by V. cholerae, V. vulnificus, and possibly E. coli. 
6.5. Function of Tap pili 
As mentioned in section 6.4, experiments conducted in this thesis indicate that 
Tap pili are not essential for gastrointestinal colonisation by Aeromonas species. 
Mutation of tapA did not affect the ability of A. veronii biovar sobria BC88 to adhere 
to cell lines or to intestinal tissue in vitro, or to colonise the intestinal tract of mice or 
rabbits. However, there are several other possibilities that could account for these 
observations 
Firstly, the experiments described in this thesis were conducted with a wild-
type and an isogenic tapA mutant strain of A. veronii biovar sobria BC88, both of 
which expressed functional Bfp pili. Recent experiments in our laboratory have 
demonstrated that Bfp pili mediate adhesion of BC88 to enterocytes and intestinal 
tissue (Kirov et al., 1999). Therefore, it is possible that the presence of Bfp pili on 
BC88tapA::f2 (tapA mutant) could mask the effect of the tapA:S2 mutation. 
Alternatively, the Bfp and Tap pili may have redundant roles in adhesion and 
colonisation. When the gene encoding the Bfp pilin is cloned and mutated, these 
possibilities will be able to be explored more fully. 
Another possibility is that the low levels, or complete lack, of assembly of Tap 
pili by A. veronii biovar sobria BC88 make the tapA:S2 mutation hard to 
characterise. Although A. veronii biovar sobria BC88 is a clinical strain isolated from 
a child with severe dysentery, this strain was isolated in 1980 and has been subjected 
to numerous subcultures. Many pathogenic bacteria lose the ability to express 
essential virulence factors following in vitro subculture. It is possible that this could 
account for why Tap pili are poorly expressed. Passage through the intestinal tract of 
test animals is known to increase toxin production by Aeromonas species (Singh and 
Sanyal, 1992b). In vivo passage of BC88 may be useful to investigate this possibility. 
Alternatively, investigations using recent clinical or environmental isolates of 
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Aeromonas species that have been subjected to minimal subculture could resolve 
these issues. 
Overall, results from this thesis indicate that Tap pili are not as important as the 
Bfp pili for intestinal colonisation by Aeromonas bacteria. However, all of the genes 
that comprise the tap gene cluster encode functional proteins and are widely 
conserved in both pathogenic and non-pathogenic Aeromonas species. The reason for 
this wide conservation is not known. Recently, it has been shown that the V. cholerae 
MSHA pilus is involved in adhesion to inorganic substrates (Watnick et al., 1999). 
Although MSHA pili exhibit greater homology to the Aeromonas Bfp pili, a similar 
role for Tap pili in environmental adhesion cannot be discounted. 
Another less likely possibility is that the tap gene cluster is conserved because 
of the role that tapD plays in the secretion of extracellular proteins. Hence, the 
remaining genes, tapABC, are retained simply because of their physical linkage to 
tapD. This theory, however, does not account for why tapABC encode functional 
proteins, or why expression of tapA has been maintained. If tapA plays no role in the 
biology of Aeromonas it would be expected that, at the very least, expression of this 
gene would cease due to the accumulation of random mutations. Expression of TapA 
would be maintained if this protein is directly involved in protein secretion. This idea 
is based on recent observations by Lu et al. (1997). In P aeruginosa, the TapA-
homologue, PilA, is the major subunit protein of the P. aeruginosa pili. However, 
PilA also forms part of the membrane structure responsible for extracellular protein 
secretion. PilA was shown to interact with another pilin-like protein, XcpT, and a 
defined mutation in pilA caused pleiotrophic defects in the secretion of elastase, 
exotoxin A and P-lactamase. It is unlikely, however, that TapA performs this 
function since mutation of tapA had no effect on the haemolytic, cytotoxic or 
enterotoxic activities of A. veronii biovar sobria. These phenotypes would be 
disrupted if TapA is involved in extracellular secretion of proteins. 
A final possibility is that TapA is secreted to divert an immune response, in a 
similar manner to the secretion of pilin proteins by pathogenic Neisseria species 
(Haas et al., 1987). It could be reasoned that this possibility is unlikely since 
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Aeromonas bacteria, unlike N. meningitidis and N. gonorrhoeae, are not obligate 
pathogens. Aeromonas bacteria are primarily water-borne organisms, so such a 
defined virulence mechanism would not be required. 
6.6. Further studies 
In conclusion, with respect to the tap gene cluster, there are several outstanding 
issues that need to be resolved. These are the subject of ongoing work in our 
laboratory. 
Firstly, additional investigations are required into the apparent difference 
between clinical and environmental isolates of A. veronii biovar sobria in the BamH I 
restriction fragment size to which tapA hybridises. For this study, strains typed by 
genetic methods are being used. The clinical strains should preferably be diarrhoeal 
isolates that have been isolated as the sole potential pathogen so as to maximise the 
chance that they represent pathogenic strains. Similarly, environmental isolates 
should be isolated from true environmental sources such as fresh surface water and 
soil sources. 
Studies that involve the shearing of filamentous surfaces from the cell surface 
have been used to demonstrate that Tap pili are assembled on the surface of A. 
hydrophila Ah65 (Dr. M. S. Strom, personal communication). However, their low 
level of expression complicates the investigation of these structures as adhesive 
organelles. This could be overcome by heterologous expression of Tap pili in P. 
aeruginosa, as has been done for the pili of Neisseria gonorrhoeae, Moraxella bovis, 
and Dichelobacter nodosus (Elleman et al., 1986; Elleman and Peterson, 1987; 
Mattick et al., 1987; Beard et al., 1990; Hoyne et al., 1992). P. aeruginosa strains 
with and without Tap pili on the cell surface could then be analysed using in vitro 
adhesion assays and in vivo colonisation models, assuming that methods allowing the 
expression of tapA in vivo can be established. The construction of these strains would 
also allow the role of Tap pili as adhesins in environmental settings to be established. 
With respect to further investigations of intestinal colonisation by Aeromonas, 
it is important that the genetic locus encoding the Bfp pilus is cloned, mutated and 
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characterised. A number of the traditional methods used to clone genes encoding 
type IV pili from other bacteria were investigated in this thesis. Initial studies 
involving the use of various DNA probes were not successful, presumably because 
the codon usage of the bfp gene(s) was not similar enough to the general Aeromonas 
codon usage (used in the degenerate oligonucleotide probe), or the codon usage of 
the V. cholerae mshA gene. The subsequent construction and screening of a cosmid 
DNA library for clones containing the bfp gene(s) was unsuccessful because these 
genes were not expressed in the host background, despite being transferred to an 
Aeromonas recipient. Unfortunately, the cosmid library could not be transferred to an 
Aeromonas strain expressing an antigenically-distinct Bfp pilus due to the low 
conjugation frequencies into these strains. 
Experiments outlined in chapter 3 did result in the cloning, by PCR, of a small 
region of a gene encoding the bfp pilin. The sequence of this small region has been 
used to design nested PCR primers, and it is hoped that these can be used to amplify 
the bfp-flanking DNA from a plasmid DNA library by inverse PCR. This approach 
should allow the identification of cosmid DNA clones containing the bfp gene(s), and 
the cloning and sequencing of these genes as well as analysis of flanking genes that 
may be involved in Bfp pilus expression and assembly. This will ultimately lead to 
the construction of strains lacking Bfp pili, and the investigation of these strains in in 
vitro adhesion and in vivo colonisation experiments. These studies are essential, as it 
appears that Bfp pili are structures that mediate intestinal adhesion and colonisation 
by Aeromonas bacteria. 
6.7. Conclusion 
In conclusion, this thesis has made a number of significant advances in our 
understanding of Aeromonas filamentous adhesins. Aeromonas species have been 
shown to encode two distinct families of type IV pili, Bfp and Tap. The type IV pili 
expressed on the surface of diarrhoeal isolates (Bfp pili) are not encoded by the tap 
gene cluster. Bfp pili are expressed under in vitro growth conditions, and progress 
was made on their genetic characterisation. The genes encoding Tap pili have been 
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cloned from a second species of Aeromonas, A. veronii biovar sobria. Experiments 
described in this thesis demonstrated that the tap gene cluster is widely conserved, 
and is very similar to gene clusters from pathogenic Vibrio species. Tap pili do not 
appear to be essential for colonisation of the gastrointestinal tract, although Tap pili 
were not demonstrated on the surface of A. veronii biovar sobria BC88 grown under 
standard culture conditions. However, the fact that all of the genes that comprise the 
tap cluster encode functional proteins, and that the subunit protein, TapA, is 
expressed, suggests that Tap pili are likely to play an important role in the biology of 
Aeromonas bacteria. Further work is required to investigate the role of this pilus in 
environmental settings, such as in biofilm development, and factors required for 
expression of these pili on the bacterial surface. 
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Appendix 1.1. Aeromonas veronii biovar sobria isolates used in this 
thesis 
Strain Isolation Typing method Source 
Clinical isolates 
123c stool ribotyping` Dr. M.J. Figueras 
129c stool ribotypingc Dr. M.J. Figueras 
147c stool ribotyping` Dr. M.J. Figueras 
15c stool ribotypingc Dr. M.J. Figueras 
187c blood ribotypingc Dr. M.J. Figueras 
189c stool ribotypingc Dr. M.J. Figueras 
206c stool ribotypingc Dr. M.J. Figueras 
20c ulcer ribotyping` Dr. M.J. Figueras 
215c stool ribotypingc Dr. M.J. Figueras 
234c stool ribotyping` Dr. M.J. Figueras 
55c stool ribotypingc Dr. M.J. Figueras 
74c stool ribotyping` Dr. M.J. Figueras 
78c stool ribotypingc Dr. M.J. Figueras 
79c stool ribotypingc Dr. M.J. Figueras 
93c stool ribotypingc Dr. M.J. Figueras 
Ael human diarrhoeal biotypinga Dr. M. Iwanaga 
Ae24 human diarrhoeal biotypinga Dr. M. Iwanaga 
AM 10111 human diarrhoeal biotypingd Dr. M.J. Albert 
AM 10978 human diarrhoeal biotypingd Dr. M.J. Albert 
AM 14078 human diarrhoeal biotypingd Dr. M.J. Albert 
AM18155 human diarrhoeal biotypingd Dr. M.J. Albert 
AM 18476 human diarrhoeal biotypingd Dr. M.J. Albert 
AM8998 human diarrhoeal biotypingd Dr. M.J. Albert 
BC101 human diarrhoeal biotypinga Dr. B.J. Chang 
BC126 human diarrhoeal biotypinga Dr. B.J. Chang 
BC88 human diarrhoeal ribotypingb Dr. B.J. Chang 
BC96 human diarrhoeal ribotypingg Dr. B.J. Chang 
CA 110 human diarrhoeal ribotypingg A/Prof. S.M. Kirov 
CA 112 human diarrhoeal biotypinga A/Prof. S.M. Kirov 
CA118a clinical biotypinga A/Prof. S.M. Kirov 
CA164 stool biotypinga A/Prof. S.M. Kirov 
CA 167 human diarrhoeal biotypinga A/Prof. S.M. Kirov 
CA17 human diarrhoeal biotypinga A/Prof. S.M. Kirov 
CA 18 human diarrhoeal biotypinga A/Prof. S.M. Kirov 
CA 199 stool biotypinga A/Prof. S.M. Kirov 
CA205.1 clinical biotypinga A/Prof. S.M. Kirov 
CA212.1 human diarrhoeal biotypinga A/Prof. S.M. Kirov 
CA217 stool biotypinga A/Prof. S.M. Kirov 
CA25 human diarrhoeal biotypinga A/Prof. S.M. Kirov 
CA26 clinical biotypinga A/Prof. S.M. Kirov 
CA29 human diarrhoeal biotypinga A/Prof. S.M. Kirov 
NZ107 stool biotypinga A/Prof. S.M. Kirov 
NZ2110 stool biotypinga A/Prof. S.M. Kirov 
NZ403 stool biotypinga A/Prof. S.M. Kirov 
TAP 13 human diarrhoeal biotypinga Dr. M. Iwanaga 
UTS7 human biotypingr Dr. J. Oakey 
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Strain Isolation Typing method Source/Reference 
Animal isolates 
111f shellfish ribotyping` Dr. M.J. Figueras 
AK176 live fish Rutilus rutilus DNA-DNA hybridisation` Dr. A. Kaznowski 
UTS13 koi carp anal swab biotypind Dr. J. Oakey 
UTS16 koi carp anal swab biotypind Dr. J. Oakey 
UTS17 koi carp anal swab biotypind Dr. J. Oakey 
UTS19 koi carp anal swab biotypingf Dr. J. Oakey 
UTS21 bull rout skin swab biotypingf Dr. J. Oakey 
UTS2lb bull rout biotypind Dr. J. Oakey 
UTS25 long neck tortoise anal biotypingf Dr. J. Oakey 
UTS29 long neck tortoise anal biotypind Dr. J. Oakey 
Environmental isolates 
124p fountain ribotypingc Dr. M.J. Figueras 
126 lake ribotyping` Dr. M.J. Figueras 
128 river ribotypingc Dr. M.J. Figueras 
347 river ribotypingc Dr. M.J. Figueras 
443 lake ribotyping` Dr. M.J. Figueras 
63 lake ribotyping` Dr. M.J. Figueras 
AK 12 water DNA-DNA hybridisation` Dr. A. Kaznowski 
AK279 sewage DNA-DNA hybridisation` Dr. A. Kaznowski 
AK413 water DNA-DNA hybridisation` Dr. A. Kaznowski 
AK59 water DNA-DNA hybridisation` Dr. A. Kaznowski 
AS 101 water biotypinga A/Prof. S.M. Kirov 
AS398 water biotypinga A/Prof. S.M. Kirov 
EA34 water ribotypingg A/Prof. S.M. Kirov 
EA39 water biotypinga A/Prof. S.M. Kirov 
EA42 water biotypinga A/Prof. S.M. Kirov 
EA49 water biotypinga A/Prof. S.M. Kirov 
EA50 water biotypinga A/Prof. S.M. Kirov 
EA57 water biotypinga A/Prof. S.M. Kirov 
EA60 water biotypinga A/Prof. S.M. Kirov 
P13 water biotypinga A/Prof. S.M. Kirov 
P14 water biotypinga A/Prof. S.M. Kirov 
P18 water biotypinga A/Prof. S.M. Kirov 
R207 water biotypinga A/Prof. S.M. Kirov 
S129 effluent ribotypingg A/Prof. S.M. Kirov 
S132 river ribotypingg A/Prof. S.M. Kirov 
S16 water ribotypingg A/Prof. S.M. Kirov 
a 	Biotyping performed as described by Kirov etal. (1986) 
Ribotyping performed as described by Martinetti Lucchini and Altwegg (1992) 
Ribotyping performed as described by Borrell etal. (1997) 
• Biotyping performed as described by Carnahan etal. (1991b) 
• DNA-DNA hybridisation performed as described by Kaznowski (1998) 
Biotyping performed as described by Oakey etal. (1996) 
• Ribotyping performed as described by Dorsch etal. (1994) 
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Appendix 1.2. Aeromonas hydrophila isolates used in this thesis 
Strain Isolation Typing method Source/Reference 
Clinical isolates 
Ae6 human diarrhoea! biotypinga Dr. M. Iwanaga 
Ah26 human diarrhoeal biotypinga Dr. A. Ho 
BC56 human diarrhoeal biotypinga Dr. B. J. Chang 
CA1 human diarrhoea! biotypinga A/Prof. S.M. Kirov 
CA111 human diarrhoeal biotypinga A/Prof. S.M. Kirov 
CA 114 human diarrhoeal biotypinga A/Prof. S.M. Kirov 
CAl2 human diarrhoea! biotypinga A/Prof. S.M. Kirov 
CA 162 human diarrhoea! biotypinga A/Prof. S.M. Kirov 
CA9 stool biotypinga A/Prof. S.M. Kirov 
P8 human diarrhoea! biotypinga A/Prof. S.M. Kirov 
Q 1 human diarrhoea! biotypinga A/Prof. S.M. Kirov 
Animal isolates 
Ah65 Rainbow trout ribotypingb Dr. M. S. Strom 
Environmental 
FAl29 poultrycarcass biotypinga A/Prof. S.M. Kirov 
FA131 poultrycarcass biotypinga A/Prof. S.M. Kirov 
FA136 poultrycarcass biotypinga A/Prof. S.M. Kirov 
FA145 poultrycarcass biotypinga A/Prof. S.M. Kirov 
EA32 river water biotypinga A/Prof. S.M. Kirov 
EA46 water biotypinga A/Prof. S.M. Kirov 
EA51 water biotypinga A/Prof. S.M. Kirov 
EA94 water biotypinga A/Prof. S.M. Kirov 
EA95 water biotypinga A/Prof. S.M. Kirov 
a Biotyping performed as described by Kirov etal. (1986) 
Ribotyping performed as described by Martinetti Lucchini and Altwegg (1992) 
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Appendix 1.3. Aeromonas caviae isolates used in this thesis 
Strain Isolation Typing method Source/Reference 
Clinical isolates 
CA 163 human diarrhoea! biotypinga A/Prof. S.M. Kirov 
CA 182 stool biotypinga A/Prof. S.M. Kirov 
CA 183 stool biotypinga A/Prof. S.M. Kirov 
CA185 stool biotypinga A/Prof. S.M. Kirov 
CA186 stool biotypinga A/Prof. S.M. Kirov 
CA195 human diarrhoeal ribotyping b A/Prof. S.M. Kirov 
CA196 stool biotypinga A/Prof. S.M. Kirov 
CA198 stool biotypinga A/Prof. S.M. Kirov 
CA202 human diarrhoeal biotypinga A/Prof. S.M. Kirov 
CA203 human diarrhoeal biotypinga A/Prof. S.M. Kirov 
CA207 human diarrhoea! biotypinga A/Prof. S.M. Kirov 
CA210 stool biotypinga A/Prof. S.M. Kirov 
CA214 human diarrhoeal biotypinga A/Prof. S.M. Kirov 
Environmental 
DH31 raw milk biotypinga A/Prof. S.M. Kirov 
DH61 raw milk biotypinga A/Prof. S.M. Kirov 
S5 river biotypinga A/Prof. S.M. Kirov 
S9 river biotypinga A/Prof. S.M. Kirov 
S30 effluent biotypinga A/Prof. S.M. Kirov 
a  Biotyping performed as described by Kirov etal. (1986) 
Ribotyping performed as described by Martinetti Lucchini and Altwegg (1992) 
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Appendix 1.4. Aeromonas reference strains and miscellaneous 
strains used in this thesis 
Strain Isolation Characteristics Source/Reference 
Reference strains 
A306 ATCC 7966 HG1 Dr. M Altwegg 
A307 CDC 9533-76 HG2 Dr. M Altwegg 
A308 CDC 1434-84 HG3 Dr. M Altwegg 
A309 ATCC 15468 HG4 Dr. M Altwegg 
A310 CDC 0862-83 HG5A Dr. M Altwegg 
A912 ATCC 23212 HG5B Dr. M Altwegg 
A311 ATCC 23309 HG6 Dr. M Altwegg 
A312 CIP 7433 HG7 Dr. M Altwegg 
A313 CDC 0437-80 HG8 Dr. M Altwegg 
A314 CDC 0787-80 HG9 Dr. M Altwegg 
A901 ATCC 35624 HG10 Dr. M Altwegg 
A902 CDC 1306-83 HG11 Dr. M Altwegg 
A903 ATCC 43700 HG12 Dr. M Altwegg 
A1792 LMG 17541 HG17 Dr. M Altwegg 
Other strains 
Pzl human diarrhoeal A. trota HG14 Dr. G Pazzaglia 
Pz2 human diarrhoeal A. trota HG14 Dr. G Pazzaglia 
Pz3 water A. trota HG14 Dr. G Pazzaglia 
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JM109 	F' {traD36 proAB + lacP lacZAM15} endAl recAl hsdR17 
mK+) supE44 thi-1 gyrA96relA1 A(lac-proAB) 
TOP1OF' 
S17-1 
S17-1kpir 
SMIO 
BL21(DE3) 
F' {lacP Tn10(Tee)} mcrA A(mrr-hsdRAIS-mcrBC) 
001acZAM15 AlacX74 deoR recAl araD139 A(ara-leu)7697 
galU galK rpsL(StrR) endAl nupG 
supE44 hsdR endAlrecA thi pro RP4-2-Tc::Mu 
supE44 hsdR endAlrecA thi pro RP4-2-Tc::Mu-kan::Tn7 
(Apir) 
thi thr leu tonA lacY supE recA::RP4-2-Tc::Mu 
F- ompT hsdS B(r,", m, -) gal dcm (DE3) 
Appendix 1.5. Escherichia coli strains used in this thesis 
Strain 	Properties 	 Source/Reference 
Promega, Madison, 
U.S.A.; Yanisch-
Perron et al. (1985) 
Invitrogen, San Diego, 
U.S.A. 
Simon etal. (1983) 
de Lorenzo and 
Timmis (1994) 
Simon etal. (1983) 
Novagen, Madison, 
U.S.A.; Studier and 
Moffatt (1986) 
Promega, Madison, 
U.S.A. 
M. J. Albert 
Gibco BRL, 
Gaithersburg, U.S.A. 
JM109(DE3) 
EC 101 
DH5oc 
F' {traD36 proAB + laclq lacZAM15} endAl recAl hsdR17 
mic+) supE44 thi-1 gyrA96 relAl A(lac-proAB) (DE3) 
K12 
F 480/acZAM15 recAl endAl gyrA96 thi-1hsdR17 (ric- mK 
supE44 relAl deoR A(1acZYA-argF)U169 
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Appendix 2. Plasmids used in this thesis 
Strain 	 Properties 	 Source/Reference 
E. coli-Pseudomonas shuttle vector, Amp R 
General purpose cloning vector, Amp' 
General purpose cloning vector, AmpR 
General purpose cloning vector, Kan' 
Cosmid cloning vector, Amp'', Tee 
His•tag fusion protein expression vector, Amp' 
Hisetag fusion protein expression vector, Amp R 
Encodes 17 lysozyme. Used to inhibit T7 RNA 
polymerase 
Broad-host-range cloning vector, Cm1 R 
1.2 kb Hind III fragment (pilA) from Pseudomonas 
aeruginosa PA01 cloned into pBluescript SK+ 
Chloramphenicol (cat) gene cassette flanked with 
pBluescript polylinker sequences 
1.0 kb BamH I fragment (tapA) from A. hydrophila 
Ah65 cloned into pBluescript II SK- 
2.7 kb Pst I fragment (tapD) from A. hydrophila 
Ah65 cloned into pBluescript II SK- 
tapil from A. hydrophila Ah65 cloned into pET15b 
3.3 kb Pst I fragment from pTB032 containing the 
tapA-proximal region from A. veronii biovar sobria 
BC88 cloned into pZEr0-2.1 
1.8 kb BamH I fragment from pG01 cloned into 
pZEr0-2.1 
1.0 kb EcoR V fragment from pG01 cloned into 
pZEr0-2.1 
2.6 kb SalIlEcoR I fragment (mshA) from Vibrio 
cholerae 01 Phil6973 cloned into pWKS130 
Omega interposon (f2) cloned into pUC19 
5.8 kb BamH I fragment from A. veronii biovar 
sobria BC88 identified by hybridisation with P001 
cloned into pGEM3zf(+) 
1.5 kb EcoR I / Kpn I fragment from pTB001 
cloned into pGEM3zf(+) 
Cloning vectors 
pUCP19 
pGEM-3z(f)+ 
pLitmus29 
pZEr0-2.1 
pHC79 
pQE32 
pET15b 
pLysS 
pBBR1MCS 
Recombinant plasmids 
pAW102 
pBSL121 
pCP1085 
pCP1089 
pCP1183 
pG01 
pG02 
pG03 
pGJX111 
pUC19n 
pTB001 
pTB002 
Schweizer (1991) 
Promega, Madison, 
U.S.A. 
New England Biolabs, 
Beverly, U.S.A. 
Invitrogen, San Diego, 
U.S.A. 
Hohn and Collins, 1980 
Qiagen, Hilden, 
Germany 
Novagen, Madison, 
U.S.A. 
Novagen, Madison, 
U.S.A.; Studier and 
Moffatt (1986) 
Kovach et al. (1994) 
R. A. Alm 
Alexeyev et al. (1995) 
Pepe et al. (1996) 
Pepe etal. (1996) 
M. S. Strom 
This thesis 
This thesis 
This thesis 
Jonson et al. (1994) 
Koga etal. (1993) 
This thesis 
This thesis 
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Strain 	 Properties 	 Source/Reference 
pTB003 5.8 kb BamH I fragment from p113001 cloned into 	This thesis 
pBBR1MCS 
p113004 	 1.2 kb BamH I fragment from A. veronii biovar 	This thesis 
sobria BC88 identified by hybridisation with P001 
cloned into pZEr0-2.1 
pTB005 	 0.69 kb BamH I fragment from A. veronii biovar 	This thesis 
sobria BC88 identified by hybridisation with P001 
cloned into pZEr0-2.1 
pTB006 	 0.74 kb BamH I fragment from A. veronii biovar 	This thesis 
sobria BC88 identified by hybridisation with P001 
cloned into pZEr0-2.1 
pTB011 	 1.0 kb BamH I fragment from A. veronii biovar 	This thesis 
sobria BC88 identified by hybridisation with tapA 
from A. hydrophila Ah65 cloned into pUCP19 
pTB012 	 1.0 kb BamH I fragment from pTB011 cloned into 	This thesis 
pGEM-3zf(+) 
pTB013 	 0.5 kb BamH I I Pst I fragment from pTB011 	This thesis 
cloned into pGEM-3zf(+) 
pTB014 	 1.0 kb Pst I I BamH I fragment from pTB011 	This thesis 
cloned into pGEM-3zf(+) 
pTB019 	 b/a-deleted version of pHC79 created by PCR with This thesis 
primers P006 and P007 
pTB020 	 1.9 kb BamH I fragment (mob) from pSUP201-1 	This thesis 
cloned into the EcoR I site of pTB019 
013022 	 1.0 kb BamH I fragment from pBSL121 (cat) 	This thesis 
cloned into the Bgl II site of pLitmus29 
pTB023 	 1.0 kb Pst I fragment from pTB022 (cat) cloned 	This thesis 
into the Pst I site of pTB020 
pTB024 	 111 bp EcoR V / BstU I fragment from pGJX111 	This thesis 
(mshA N-terminal region) cloned into the EcoR V 
site of pZEr0-2.1 
pTB025 	 0.45 kb fragment from A. veronii biovar sobria 	This thesis 
BC88 (tapA) generated by PCR with primers P004 
and P005, digested with BamH I I EcoR V and 
cloned into pQE32 
pTB028 	 0.44 kb fragment from A. veronii biovar sobria 	This thesis 
BC88 (tapA) generated by PCR with primers P013 
and P014, digested with Nde I I BglII and cloned 
into the Nde I I BamH I sites of pET15b 
pTB032 	 pTB023 cosmid clone identified by hybridisation 	This thesis 
with tapA and tapD from A. veronii biovar sobria 
BC88 
pTB037 	 78 bp fragment from A. veronii biovar sobria BC88 This thesis 
(bfp) generated by PCR with primers P023 and 
P024, digested with Hind III and Xba I and cloned 
into pZEr0-2.1 
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Appendix 3. Bacterial and tissue culture media 
3.1. Bacterial culture media 
Unless otherwise stated, all media were sterilised by autoclaving at 121°C for 
15 min. 
3.1.1. Minimal maintenance medium (MMM) 
Bacteriological agar (Oxoid L11) 	 5.0 g 
NaC1 	 5.0 g 
Bacteriological peptone (Oxoid L37) 	 2.5 g 
Neutralised bacteriological peptone (Oxoid L34) 	2.5 g 
Na2HPO4 .12H20 	 2.8 g 
KH2P 04 	 1.4g 
milliQ water to 	 1000 ml 
Dissolve by heating and adjust pH to 6.7. Dispense into 3 ml aliquots and 
sterilise by autoclaving. 
3.1.2. Glycerol freezing medium 
Bacteriological peptone (Oxoid L37) 	 1.0 g 
NaC1 	 0.5 g 
Glycerol 10.0 ml 
milliQ water to 	 100 ml 
Sterilise by autoclaving and dispense 1.5 ml aliquots into cryogenic vials. 
3.1.3. Tryptone soya broth + 0.6% yeast extract (TSBY) 
Tryptone soya broth (Oxoid CM 129) 
Yeast extract (Oxoid L21) 
milliQ water to 
Sterilise by autoclaving and store at room temperature. 
30.0 g 
6.0 g 
1000 ml 
3.1.4. Tryptone soya agar + 0.6% yeast extract (TSAY) 
Tryptone soya broth (Oxoid CM 129) 	 30.0 g 
Yeast extract (Oxoid L21) 	 6.0 g 
Bacteriological agar (Oxoid L11) 	 15.0 g 
milliQ water to 	 1000 ml 
Sterilise by autoclaving and store at room temperature. 
3.1.5. Luria-Bertani (LB) broth 
Tryptone (Oxoid L42) 	 10.0 g 
Yeast extract (Oxoid L21) 5.0 g 
NaC1 	 10.0 g 
milliQ water to 	 1000 ml 
Sterilise by autoclaving and store at room temperature. 
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3.1.6. Luria-Bertani (LB) agar 
Tryptone (Oxoid L42) 	 10.0 g 
Yeast extract (Oxoid L21) 5.0 g 
NaCl 	 10.0 g 
Bacteriological agar (Oxoid L11) 	 15.0 g 
milliQ water to 	 1000 ml 
Sterilise by autoclaving and store at room temperature. 
3.1.7. Terrific broth (TB) 
Tryptone (Oxoid L42) 	 12.0 g 
Yeast extract (Oxoid L21) 24.0 g 
Glycerol 	 4.0 ml 
milliQ water to 	 900 ml 
Sterilise by autoclaving. Allow the solution to cool and add 100 ml of sterile 
TB salts solution. Store at room temperature. 
3.1.8. TB salts solution 
KH2P 04 	 2.31 g 
K2HPO4 12.54g 
milliQ water to 	 100 ml 
Sterilise by autoclaving and store at room temperature. 
3.1.9. SOC medium 
Tryptone (Oxoid L42) 	 20.0 g 
Yeast extract (Oxoid L21) 5.0 g 
NaC1 	 0.5g 
1 M KC1 2.5m1 
milliQ water to 	 1000 ml 
Adjust pH to 7.0 and sterilise by autoclaving. Allow the solution to cool and 
add 10 ml sterile 1 M MgC1 2 and 20 ml sterile 18% glucose. Store at room 
temperature. 
3.1.10. Brain heart infusion broth (BHIB) 
Brain heart infusion broth (Oxoid CM225) 
milliQ water to 
Sterilise by autoclaving. 
37.0 g 
1000 ml 
3.2. Cell culture media 
3.2.1. Minimal essential medium (Eagle) with non-essential amino acids and 
Earl's salts (MEM) 
MEM powder (ICN 10-121-22) 	 9.61 g 
NaHCO 3 	 1.1 g 
milliQ water to 	 1000 ml 
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Filter sterilise and incubate for one week at 37°C to ensure sterility. Add 5 to 
10% foetal calf serum (FCS) as required. Store at 4°C. 
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Appendix 4. Antibiotics 
Stock solution 
50 mg/ml in water 
25 mg/ml in ethanol 
50 mg/ml in water 
50 mg/ml in water 
50 mg/m1 in water 
12.5 mg/ml in 1:1 water/ethanol 
200 mg/ml in methanol, 
made fresh 
Antibiotic  
ampicillin 
chloramphenicol 
kanamycin 
spectinomycin 
carbenicillin 
tetracycline 
rifampicin 
Final concentration 
100 pg/m1 
25 pg/ml 
50 pg/m1 
50 .t.g/m1 
100 vig/m1 
12.51.1g/m1 
200 Ag/m1 
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Appendix 5. Enzymes and immunochemicals 
Enzyme 	 Supplier 
Restriction enzymes 
BamH I 	 MBI Fermentas, Vilnius, Lithuania 
Bgl II MB! Fermentas, Vilnius, Lithuania 
BstU I 	 New England Biolabs, Beverly, 
U.S.A. 
EcoR I 	 MB! Fermentas, Vilnius, Lithuania 
EcoR V 	 MB! Fermentas, Vilnius, Lithuania 
Hind III MB! Fermentas, Vilnius, Lithuania 
Kpn I 	 MB! Fermentas, Vilnius, Lithuania 
Msp I MBI Fermentas, Vilnius, Lithuania 
Nde I 	 MBI Fermentas, Vilnius, Lithuania 
Pst I MB! Fermentas, Vilnius, Lithuania 
Sac I 	 MB! Fermentas, Vilnius, Lithuania 
Sau3A I 	 MB! Fermentas, Vilnius, Lithuania 
Xba I 	 MBI Fermentas, Vilnius, Lithuania 
Modifying enzymes 
DNA polymerase I large (Klenow) fragment 	 Promega, Madison, U.S.A. 
HotStarTaq DNA polymerase 	 Qiagen, Hilden, Germany 
RNase A 	 Boehringer Mannheim, Castle Hill, 
Australia 
T4 DNA ligase 	 Gibco, Gaithersburg, U.S.A. 
Immunoconjugates 
Goat anti-rabbit IgG-10 nm gold 
	 BioCell, Cardiff, U.K. 
Goat anti-rabbit IgG-alkaline phosphatase 	 Dako, Carpinteria, U.S.A. 
Rabbit anti-mouse IgG-alkaline phosphatase Dako, Carpinteria, U.S.A. 
Sheep anti-digoxygenin-alkaline phosphatase Fab 
	Boeluinger Mannheim, Castle Hill, 
Australia 
tetraoHis antibody (mouse monoclonal) 
	 Qiagen, Hilden, Germany 
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Appendix 6. Buffers and solutions 
6.1. DNA extraction 
6.1.1. 100 x TE buffer 
Tris base 	 12.1 g 
0.5 M EDTA 	 20m1 
milliQ water to 100 ml 
Sterilise by autoclaving. 
6.1.2. CTAB/NaCI solution 
hexadecyl-trimethyl-ammonium bromide 	10.0 g 
NaC1 	 4.1 g 
milliQ water to 	 100 ml 
Store at room temperature. 
6.1.3. STT buffer 
sucrose 	 8.0 g 
1M Tris-HC1, pH 8.0 	 5.0 ml 
Triton X-100 	 5.0 ml 
milliQ water to 100 ml 
Soter at room temperature. 
6.1.4. Solution I 
glucose 	 2.25 g 
Tris base 0.98 g 
0.5 M EDTA 	 5.0 ml 
milliQ water to 250 ml 
Sterilise by autoclaving. Store at 4°C. 
6.1.5. Solution II 
10% SDS 
milliQ water 
5 M NaOH 
Store at room temperature for up to one week. 
1.0 ml 
8.6 ml 
0.4 ml 
6.1.6. Solution III 
1(Ac 	 29.4g 
glacial acetic acid 	 11.5 ml 
milliQ water to 100 ml 
Sterilise by autoclaving and store at 4°C. 
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6.2. Agarose gel electrophoresis 
6.2.1. 50 x TAE buffer 
Tris base 
Na2EDTA.(2H20) 
glacial acetic acid 
milliQ water to 
Store at room temperature. 
242 g 
37.2g 
57.1 ml 
1000 ml 
6.2.2. Agarose gel loading buffer 
bromphenol blue 	 10 mg 
glycerol 	 2 ml 
20 mg/ml RNase A 	 0.5 ml 
milliQ water to 	 10 ml 
Store at 4°C. 
6.3. End-filling with Klenow fragment 
6.3.1. 10 x Klenow buffer 
1 M Tris-HC1, pH 8.0 	 20 Ill 
1 M MgC12 	 100 p1 
milliQ water to 1000 pl 
Store at —20°C. Dilute to 1 x and add 0.1U/[11Klenow DNA polymerase before 
use. 
6.3.2. dNTP mix 
10 mM dATP 
10 mM dCTP 
10 mM dGTP 
10 mM dTTP 
milliQ water to 
Store at —20°C. 
1.25 IA 
1.25 
1.25 pl 
1.25 IA 
100 il 
6.4. Preparation of competent E. coli 
6.4.1. Solution a 
1 M KAc 	 3.0 ml 
1 M KC1 10.0 ml 
1 M CaC12 	 1.0 ml 
1 M MnC12 5.0 ml 
glycerol 	 15.0 ml 
milliQ water to 	 100 ml 
Sterilise by filtration. Store at room temperature. 
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6.4.2. Solution 13 
1 M MOPS 	 1.0 ml 
1 M CaC1 2 7.5 ml 
1 M KC1 	 1.0 ml 
glycerol 15.0 ml 
milliQ water to 	 100 ml 
Sterilise by filtration. Store at room temperature. 
6.5. Preparation of cosmid DNA libraries 
6.5.1. Phage buffer 
1 M Tris-HC1, pH 7.4 
5 M NaC1 
1 M MgS0, 
milliQ water to 
Sterilise by filtration. Store at room temperature. 
6.6. Polymerase chain reaction 
6.6.1. 10 x PCR buffer 
1 M KC1 
1 M Tris-HC1, pH 8.4 
1 M MgC12 
milliQ water to 
Sterilise by filtration. Store at —20°C. 
0.2 ml 
0.2 ml 
0.1 ml 
10 ml 
5.0 ml 
1.0 ml 
150 IA 
10 ml 
6.7. DNA blotting and hybridisation 
6.7.1. 20 x SSC 
NaCl 	 175.3g 
sodium citrate 	 88.2 g 
milliQ water to 1000 ml 
Adjust pH to 7.0. Sterilise by autoclaving and store at room temperature. 
6.7.2. Hybridisation solution — high stringency 
20 x SSC 
10% sarcosyl 
10% SDS 
10% blocking reagent (Boehringer Mannheim) 
deionised formamide 
milliQ water to 
Store at 4°C. 
50.0 ml 
2.0 ml 
0.4 ml 
20.0 ml 
80 ml 
200 ml 
6.7.3. Hybridisation solution — low stringency 
20 x SSC 	 50.0 ml 
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10% sarcosyl 
10% SDS 
10% blocking reagent (Boehringer Mannheim) 
milliQ water to 
Store at 4°C. 
2.0 ml 
0.4 ml 
20.0 ml 
200 ml 
6.7.4. Buffer 1 
maleic acid 
NaC1 
milliQ water to 	 1000 ml 
Adjust pH to 7.5 with solid NaOH. Store at room temperature. 
6.7.5. Wash buffer 
Buffer 1 	 1000 ml 
Tween-20 3.0 ml 
Store at room temperature. 
6.7.6. Buffer 2 
Buffer 1 
10% blocking reagent (Boehringer Mannheim) 
Store at 4°C. 
6.7.7. Buffer 3 
1 M Tris-HC1, pH 9.5 
5 M NaC1 
1M MgCl2 
milliQ water to 
Store at room temperature. 
6.7.8. Lysis solution 
10 M NaOH 
5 M NaC1 
milliQ water to 
Store at room temperature. 
500 ml 
50 ml 
100 ml 
20 ml 
50m1 
1000 ml 
25 ml 
150 ml 
500 ml 
6.7.9. Neutralisation solution 
Tris base 
NaC1 
milliQ water to 
Adjust pH to 7.5. Store at room temperature. 
500 ml 
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6.8. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
6.8.1. 2 x Lugtenberg's 
1M Tris-HC1, pH 6.8 	 6.25 ml 
10% SDS 	 20.0 ml 
glycerol 10.0 ml 
P-mercaptoethanol 	 5.0 ml 
0.5% bromphenol blue 4.0 ml 
milliQ water to 	 50 ml 
Store at room temperature. 
6.8.2. Stock 1 acrylamide 
acrylamide 	 44.0 g 
bis-acrylamide 0.8 g 
milliQ water to 	 100 ml 
Store protected from light at 4°C. 
6.8.3. Stock 2 acrylamide 
acrylamide 	 30.0 g 
bis-acrylamide 0.8 g 
milliQ water to 	 100 ml 
Store protected from light at 4°C. 
6.8.4. Resolving gel (15%) 
stock 1 acrylamide 	 3.5 ml 
0.75 M Tris-HC1, pH 8.8 	 5.5 ml 
milliQ water 	 1.75 ml 
10% SDS 235 IA 
10% ammonium persulphate 	 50 1.11 
TEMED 	 8 
Mix gently and pipette into gel apparatus to within 1 cm from the bottom of the 
comb. Overlay gently with 0.1% SDS. Allow to polymerise for 30 min. 
6.8.5. Stacking gel 
stock 2 acrylamide 	 0.63 ml 
0.25 M Tris-HC1, pH 6.8 	 1.88 ml 
milliQ water 	 1.20 ml 
10% SDS 38p1 
10% ammonium persulphate 	 25 
TEMED 	 8 ill 
Mix gently. Remove 0.1% SDS overlay and pipette stacking gel onto resolving 
gel. Place comb and allow to polymerise for 30 to 60 min. 
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6.8.6. 5 x SDS-PAGE running buffer 
Tris base 	 15.1 g 
glycine 71.3g 
SDS 	 5.0 g 
milliQ water to 	 1000 ml 
Store at room temperature. Dilute to 1 x concentration before use. 
6.8.7. Coomassie stain 
Coomassie blue R250 (Bio-Rad) 	 2.5 g 
methanol 	 400 ml 
glacial acetic acid 	 100 ml 
milliQ water to 1000 ml 
Store at room temperature. 
6.8.8. Coomassie destain 
methanol 	 800 ml 
glacial acetic acid 	 200 ml 
milliQ water to 2000 ml 
Store at room temperature. 
6.8.9. Gel drying solution 
methanol 	 300 ml 
glycerol 100 ml 
milliQ water to 	 600 ml 
Store at room temperature. 
6.9. Protein blotting and detection 
6.9.1. Western transfer buffer 
Tris base 	 3.03g 
glycine 14.40g 
milliQ water to 	 500 ml 
Store at 4°C. 
6.9.2. 20 x TBS 
Tris base 	 48.5g 
NaC1 180.0 g 
milliQ water to 	 1000 ml 
Adjust pH to 7.5. Store at room temperature. 
6.9.3. TTBS 
20 x TBS 	 100 ml 
Tween-20 1 ml 
milliQ water to 	 2000 ml 
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Store at room temperature. 
6.9.4. Blocking solution 
bovine serum albumin 
20 x TBS 
20% NaN3 
milliQ water to 
Store at 4°C. 
30g 
50m1 
1 ml 
1000 ml 
6.9.5. Colour development solution 
1 M Tris-HC1, pH 9.5 	 100 ml 
5 M NaC1 	 20m1 
1M MgC12 50 ml 
milliQ water to 	 1000 ml 
Store at room temperature. Add 0.67 ml 5% NBT and 0.33 ml 5% BCIP per 
100 ml immediately before use. 
6.10. Expression and purification of recombinant TapA protein 
6.10.1. Sonication buffer 
1 M NaH2PO4, pH 7.8 
5 M NaC1 
milliQ water to 
Sterilise by autoclaving and store at room temperature. 
6.10.2. Suspension buffer 
1 M NaH2PO4, pH 7.8 
1 M Tris-HC1, pH 8.0 
milliQ water to 
Sterilise by autoclaving and store at room temperature. 
6.11. Electron microscopy 
6.11.1. Formvar 
formvar 
chloroform 
Store at room temperature. 
25 ml 
30m1 
500 ml 
50m1 
5 ml 
500 ml 
0.3 g 
100 ml 
6.11.2. TTB 
1 M Tris-HC1, pH 8.2 	 2.0 ml 
5 M NaC1 	 0.5 ml 
bovine serum albumin 	 0.1 g 
Tween-20 	 50 tl 
milliQ water to 	 100 ml 
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Filter sterilise and store at 4°C. 
6.11.3. Uranyl acetate 
uranyl acetate 	 0.1 g 
milliQ water to 10 ml 
Store protected from light at 4°C. 
6.12. Haemolysin assay 
6.12.1. Alsever's solution 
glucose 	 2.1 g 
sodium citrate 	 0.8 g 
NaC1 	 0.4g 
milliQ water to 	 100 ml 
Filter sterilise, dispense into 10 ml aliquots and store at —20°C. 
6.13. Cell culture 
6.13.1. 10 x PBS 
NaC1 	 80.0 g 
KC1 2.0 g 
Na2HPO4 	 14.4g 
KH2PO4 2.4g 
milliQ water to 	 1000 ml 
Adjust pH to 7.4 and sterilise by autoclaving. Store at room temperature. 
6.13.2. Trypsin solution 
trypsin 	 0.1 g 
PBS 100 ml 
Sterilise by filtration. Dispense into 3 ml aliquots and store at —20°C. 
6.13.3. pH 6.8 water 
Buffer (pH 6.8) tablets 	 1 
milliQ water to 	 1000 ml 
Sterilise by autoclaving and store at room temperature. 
6.13.6. May-Grunwald stain 
May-Grunwald stain 	 30 ml 
pH 6.8 water 	 30 ml 
Prepare immediately before use and filter sterilise. 
6.13.5. Giemsa stain 
Geimsa stain 	 5 ml 
pH 6.8 water 45 ml 
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Prepare immediately before use and filter sterilise. 
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Appendix 7. Oligonucleotides described in this thesis 
Name Description T. (°C) Compan 
M13f 5'-GTT TTC CCA GTC ACG AC-3' 
pUC/M13 forward (17mer) (-40) sequencing primer. 
52 Becicrnar 
M13r 5'-CAG GAA ACA GCT ATG AC-3' 
pUC/M13 reverse (17mer) sequencing primer. 
50 Beckmar 
T7 5'-TAA TAC GAC TCA CTA TAG GG-3' 56 Beckmar 
T7 RNA polymerase promoter sequencing primer 
P001 5'-ACC GCS GCS CCS AAG TTC TC-3' 68 Arnitof 
Degenerate oligonucleotide probe designed against Bfp pilin protein N- 
terminal amino acid sequence. Biotech 
P004 5'-AGG AGG ATC CAA ATG AAG AAA CAA TCG-3' 56 Beckmar 
Forward primer for amplifying tapA from A. veronii biovar sobria BC88 for 
cloning into pQE32. BamH I site is underlined. 
P005 5'-TTA GGG CTA GAT ATC AU ATT TGG-3' 48 Beckrnar 
Reverse primer for amplifying tapA from A. veronii biovar sobria BC88 for 
cloning into pQE32. EcoR V site is underlined. 
P006 5'-CCC CGA AAA GTG CCA CCT GCA GTC TAA GAA ACC-3' 82 Beckman 
Forward primer for deletion of bla from pHC79. Pst I site is underlined. 
P007 5'-CTG AU AAG CAT TGG TAA CTG CAG ACC AAG TTT ACT C-3' 80 Beckman 
Reverse primer for deletion of bla from pHC79. Pst I site is underlined. 
P010 5'-CCG GAT CCT CCC AGG AAC CAA GG-3' 48 Beckman 
Forward primer for amplifying tapA from A. hydrophila Ah65 for probe 
construction. BamH I site is underlined. 
P011 5'-CCA GGT ACC TAT TAG GGC TAG AGG-3' 46 Beckman 
Reverse primer for amplifying tapA from A. hydrophila Ah65 for probe 
construction. Kpn I site is underlined. 
P013 5'-TGA AGA AAC AAC ATA TGT TTA CCC TTA TTG-3' 62 Beckman 
Forward primer for amplifying tapA, without the leader sequence, from A. 
veronii biovar sobria BC88 for cloning into pET15b. Nde I site is 
underlined. 
P014 5'-CTA TTA GAT CTA GAG GTC AU AU TGG-3' 60 Beckman 
Reverse primer for amplifying tapA, without the leader sequence, from A. 
veronii biovar sobria BC88 for cloning into pET15b. Bgl II site is 
underlined. 
P015 5'-GTT GCC ATG ACA CTC GCA CC-3' 64 Beckman 
Forward primer for amplifying an internal 414 bp fragment of tapD from A. 
hydrophila Ah65 for probe construction. 
P016 5'-TCT GAT GGT GAT TGC GCA GC-3' 62 Beckman 
Reverse primer for amplifying an internal 414 bp fragment of tapD from A. 
hydrophila Ah65 for probe construction. 
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P019 5'-ATG ACI YTI ATH GAR YTI GT-3' 40 Gibco 
Degenerate forward primer used to amplify N-terminal region of bffi. from 
A. veronii biovar sobria BC88. 
P020 5'-ATH GTI ATH ATH ATH YTI GG-3' 40 Gibco 
Degenerate forward primer used to amplify N-terminal region of bfp from 
A. veronii biovar sobria BC88. 
P021 5'-TGI ARR TTI ARR AAY TTI GG-3' 40 Gibco 
Degenerate reverse primer used to amplify N-terminal region of bfii from A. 
veronii biovar sobria BC88. 
P022 5'-TTI ARR AAY TTI GGI GCI GC-3' 40 Gibco 
Degenerate reverse primer used to amplify N-terminal region of bfp from A. 
veronii biovar sobria BC88. 
P023 5'-GCA AGC TTA TGA CIY TIA THG ARY TIG T-3' 40 Gibco 
Degenerate forward primer used to clone N-terminal region of bfp from A. 
veronii biovar sobria BC88. Hind III site is underlined. 
P024 5'-GCT CTA GAT TIA RRA AYT TIG GIG CIG C-3' 40 Gibco 
Degenerate reverse primer used to clone N-terminal region of bfi, from A. 
veronii biovar sobria BC88. Xba I site is underlined. 
GM2 5'-CGA GCC ATA TCA GAT CGC-3' 56 Gibco 
Primer used to sequence from pG01. 
GM3 5'-GCC TGC TGA CCC TCT AU TTC-3' 64 Gibco 
Primer used to sequence from pG01. 
GM4 5'-GGG TCT GGA CAA AGT TC-3' 52 Gibco 
Primer used to sequence from pG01. 
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